Glycation of Extracellular Matrix: A Solid-State NMR Study by Li, Rui
 Glycation of Extracellular Matrix: 
A Solid-State NMR Study 
 
Rui Li 
 
 
          
 
 
Robinson College and Department of Chemistry 
University of Cambridge 
September 2019 
 
 
 
This thesis is submitted for the degree of Doctor of Philosophy. 
   
 Declaration 
This thesis is the result of my own work and includes nothing which is the outcome of work 
done in collaboration except as specified in the text. It is not substantially the same as any that 
I have submitted, or, is being concurrently submitted for a degree or diploma or other 
qualification at the University of Cambridge or any other University or similar institution. I 
further state that no substantial part of my dissertation has already been submitted, or, is being 
concurrently submitted for any such degree, diploma or other qualification at the University of 
Cambridge or any other University or similar institution. It does not exceed the prescribed word 
limit for the Degree Committee.  
 
 
 
Rui Li 
September 2019 
  
   
 Glycation of Extracellular Matrix:  
A Solid-State NMR Study 
Rui Li  
The main aim of this thesis is to investigate the glycation products, especially glycation 
intermediate products, generated in the glycation reaction model in vitro extracellular matrix 
(ECM) and ribose-5-phosphate using solid-state nuclear magnetic resonance (SSNMR) 
spectroscopy. The background and motivations of this project are outlined in chapter 1.  
 
Chapter 2 reviews the current understanding of the composition and organisation of the ECM, 
the structure of collagen and the critical roles collagen plays in the ECM. Chapter 3 introduces 
the glycation reaction and summarises the glycation products identified to date, with a 
discussion of the most widely-used characterisation techniques and in vitro model systems for 
studying the glycation reaction and glycation products. Chapter 4 covers the basic theory of 
SSNMR spectroscopy, which is the major analytical technique used in this thesis, and the 
principles behind the SSNMR experiments used in this project. Above three chapters provide 
the essential background knowledge for studying the glycation reaction chemistry and the 
glycation products in in vitro collagenous ECM model using SSNMR spectroscopy.  
 
Protocols for preparing, glycating and characterising in vitro ECM samples as well as all 
relevant experimental details are included in chapter 5, which is followed by a discussion in 
chapter 6 on the development of a method to extract collagen from in vitro ECM. In chapters 
7 and 8, glycation products identified in different in vitro glycation models using SSNMR are 
outlined, where chapter 7 focuses on glycation products derived from the glycation reaction 
between non-isotope-enriched collagenous materials and 13C-enriched glycating agents, while 
chapter 8 concentrates on the effects of glycation on lysine and arginine residues in collagenous 
samples using 13C, 15N-enriched collagenous materials and 13C-enriched glycating agents. 
Chapter 9 discusses the development of a protocol to extract cellular metabolites, specifically 
carbonyl metabolites, and estimate their glycation potential, in order to understand the 
contribution that cell necrosis may have on glycation in patients. Conclusion and future work 
are outlined in chapter 10.  
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1 Introduction 
Diabetes is an increasingly serious global problem due to the constantly high sugar level 
circulating in the body, causing numerous diabetic complications and ultimately affecting all 
organs and tissues. Though the pathology of diabetes and diabetic complications is complex 
and not fully understood, one of the factors is proposed to be a dramatic increase in the 
frequency of glycation and accumulation of advanced glycation end-products (AGEs). 
Glycation is a non-enzymatic chemical reaction between aldehyde groups of reducing sugars 
and protein amine groups, via a cascade of molecular rearrangements, oxidations, and 
crosslinking reactions, ultimately forming AGEs.  
 
The most likely candidates to be affected by glycation are long-lived proteins, such as collagen 
in the extracellular matrix (ECM) where the cellular protection mechanisms against glycation 
are not present. Glycation and AGE formation degrade ECM structure and mechanical strength 
of the tissue and disturb critical cell behaviours, including signalling, adhesion, proliferation 
and differentiation, eventually causing widespread cell necrosis. Cell necrosis, an inherent part 
of many diseases, potentially releases reactive metabolites into the ECM, prompting further 
ECM glycation and damage. Other consequences of glycation include the production of more 
reactive carbonyl species and reactive oxygen species, resulting in a vicious circle in which 
reactive molecules are produced in the ECM, triggering further ECM glycation and more 
deleterious effects.  
 
The glycation reactions are complex with many possible reaction routes, and their detailed 
mechanisms still remain poorly understood even after decades of research. Although some 
AGEs have been well-characterised in literature, increasing evidence suggests that it is not 
AGEs but glycation intermediate products that are primarily responsible for the structural and 
functional ECM changes caused by glycation.  
 
This project aims to uncover the structures of abundant glycation products, including both 
intermediate and end products, present at the complex chemical equilibrium of the glycation 
reaction in the ECM, and exploring their effects on collagen molecular structure and potentially 
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fibrillar organisation using a combination of solid-state Nuclear Magnetic Resonance (SSNMR) 
spectroscopy and multiple analytical techniques, including Transmission Electron Microscopy 
(TEM), fluorescence spectroscopy and biological assays. SSNMR spectroscopy can identify 
specific AGEs and probe the effects of glycation on the ECM structure and molecular dynamics 
down to the atomic level. We use vascular smooth muscle cell and osteoblast in vitro ECM as 
experimental models to mimic the pathological condition of diabetic blood vessels and bone, 
where diabetes pathology has particular deleterious effects, such as increased bone fragility 
and risk of fracture and increased risk of cardiovascular diseases. Our primary focus is the 
effect of glycation on collagen. Collagen fibrils constitute the dominant component of most 
ECM in the body and are essential for ECM organisation and cell support. We employ isotope 
labelling schemes in a range of selectively 13C- and 15N-enriched ECM and 13C-enriched 
biogenic glycating agents, U-13C5-ribose and U-13C5-ribose-5-phosphate, in order to overcome 
the sensitivity issue of SSNMR and use SSNMR spectroscopy to identify glycation products 
in the ECM and study the effects of glycation on the ECM. This approach allows us to look at 
the effects of glycation on specific amino acids, probe the glycation sites in collagen and 
identify the major glycation products. Such knowledge will advance approaches to inhibit the 
consequences of diabetic glycation and oxidative damage, and ultimately lead to more effective 
treatments for diabetes and diabetic complications.  
 
Primary glycation sites are on lysine and arginine, which are not only critical to balance charges 
on the collagen fibril surface but also essential to maintain normal cell function, integrin 
binding and cell recognition. Modifications by glycation on these residues is already known to 
result in abnormal cell behaviours, though the mechanism of disruption is not yet clear. Stiffer 
ECM in diabetic patients, normal ageing and even cancer, has been attributed to collagen 
crosslinks from glycation. However, our results here show that glycation crosslinks are 
relatively insignificant and unlikely to make a huge difference to ECM properties, while the 
major glycation products that cause all the pathological consequences of glycation are lysine 
and arginine sidechain modifications. We propose that instead of crosslink formation, the 
disruption of charge balance on the surface of collagen fibrils and the addition of bulky AGE 
substituents to collagen lysine and arginine sidechains makes a considerable contribution to the 
increases in collagen stiffness and other property changes.  
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2 Collagen and The Extracellular Matrix 
(ECM) 
The ECM is an essential non-cellular element of all tissues, such as skin, bone, blood vessels, 
etc. It fills the extracellular space and provides a physical scaffold for resident cells in almost 
every tissue. Additionally, the ECM involves in and regulates diverse cellular activities via 
cell-ECM interactions, which is essential to maintain tissue functions. The tissue-specific 
requirements on the ECM, such as structural, mechanical and biological properties, are 
achieved by its complex composition and organisation, which are under tight enzymatic 
regulation to maintain tissue homeostasis. Disrupted ECM composition or organisation 
potentially changes the ECM-cell interactions, affects tissue homeostasis and eventually leads 
to impaired tissue functions and diseases.  
 
The ECM is composed of two structurally distinctive components, which are the basement 
membrane (the BM) and the interstitial matrix (the IM). The BM is a specialised form of the 
ECM which bridges between resident cells and the IM. The 3D architect of the ECM is built 
by hundreds of different types of proteins, polysaccharides and water in a tissue-specific 
manner. All the ECM components collaboratively achieve the intact ECM structure and 
functions.  
 
This chapter reviews essential ECM composition and functions with a special focus on collagen 
because collagen, as the major ECM component, plays diverse and essential roles to maintain 
tissue structural integrity and overall tissue homeostasis and guarantee the specialised tissue 
functions. Alterations in the collagen structure can lead to disrupted ECM composition or 
organisation and impaired cell-ECM interactions, ultimately causing a variety of diseases and 
tissue dysfunctions.  
 
Most information included in this chapter is from Cell Biology of Extracellular Matrix [1], if 
not specifically cited.  
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2.1 Collagen 
In mammals, the ECM is composed of around 300 proteins with different sizes and functions. 
The most prevalent ECM protein is collagen, which is found in many tissue ECMs, such as 
skin, bone, blood vessels, cartilage, etc. For example, in bone ECM, collagen can make up ~90% 
its dry weight [2]. This ubiquitous distribution of collagen suggests that collagen is a versatile 
biomaterial that can match tissue-specific requirements, such as providing tissue scaffolds, 
supporting biological functions and meeting mechanical requirements.  
 
This section reviews collagen structure and organisation and briefly covers the diverse roles 
collagen plays in the ECM and its relations to diseases, in order to provide key background 
knowledge for studying and understanding collagen structure and property changes under 
diseased conditions, i.e. glycation later in this thesis.  
 
Unless specific cited in the text, information is summarised from the following books: Collagen: 
Primer in Structure, Processing and Assembly [3], Collagen: Structure and Mechanics [4] and 
Fibrous Proteins: Structures and Mechanisms (Chapter 14) [5]. 
2.1.1 The Collagen Family 
Collagen is a family of structural proteins sharing a unique secondary structure: the triple helix. 
This distinctive triple helix is formed by an association of three left-handed polypeptide chains, 
called a chains, in a right-handed manner. Three a chains within one collagen molecule can 
be identical, forming a homotrimer, or different, forming a heterotrimer. Up to now, forty-two 
a chains have been identified, giving rise to a total of twenty-eight collagen types. [6][7][8]  
 
Besides triple helical domains (or collagenous domains, COL domains), collagen molecules 
have non-collagenous domains (NC domains). Depending on the location, length and number 
of NC domains, the collagen family is categorised into subfamilies, such as fibrillar collagens, 
network-forming collagens, the fibril-associated collagens with interrupted triple helices 
(FACITs), membrane-associated collagens with interrupted triple helices (MACITs), multiple 
triple helix domains and interruptions (MULTIPLEXINs), etc. (Table 2-1).   
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Fibrillar collagens are the most abundant collagen types. They have the fewest number of NC 
domains per molecule, only occurring at either side of the COL domain, in the N- and C-termini 
(an example molecule is shown in Figure 2-1 A). Among different fibrillar collagens, this work 
focuses on collagen type I, the most widely occurring collagen found in skin, tendon, bone, 
cornea, lung and the vasculature. Major collagen types relevant to this project are detailed in 
Table 2-2. 
 
Table 2-1 Twenty-eight types of collagens are numbered by Roman numerals from I to XXVIII. 
They can be divided into different categories based on their molecular and 
aggregation structures, including but not limited to fibrillar collagens, network 
collagens, the fibril-associated collagens with interrupted triple helices (FACITs), 
membrane-associated collagens with interrupted triple helices (MACITs) and 
multiple triple helix domains and interruptions (MULTIPLEXINs). [7]  
Category  Type 
Fibrillar I, II, III, V, XI, XXIV, XXVII 
Network IV, VI, VIII, X 
FACIT IX, XII, XIV, XVI, XIX, XX, XXI, XXII, XXVI 
MACIT XIII, XVII, XXIII, XXV 
MULTIPLEXIN XV, XVIII 
Others VII, XXVIII 
 
Table 2-2 Major collagen types mentioned in this project. a chains are numbered by Arabic 
numerals. Collagen type IV has two different molecular compositions. [9] 
Type a Chain Composition Structural Features Tissues 
Fibrillar Collagens 
I [a1(I)]2a2(I) 300 nm long molecules, forming 
periodic fibrils 
Skin, tendon, bone, etc.  
III [a1(III)]3 300 nm long molecules; often with 
type I 
Skin, muscle, blood 
vessels, etc. 
V a1(V)a2(V)a3(V) 390 nm long molecules with globular 
N-terminal domain; often with type I 
Similar to type I; cell 
cultures, foetal tissues 
Network Collagen 
IV [a1(IV)]2, a2(IV) 
a3(IV), a4(IV), a5(IV) 
Two-dimensional parallelogram 
network 
All basal laminas 
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2.1.2 Collagen Molecules 
Before folding into a triple helix, a chains are transcribed and translated from specific collagen 
genes, and extensively post-translationally modified by enzymes, including hydroxylation of 
proline (P) and lysine (K) to hydroxyproline (O) and hydroxylysine (Hyl) respectively, and 
glycosylation of Hyl. Three a chains then associate to form a procollagen molecule with a 
central, long COL region and two NC regions on each side, called N- and C-propeptides. 
Propeptides are removed by enzymes, leaving short N- and C-telopeptides. The removal of the 
propeptide segments transforms procollagen into collagen (Figure 2-1 B). Typical collagen 
type I molecules are composed of three a chains with ~1000 amino acids each, giving a 
molecule of ~300 nm in length (L) and ~1.5 nm in diameter (d).  
 
 
Figure 2-1 A: A fibrillar collagen molecule is composed of a uninterrupted central collagenous 
region (COL region) and NC regions, N-terminus and C-terminus, on each side of 
its COL region. B: Three a chains associate into a collagen molecule, via a 
procollagen. This figure is modified from Figure 1 in reference [10].  
The Collagen Triple Helix: Structure and Stability  
The collagen triple helix is stabilised by several factors. Each a chain has a conformation of 
three residues per turn, and every third residue in the triple helical region has to be the smallest 
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amino acid, glycine (G) [11]. This arrangement ensures G is always at the axial centre of a 
triple helix and its sidechain (-H) allows a close approach of the three a-chains and a tightly 
wound triple helix. It also makes a collagen molecule composite a multiple of G-X-Y repeating 
tripeptides (Figure 2-2). The X and Y positions can be occupied by any amino acids but are 
most often occupied by P (28%) and 4-hydroxyproline (O) (38%) respectively. Of all possible 
G-X-Y combinations, the most frequently occurring motif in collagen is GPO (10.5%) [7][12].  
 
Figure 2-2 Collagen triple helix is composed of three a chains and each a chain has three 
residues per turn and is entirely composed of G-X-Y repeats to ensure G is always 
at the centre of a triple helix to allow tight packing.  
 
P and O stabilise triple helices by their specific steric restrictions posed by their puckered rings. 
O at Y positions further stabilises the triple helix via a stereoelectronic effect. The stabilisation 
effects of P and O on the triple helix structure are well studied using collagen-like model 
peptides. [3][5][7][13] When the X and Y positions are not occupied by P and O, interchain 
salt bridges between two charged residues may also contribute to collagen triple helix stability. 
[14] 
 
Additionally, the triple helix is stabilised by interchain hydrogen bonds primarily between the 
backbone N-H group of G and the backbone C=O group of the X position amino acid on the 
adjacent chain (N-H(G) ⋯  O=C(X)) across the axis of the triple helix (Figure 2-3). Other 
hydrogen bonds are also proposed either mediated by water or bonded directly between 
residues; some of them are identified in the crystal structures of collagen-like peptides. For 
example, Ca-H(G/Y) ⋯ O=C(X/G) or N-H(X) ⋯ O=C(G) or N-H(X) ⋯ H2O ⋯ O=C(G) when the X 
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position is not occupied by P or O. Hydroxyl groups on O can also participate in hydrogen 
bonding. [3][5][15] 
 
It is worth noting that the collagen triple helix pitch changes along the sequence. Imino acid-
rich regions are more tightly wound than imino acid-dilute regions. Pure GPO molecules are 
closer to a 7/2 helix, while native collagen type I is closer to a 10/3 helix [16]. Also, local 
arrangements within collagen higher-order structures affect local triple helix conformation [16].  
 
Figure 2-3 An illustration of collagen interchain hydrogen bonding, indicated by black dotted 
lines, between the N-H groups of G and C=O groups of the residue on X position, 
here P.  
The Non-Collagenous (NC) Domains 
NC domains are essential to collagen structure at both molecular and fibril level. They play an 
important role in triple helix folding and fibril formation [17]. They also include sites for 
intermolecular crosslinks to stabilise collagen higher-order structures [18][19]. 
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2.1.3 Collagen Fibrils and Higher-Order Structures in the ECM 
In the ECM, collagen molecules participate in higher-order assemblies in a complex and 
hierarchical manner to ultimately form tissue scaffolds and achieve biological functions. In 
terms of fibrillar collagens, the first step is to form collagen fibrils.  
 
In collagen type I rich fibrils, five collagen molecules pack laterally with a D stagger between 
adjacent molecules [20] (Figure 2-4 top). Because L (the length of each collagen molecule) is 
not an integral multiple of D (in the tendon, D = ~ 67 nm = ~ 0.22 L), this packing will result 
in gap zones and overlap zones. Generally speaking, gap zones (~ 0.54 D) are longer than 
overlap zones (~ 0.46 D). These alternating gap- and overlap-zones along the fibril give the 
unique banding patterns seen in EM images.  
 
While G is packed around the triple helix inner axis, sidechains of residues at X and Y positions 
tend to point outwards interacting with neighbouring molecules and these intermolecular 
interactions, electrostatic and hydrophobic interactions [21], are suggested to drive fibril 
formation and maintain fibril stability. Collagen fibrils are further stabilised by enzymatically-
derived crosslinks between collagen molecules via K or Hyl residues in terminal NC regions, 
such as dehydro-hydroxylysino-norleucine (deH-HLNL) and dehydro-lysinonorleucine (deH-
LNL). These divalent crosslinks can then undergo further reaction to form mature trivalent 
crosslinks, such as lysyl pyridinoline (L-Pyr) and hydroxylysyl pyridinoline (HL-Pyr) (Figure 
2-4 bottom) [22]. Depending on the developmental stage of collagenous tissues, additional 
non-enzymatic crosslinks are also found, commonly derived from the glycation reaction (will 
discuss in Chapter 3). Unlike well-regulated enzymatic crosslinks, glycation-derived crosslinks 
are not regulated by enzymes, but formed via pure chemical reactions, and often associated 
with ageing and pathologies.  
 
In the ECM, collagen fibrils are not comprised solely of one collagen type; they are co-
assembled from different collagen types and NC proteins and eventually construct the different 
complex hierarchical structures of different tissues in order to adapt their tissue-specific 
requirements. For example, so-called type I collagen fibrils also contain a minor quantity of 
collagen type III in skin [23] and blood vessels [24]. The presence of major collagen types, 
such as collagen type I, and minor collagen types, such as collagen type III and V, in collagen 
fibrils in different tissues is relatively well-studied and their roles in different tissues are slowly 
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being revealed. Quantitatively minor collagen types are suggested to be critical to collagen 
fibril formation in initiating fibril genesis and regulating fibril diameters. For example, collagen 
type V and XI in tendon have been suggested to regulate fibril assembly in developing tendon 
[25].  
 
 
 
 
Figure 2-4 Top: Collagen molecules assemble with a D stagger between two molecules along 
their long axis and pack laterally with other four molecules into collagen fibrils. 
This molecular organisation within collagen fibrils results in gap zones and overlap 
zones and gives banded patterns in electron micrographs. Enzymatic crosslinks 
further stabilise collagen fibrils (indicated by the black wavy lines). Bottom: 
Chemical structures of example enzymatic crosslinks.  
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2.1.4 Roles of Collagen 
The primary function of collagen is to provide mechanical stability required by different tissues. 
For example, in blood vessels, the collagen scaffold is assembled to resist multidirectional 
stresses, whereas in tendon or bone, the collagen superstructure is required to resist axial stress. 
The mechanical properties of collagen fibrils primarily are suggested to depend on the 
enzymatic crosslinks and their maturation and are also related to the minor collagen types co-
assembled in the fibrils. Addition of glycation crosslinks may change the mechanical properties 
of collagen fibrils.  
 
Collagen also have ligand binding sites for other ECM proteins and can achieve biological 
functions via collagen-cell surface receptor interactions. Collagen-protein and collagen-cell 
interactions play an important role in regulating ECM composition and structure as well as cell 
behaviours, such as adhesion, migration or proliferation. For example, GFOGER sequences on 
collagen are recognised by several integrins to transmit biological information between cells 
and their extracellular environments [26]. This means modifying some amino acid sites can 
easily affect cell-ECM communications.  
 
Collagen, as well as many other ECM components, is not a static structure but is under dynamic 
remodelling. Collagen is constantly deposited, degraded and modified in the ECM, which is 
mediated strictly by different enzymes, such as matrix metalloproteinases (MMPs) and lysyl 
oxidase [27]. Modified collagen may also interrupt this regular remodelling, causing abnormal 
collagen accumulation.  
2.2 The ECM, Collagen and Diseases 
The ECM components and organisation are vital to both structural and functional homeostasis 
of tissues. However, abnormal ECM structure and function can result from both internal factors, 
such as genetic mutations and imbalanced enzymatic activities, and external factors, such as 
oxidative stress and non-enzymatic glycation reactions (see Chapter 3). Given its significance 
in regulating cell behaviours, any defect in the ECM can contribute to alterations of cellular 
pathways, eventually leading to tissue dysfunction and the development or progression of 
diseases.  
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A long list of diseases has been observed to associate with abnormal ECM structure or 
composition (either causing the disease or resulting from the disease), such as ageing, the 
development of diabetic complications, cancer genesis and progression. Consequently, the 
ECM can be treated as diagnostic and therapeutic targets for the above-mentioned diseases. 
Hence, a better understanding of both native ECM and diseased ECM will contribute to the 
development of novel therapies of ECM related diseases. [27][28]  
Ageing, Diabetes and Diabetic Complications 
Numerous changes have been observed in the ECM when tissues age, involving compositional, 
structural and mechanical changes. ECM changes associated with diabetes and diabetic 
complications are similar to those associated with ageing, suggesting common mechanisms 
behind those ECM changes. In this regard, diabetes is considered as accelerated ageing.  
 
Increased stiffness has been observed in aged and diabetic tissues, which is widely attributed 
to the increase of crosslinking in aged tissues. The profile of enzymatic crosslinks changes with 
age from immature bivalent crosslinks to mature trivalent crosslinks, which is attributed to age-
related mechanical property changes [22]. A second crosslinking origin recognised in aged 
tissues is glycation-derived crosslinks, a type of advanced glycation endproducts (AGEs) (see 
Chapter 3) [29][30]. However, whether the increase in crosslinks is the main reason behind 
age/diabetes-related tissue stiffening and which crosslink molecules contribute the most to the 
increased stiffness remain unrevealed.  
Cancer 
Cancerous tissues have been demonstrated to be stiffer than the surrounding normal tissues and 
the increased stiffness has been suggested to promote cancer progression in breast cancer via 
cancer cell-ECM interactions [31][32]. Increased collagen crosslinking and stiffening has been 
suggested to contribute to breast cancer invasion [33]. However, more work needs to be done 
to fully understand the molecular mechanism driving cancer ECM stiffening.  
2.3 Non-Collagenous ECM Proteins 
Other than collagen, various NC proteins, including proteoglycans (PGs), glycoproteins (GPs), 
etc., fill the space between cells and collagen scaffold in the ECM, providing connections 
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between collagen fibrils and between collagen fibrils and cells. Even though NC proteins are 
in minor quantities relative to collagen, their relative amount and composition of the NC 
proteins defines tissue features such as viscoelasticity. The structural modifications of NC 
proteins can also disrupt cell-ECM communications and lead to deleterious consequences. [34]  
 
Minor proteins are present in lower amounts than collagens in in vivo tissues, thus their roles 
and their changes in diseases are much less documented compared to the major collagen types. 
In this project, the in vitro ECM used to mimic diseased ECM contains, in theory, most of the 
NC proteins - some might be lost during the decellularisation process – and therefore allows 
study of NC protein changes under disease conditions. A brief introduction to some NC 
proteins is included in this section to provide insights on possible changes related to ECM NC 
proteins in diseases.  
Proteoglycans (PGs)  
PGs are a group of proteins, consisting of a protein core with covalently-bonded 
glycosaminoglycan (GAG) chains. Hyaluronic acid (HA) is a special case in the PG family; it 
is not bound to a protein core but consists entirely of a long GAG chain. The most abundant 
ECM PGs are the small leucine-rich proteoglycans (SLRPs), which are characterised by 
relatively small protein cores containing leucine-rich repeats [35]. Because of the presence of 
GAG chains, the PG family members are negatively charged and extremely hydrophilic; 
therefore, they can interact with surrounding water molecules to maintain the hydration level 
of the ECM. GAGs with their surrounding water network are suggested to make a contribution 
towards resistance to compressive stress for tissues. [36][37][38] 
 
Additionally, the PG family participates in a wide variety of activities, including regulating 
cell behaviours, collagen fibrillogenesis and ECM assembly. In the ECM, PGs interact with 
collagen via their protein cores and bridge between collagen fibrils to maintain the 
macrostructure of the ECM. [28][39] 
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Elastin (ELN) 
ELN is critical to the elasticity and resilience of tissues, especially to tissues under repeated 
cycles of stretching and compressing such as blood vessels and the lung. In some aortic tissues, 
ELN can make up to 40% of dry, defatted tissue weight. [40] 
 
In terms of amino acid composition, ELN is rich in hydrophobic and nonpolar amino acids. It 
has similar G and P molar ratios to collagen, ~33% and ~10% respectively and contains a small 
number of O. It is crosslinked similarly to collagen, via lysine derivatives. This amino acid 
composition and crosslinked nature make ELN insoluble and chemically inert.  
 
ELN is the predominant protein to form elastic fibres that allow tissues to extend and recoil. 
Different elastin isoforms and elastic fibre morphologies from different assemblies are 
observed in different tissues to accommodate diverse tissue functions. [34][41][42] 
Fibronectin (FN) 
FN is a fibril-forming and cell-interacting ECM protein, which plays roles in mediating cell 
adhesion with the ECM and cell migration.  
 
FN is extensively glycosylated and therefore, is categorised as a glycoproteins (GP). The GPs 
family describes glycosylated proteins with oligosaccharides covalently attached to specific 
amino acid residues, usually Asn, Ser or Thr. Around 200 different GPs have been identified 
in the ECM, covering a diverse range of structures and functions. They usually have multiple 
protein-binding domains to bind to cell surface receptors, collagen, PGs and other ECM 
components to realise the two-way communications between cells and ECM components. 
[1][43] 
Other Remarks 
A significant number of ECM components has been identified so far, including 28 types of 
collagen, more than 30 PGs, around 200 GPs, etc. Besides the major structural components 
reviewed above, many other proteins, such as growth factors and enzymes, and lipids are 
present in the ECM and essential to both the ECM and resident cells. [28][44] Within the 
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integral ECM, all components interact with one another and cells to maintain tissue integrity 
and homeostasis.  
2.4 Summary 
The ECM is a complex and dynamic structure that works as an important microenvironment 
for cells in almost all tissues. The complex ECM architecture is built by a sophisticated 
assembly of ~300 different ECM components, including water, collagen, proteoglycans, etc., 
and they are all under tight enzymatic regulations to maintain structural integrity and ensure 
tissue functions. Dysregulation can easily lead to abnormal ECM composition and structure 
and ultimately affect cell behaviours and tissue function.  
 
The ECM is more than a physical scaffold for tissues. All the ECM components actively 
participate in mechanical and biological roles to complete full tissue functions. Constant and 
two-way cell-ECM communications exchange mechanical and biological information, which 
is critical to tissue homeostasis. Aberrant ECM can trigger different metabolic pathways and 
contribute to many diseases, such as diabetic complications and cancer.  
 
Increases in tissue stiffness have been observed in aged, diabetic and cancerous tissue ECM, 
implying a similar pathological reason behind the stiffening in each case. One of the widely 
accepted reasons behind these pathologies is that increased glycation crosslinking alters 
mechanical properties, manipulates cell-ECM interactions and disrupts the regular collagen 
remodelling. However, direct evidence is still lacking to associate observed age-related 
changes to crosslinked collagen. Moreover, in vivo tissue ECM have non-collagenous 
components, which may also be affected by diseases.  
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3 The Glycation Reaction 
The glycation reaction was first discovered and studied by food scientists as the browning 
effect. Only over recent decades, has glycation in biological systems been investigated 
intensively because of its implications in diseases, including ageing [45][46], diabetes and its 
complications [47][48][49][50][51][52], Alzheimer’s disease [53][54][55][56] and cancer 
[57][58][59]. The pathologies of glycation are suspected to be very similar in all disease 
contexts, though as yet there has been no systematic study and the mechanisms behind the 
pathology are not fully understood. The belief is that the pathological species are advanced 
glycation endproducts (AGEs) formation and their accumulation in tissues.  
 
This chapter includes the current understanding of the glycation reaction, reviews glycation 
products identified in different in vivo and in vitro systems, and evaluates commonly used 
characterisation techniques, in order to identify what is lacking in this research field and further 
advance the studies on the glycation chemistry and glycation products.  
3.1 Glycation and Advanced Glycation Endproducts (AGEs)  
Glycation is a non-enzymatic reaction between an amino group in proteins, DNAs and lipids, 
and a carbonyl group, such as reducing sugars, going through Maillard reaction, Amadori 
rearrangement and a cascade of subsequent reactions, eventually forming AGEs.  
 
The whole process is extremely complicated with numerous possible routes, but a simplified 
scheme between a reducing sugar and a protein is shown in Figure 3-1. The glycation reaction 
is a pure chemistry reaction, i.e. not dependent on any enzymes, starting from nucleophilic 
attack of the amine group in the protein on the aldehyde group in the reducing sugar, forming, 
via a Schiff base, an Amadori product. Up to this point, the reaction is reversible. After 
formation of the Amadori product, a series of irreversible steps occur, including oxidation and 
dehydration, generating a complex group of glycation intermediates and eventually leading to 
the formation of AGEs.  
 
Complications are introduced by several different possible reaction pathways during the 
glycation process, as indicated in Figure 3-1. Reducing sugar, Schiff base and Amadori 
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products can go through oxidation or degradation, forming more reactive (di-)carbonyl 
intermediates. The (di-)carbonyl intermediates (some examples are listed in Table 3-1) are 
much more reactive than the original reducing sugars and therefore can trigger more vigorous 
glycation reactions and generate more glycation products. Free radicals have also been detected 
during the glycation process, further increasing the variety of reaction routes and enlarging the 
pool of glycation products [60][61][62][63][64]. 
 
 
Figure 3-1 A simplified scheme of the glycation reaction, starting from reducing sugar and a 
protein, via Schiff base and Amadori product, and a cascade of reactions, ultimately 
forming advanced glycation endproducts (AGEs). 
 
Protein glycation with reducing sugars primarily occurs at e-amino groups on K and Hyl and 
to some extent, the guanidino group on R. The presence of amino groups of protein terminal 
residues can also initiate the glycation reaction with reducing sugars. Glycation products have 
also been identified on residues other than K, Hyl and R, such as amino groups on H (from 
reaction with malondialdehyde) [65] and W (from reaction with glucose, likely from reaction 
with dicarbonyl compounds) [66] and sulfhydryl group on C (from reactions with 
methylglyoxal, glyoxal and glyceraldehyde) [67][68]. Even though the sulphide on M can be 
susceptible to nucleophilic attack, the reaction requires stronger electrophiles than reducing 
sugars and the common carbonyl species generated in the glycation reaction process; therefore, 
it is not likely to happen.  
 
AGEs generally fall into two categories: monovalent amino acid sidechain modifications, such 
as Ne-(carboxymethyl)lysine (CML), and divalent crosslinks between two residues, such as 
pentosidine and glucosepane (Figure 3-2), which are both crosslinks between K and R residues.  
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Although some AGEs have been identified in native tissues and in model systems (reviewed 
in section 3.4), and model AGE compounds have been synthesised, there is little known about 
the reaction steps and glycation intermediates between Amadori products and most AGEs in 
the glycation process.  
 
Table 3-1 Examples of possible reactive carbonyl or dicarbonyl intermediates generated in the 
glycation process [69][70].  
Reactive intermediates  Formula Structures 
Carbonyl Species 
Glycolaldehyde CH2OH-CHO 
 
Glyceraldehyde  CH2OH-CHOH-CHO 
 
Dicarbonyl Species 
Methylglyoxal (MGO) CH3-C(O)-CHO 
 
Glyoxal (GO) OHC-CHO 
 
3-Deoxyglucosone (3-DG) OHC-C(O)-CH2-(CHOH)2-CH2OH 
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Figure 3-2 Structures of some well-characterised AGEs: CML, pentosidine and glucosepane. 
3.2 Consequences of Glycation 
Two biologically relevant consequences can result from glycation. The first one is protein 
structure modifications and subsequent loss/ alteration of function. For example, decreased cell 
adhesion and spreading have been observed on glycated collagen matrix [71][72]. The second 
one is AGEs binding to receptors for AGEs (RAGEs) on cell membrane, triggering abnormal 
cell signalling pathways and enhancing ROS production, which can further promote the 
glycation reaction. RAGEs activation and subsequent cellular activities are implicated in 
contributing to the development of diseases, such as diabetic complications and cancer 
progression. [50][58] 
3.2.1 Consequences of Collagen Glycation 
Collagen provides the framework and mechanical strength for many tissues and interacts with 
many different types of cells. This collagen-cell interaction is essential in maintaining tissue 
homeostasis. However, collagen glycation has the potential to interrupt the regular collagen-
cell interactions and threaten normal tissue function. Additionally, collagen is a long-lived and 
slow-turnover structural protein, that can accumulate a significant amount of glycation 
products to potentially induce long term pathological damages.  
 
Consequences of collagen glycation are considered from three aspects here and explained in 
the following sections. However, those consequences are correlated rather than independent of 
one another.  
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Destabilising Collagen Organisation 
AGE formation can change the charge distribution on collagen surface. For example, under 
physiological pH, converting a K residue into CML adds a negatively-charged carboxymethyl 
moiety on the originally positively-charged sidechain of K (Figure 3-3). This charge 
distribution alteration has the potential to affect intermolecular electrostatic interactions, 
critical to collagen fibril assembly and thus, cause misalignments of collagen molecules in 
fibril assembly.  
 
In addition, glycation by adding a sugar adduct or derivative thereof to a free amino group of 
collagen K or R changes the bulkiness of their sidechains, which potentially affects the tight 
packing of collagen molecules and leads to local swelling in collagen fibrils.  
  
Figure 3-3 Under physiological pH, the K sidechain is positively-charged. When 
carboxymethyl-lysine (CML) forms, an extra negatively-charged carboxymethyl 
functionality at the end of the original K sidechain can alter the charge distribution 
in collagen and the bulkiness of the sidechain.  
 
Collagen glycation has been suggested to target at the same K/Hyl sites in triple helical domain 
as enzymatic crosslinks and affect the establishment of enzymatic crosslinks [73]. This possible 
interference of collagen K/Hyl glycation with enzymatic crosslinks may also affect the collagen 
molecular arrangement in the fibrils and the ability of those arrangements to be restored, e.g. 
after a tensile force. 
 
Other work (unpublished) in the Duer group has shown that the positions of positively-charged 
residues K and R are the most conserved of any amino acids in mammalian collagens. Thus, 
we anticipate that alterations of these residues by glycation can potentially have profound 
effects not yet discovered. 
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Impairing Collagen Biological Functions 
Glycation products have the potential to hinder binding of ligands at essential biological 
functional sites on collagen molecules via several possible mechanisms, such as chemical 
structure modification, steric hinderance and electrostatic repulsion, and thus, impair collagen 
biological functions.  
 
The sidechain charge alteration caused by glycation can probably influence the collagen-
protein interactions in tissue ECMs. It has been reported that KSPGs, with negatively-charged 
GAG chains, show weaker affinity towards glycated collagen than non-glycated collagen [72]. 
It is hypothesised that this reduced affinity is contributed by increased repulsion between 
glycated collagen molecules and the negatively-charged glycan groups on the KSPGs; it is also 
possible that the binding sites for KSPGs on collagen are modified during the glycation reaction 
and the loss of some binding sites causes the reduced affinity. As PG-collagen interactions 
have been proposed to regulate cell-ECM interactions, this weaker affinity between KSPGs 
and glycated collagen may further affect fundamental cell behaviours, such as adhesion and 
migration, which is also shown in the study [72].  
 
Decreased cell adhesion and proliferation on glycated collagen versus non-glycated collagen 
have been observed in other work [71], where it is proposed to relate to the glycation 
modification of R in specific integrin binding sites on collagen and result in subsequent 
decrease in integrin-mediated cell adhesion. Nonetheless, the exact mechanisms behind 
reduced collagen-protein interactions and altered cell behaviours caused by glycation are not 
clear.  
Altering Collagen Fibril Mechanics 
AGE crosslinks are believed to underlie changes in mechanical properties of glycated collagen 
fibres compared to non-glycated collagen, such as increased stiffening and breaking load [74]. 
However, mechanical properties of glycated collagen are usually measured on a macroscopic 
level, such as on a piece of glycated tissue or collagen fibres extracted from tissues [75][76], 
and there is still little known about the effects of collagen glycation and AGE accumulation on 
mechanical properties at different structural levels of collagen, in particular at the molecular 
level. In addition, whether the formation of AGE crosslinks is the sole reason underlying 
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collagen stiffening and other mechanical changes remains to be confirmed. It is important to 
underline that no study has yet characterised the full distribution of glycation products present 
in a tissue and so the presence of other glycation products in glycated collagen may yet to be 
shown to play a role in the changes of collagen mechanics.  
3.3 In vivo Relevance of AGEs  
The formation and accumulation of AGEs in aged and diseased tissues has long been suggested 
to contribute to the genesis and development of diseases. However, how exactly the glycation 
reaction and accumulation of AGEs causes tissue impairment and dysfunction is still poorly 
understood. This section includes evidence of AGEs in aged and diseased tissues in order to 
provide an overview of the possible relationship between AGEs and diseases.  
Ageing 
A number of AGEs have been identified in aged tissues, and the concentrations of AGEs are 
found to be age-dependent (Table 3-2). For example, carboxymethyl-lysine (CML), one of the 
most characterised AGEs, has been identified in human lens proteins, skin and tendon collagen 
[77][78][79]. The CML level in lens protein increases dramatically with age, with CML 
representing 0.02 to 0.8% of the total lysine residues in lens proteins aged 0 to 79-year-old. 
This age-dependent accumulation of AGEs has long been proposed to trigger age-related 
diseases.  
 
However, those studies only focus on one or two AGEs. Whether other AGEs or glycation 
intermediates are present or accumulate in aged tissues is not clear; neither is the relative 
concentrations between different AGEs and glycation intermediate products.  
  
 23 
Table 3-2 The concentrations of some AGEs in tissues are found to linearly increase with age. 
CML, carboxymethyl-lysine; CMhL, carboxymethyl-hydroxylysine; pentosidine 
and glucosepane are glycation crosslinks between Lys and Arg.  
AGEs Tissues Concentrations Ref 
CML Human lens protein  
Human skin 
~7 mmol CML/ mol Lys at age 80 
~1.5 mmol CML/ mol Lys at age 80 
[77] 
[78] 
CMhL Human skin ~5 mmol CMhL/ mol Hyl at age 80 [78] 
Pentosidine Human dura mater ~250 pmol/ mg collagen around age 100 [80] 
Glucosepane Human skin ~2000 pmol/ mg collagen at age 90 [81] 
 
Diabetes and Diabetic Complications 
AGE formation and accumulation occur at a much more accelerated rate under diabetic 
conditions [30][82][83]. For instance, glucosepane level can go up to 4000 pmol/ mg collagen 
in diabetic patients versus around 2000 pmol/mg in non-diabetic patients at the same age [84]. 
 
The amount of AGEs detected in tissues has been reported to correlate with the severity of 
diabetic complications by some immunohistochemical studies. For example, the amount of 
CML and pentosidine in diabetic renal tissues increases with the severity of diabetic 
nephropathy [85][86]. AGE accumulation potentially causes proteins to be resistant to 
enzymatic degradation and may account for part of the BM thickening in diabetic nephropathy.  
 
Also, upregulated RAGE expression has been reported in diabetic nephropathy [86] and AGE-
RAGE interactions are known to trigger abnormal cellular pathways and lead to cell death [87], 
suggesting a potential role of AGE-RAGE interactions in diabetic nephropathy and tissue 
dysfunction.  
 
Many studies suggest that there is a close relationship between AGE accumulation and diabetic 
complications, but a clear relationship is not yet established. Some hypothesises have been 
proposed: in diabetes, hyperglycaemia provides excess circulating glucose as glycating agents, 
so higher glucose concentration can be attributed to the underlying reason for the accelerated 
glycation rate and elevated AGE levels detected in diabetic patients. Additional and more 
reactive metabolites can be generated from altered metabolisms in diabetes to facilitate the 
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glycation reaction, such as fructose, both exogenous and endogenous, and fructose metabolites 
[88]. For example, elevated polyol pathway, converting glucose to fructose via sorbitol, in 
diabetes has been suggested to correlate with the development of diabetic neuropathy [89]. 
 
However, few studies have mentioned the co-presence of glycation intermediate products and 
examined their contribution towards diabetic complications and tissue failure. Most research 
published to date only focuses on one or two AGEs at a time without an assessment of other 
AGEs and glycation intermediate products. Therefore, whether the detrimental effects 
associated with diabetic complications is contributed to what extent by AGEs and to what 
extent by the glycation intermediates is not known.  
Cancer 
The concentration of AGEs was identified to be elevated in cancerous tissues and correlated 
with aggressiveness of cancer. Higher CML level is observed in prostate cancer tissues 
compared to non-cancerous tissues, and it is higher in malignant tumour tissues than benign 
tumour tissues [59]. Moreover, RAGEs are found overexpressed in a variety of cancers, such 
as in prostate, breast and lung cancers, suggesting both AGEs and AGEs-RAGEs interactions 
play a role in cancer genesis and progression. [58][90] 
 
Cancer cells usually uptake more glucose than healthy cells to generate the energy for their 
rapid proliferation, leading to a higher rate of glycolysis [91]. Alterations of several other 
metabolic pathways in cancer metabolism are also under investigation, such as increased 
pentose phosphate pathway activity for antioxidant and nucleotide production to support cancer 
cell survival and invasion. We propose here that this altered cancer cell metabolism might 
provide a more diverse collection of glycating agents to the surrounding ECM than present in 
normal tissues, resulting in more vigorous glycation reactions.  
 
Diabetic patients are found to associate with a higher risk of some cancers, such as liver and 
pancreas cancers, according to some epidemiological studies [92]. Although the exact 
underlying mechanism for this association between diabetes and cancer remains unclear, 
glycation induced changes in diabetes/hyperglycaemia, including elevated AGE accumulation, 
AGE-RAGE binding and consequential alteration of cellular pathways, ROS overproduction, 
 25 
etc., all together are speculated to generate a pro-cancerogenic condition and link diabetes and 
cancer. [57][93][94][95] 
3.4 Glycation Studies in Literature  
Glycation has been intensively investigated for decades in different systems to understand the 
chemistry behind glycation, aiming to (1) use glycation products as biomarkers for disease and 
(2) find targeted therapeutic methods to prevent the effects of glycation and eventually reverse 
them. However, due to the complex chemistry of glycation, glycation chemistry is still not yet 
fully understood, and AGEs generated from this complicated reaction pathway are far from 
fully identified. Additionally, no one has studied the glycation intermediate products.  
 
In order to study and identify unknown glycation products, especially glycation intermediate 
products, a list of glycation products identified in both in vivo systems and physiological in 
vitro systems over the past decades is reviewed in this section to compare glycation products 
identified in this work and previously in literature. Their names are numbered, and their 
structures are included in the Appendix. It is not surprising that most of the glycation products 
identified to date are AGEs; little is known between the transition from Amadori products to 
AGEs. Later in this section, commonly used analytical techniques for glycation studies are 
evaluated to identify their advantages and disadvantages and whether they are suitable for 
studying glycation intermediate products.  
3.4.1 Glycation Products Identified in In vivo Studies  
Glycated proteins, haemoglobins, were first detected in diabetic patients’ blood in 1969 [96]; 
but not until the early 1980s, glycation of long-lived proteins was brought to attention and 
proposed to contribute to tissue ageing and the development of diabetic complications. Since 
then, a number of glycation products have been identified in in vivo collagen-rich tissues, 
mostly aged or diabetic tissues.  
 
AGEs that have been detected in in vivo tissues are summarised in Table 3-3, including the 
techniques utilised to identify AGEs. Usually, biological samples are digested, either acid 
hydrolysis or enzymatic digestion, before using HPLC to separate and purify the species of 
interest, and then, the species of interest is confirmed by HPLC coupled fluorescence 
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spectroscopy or mass spectrometry or both. Sometimes, the HPLC separated AGEs are further 
studied by NMR spectroscopy to reveal chemical structures. Some research has been 
performed on biological fluids, such as urine and blood, probably because they are easier to 
sample and analyse, and those AGEs may also present in collagenous tissues.  
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Table 3-3 Glycation products have been identified in different in vivo systems using different analytical 
techniques. Many of them are studied in in vitro systems to obtain pure products and characterise 
the pure products prior to moving on to in vivo systems. Most of them are detected to be at a 
relatively low level in healthy or young tissues and higher quantities in aged or diabetic tissues. 
Their chemical structures and 13C NMR chemical shifts (from solution-state NMR) assigned in the 
literature are included in Appendix. AA, amino acid involved forming the glycation product; SIM-
GC/MS, selected ion monitor mode of gas chromatography and mass spectroscopy; ICS, 
immunohistochemical staining.  
No. Glycation Products AA In vivo Systems 
Detection 
Methods 
AGEs - Amino Acid Sidechain Modifications 
1  Ne-(carboxymethyl)lysine  
(CML) 
Lys Normal and aged human lens proteins [77] 
Human skin collagen of different ages [78] 
SIM-GC/MS 
SIM-GC/MS 
2  Ne-(carboxymethyl)hydroxylysine  
(CMhL) 
Lys Human skin collagen of different ages [78] SIM-GC/MS 
3  Ne-(carboxyethyl)lysine  
(CEL) 
Lys Various normal and diabetic human and 
animal tissues [97] 
Healthy human and diabetic rat blood [98] 
 
 
LC-MS/MS 
4  Pyrraline Lys Alzheimer’s disease tissue sections [53] 
Induced diabetic rats [99] 
ICS 
5  GA-pyridine Lys Human aorta  [100] ICS 
6  Methylglyoxal hydroimidazolone  
(MG-H1) 
Arg Various normal and diabetic human and 
animal tissues [97] 
Healthy human and diabetic rat blood [98] 
 
 
LC-MS/MS 
7  Glyoxal hydroimidazolone  
(G-H1) 
Arg Various normal and diabetic human and 
animal tissues [97] 
Healthy human and diabetic rat blood [98] 
 
 
LC-MS/MS 
8  3-Deoxyglucosone 
hydroimidazolone (3DG-H)  
Arg Healthy human and diabetic rat blood [98] LC-MS/MS 
9  Argpyrimidine Arg Diabetic tissues [101] 
Healthy human and diabetic rat blood [98] 
ICS 
LC-MS/MS 
10  Tetrahydropyrimidine  
(THP) 
Arg Diabetic tissues [102] ICS 
11  S-(carboxymethyl)cysteine  
(CMC) 
Cys Diabetic patients blood and urine [103]  
Rat liver mitochondrial [104] 
LC-MS 
GC-MS 
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12  S-(carboxyethyl)cysteine  
(CEC) 
Cys Diabetic patients blood and urine [103] LC-MS 
AGEs - Crosslinks 
13  Pentosidine Lys, 
Arg 
Human skin, aged and diabetic [49] 
Human skin, diabetic and non-diabetic [105] 
HPLC-FLUO 
 
14  Glucosepane  Lys, 
Arg 
Various normal and diabetic human and 
animal tissues [97] 
 
15  Methylglyoxal-lysine dimer 
(MOLD) 
Lys Aged lens protein and skin collagen [106] 
Healthy human blood [98] 
LC/MS 
16  Glyoxal-lysine dimer  
(GOLD) 
Lys Aged lens protein and skin collagen [106] LC/MS 
17  Lysine-dihydropyridinium 
(K2P) 
Lys Human lens protein [107] LC-MS/MS 
Intermediates 
18  Fructose-lysine 
(FL) 
Lys Normal and aged human lens proteins [77] 
Human skin collagen of different ages [78] 
Various normal and diabetic human and 
animal tissues [97] 
SIM-GC/MS 
SIM-GC/MS 
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3.4.2 Glycation Products Identified in In vitro Physiological 
Model Systems 
Because of the complexity in studying glycation in in vivo systems, much research has done in 
in vitro model systems with a wide selection of glycation substrates, including protected amino 
acids, small protein and pure collagen, and a variety of glycating agents, such as hexose, 
pentose, oxoaldehydes. A list of glycation products identified in different in vitro systems is 
summarised in Table 3-4.  
 
Table 3-4 shows that most glycation products are identified in model systems using either an 
amino acid mixture, such as N-acetyl-lysine and N-acetyl-arginine, or small proteins with 
known sequences or functions, such as bovine serum albumin (BSA). These relatively small 
and soluble glycation substrates provide access to glycation products in relatively short reaction 
time and the glycation products can be characterised easily by a number of analytical 
techniques. However, to some extent, these in vitro systems lack the biological relevance of 
what happens in diseased tissues. Formation of glycation products in collagen fibrils, the focus 
of this work, can be prohibited by a number of structural factors/restrictions posed by the 
complex collagen hierarchical structure, which is absent in amino acid solutions or small 
plasma proteins like human serum albumin (HSA). For example, the formation of glycation 
crosslinks requires two reactive residues that are spatially close and sterically able to interact, 
either within the same collagen molecule or between collagen molecules, which are less likely 
in collagen fibrils than small and flexible proteins. Therefore, it is not unexpected that some of 
the glycation products identified in vitro are not identified in glycated collagen fibrils.  
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Table 3-4 Glycation products have been identified in different physiological in vitro model systems using 
different analytical techniques. Their chemical structures and 13C NMR chemical shifts (from 
solution-state NMR) assigned in the literature are included in Appendix. AA, amino acid involved 
forming the glycation product; Glc, glucose; BSA, bovine serum albumin; Rib, ribose; GO, glyoxal; 
MGO, methylglyoxal; 3-DG, 3-deoxyglucosone; 3-DP, 3-deoxypentosulose; HSA, human serum 
albumin. 
No. Glycation products AA In vitro Model systems Detection Methods 
AGEs - Amino Acid Sidechain Modifications 
19  N-(carboxymethyl)arginine 
(CMA) 
Arg Collagen and Glc [108] MS, 1H NMR 
AGEs - Crosslinks 
20  Pentosinane  
(precursor of pentosidine) 
Lys, 
Arg 
BSA and Glc/Rib/xylose/arabinose [109] NMR 
21  Glyoxal-derived-imidazoline-
crosslink (GODIC) 
Lys, 
Arg 
BSA and GO/Glc [110] HPLC-UV, NMR 
22  Methylglyoxal-derived-
imidazoline-crosslink (MODIC) 
Lys, 
Arg 
BSA and MGO/Glc [110] NMR 
23  DOGDIC Lys, 
Arg 
BSA and 3-DG/3-
DP/Glc/Rib/xylose/arabinose [109] 
NMR 
24  DOPDIC Lys, 
Arg 
BSA and 3-DG/3-DP/Rib/xylose/arabinose 
[109] 
NMR 
25  Arg-hydroxy-triosidine Lys, 
Arg 
Human corneas and GA [111] HPLC-UV-MS 
NMR 
26  Vesperlysine A, B and C Lys BSA and Glc [112] NMR 
27  3-Deoxyglucosone-lysine dimer  
(DOLD) 
Lys Hippuryl-lysine and 3-DG [113] HPLC 
NMR 
28  GALA Lys Na-t-Boc-Lys and Rib/Glc [114] NMR 
29  GOLA Lys Na-t-Boc-Lys and Rib/Glc [114] NMR 
30  Glucose lysine dimer  
(GLUCOLD) 
Lys BSA and Glc [115] NMR 
31  Lys-hydroxy-triosidine Lys Human corneas and GA [111] HPLC-UV-MS 
NMR 
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3.4.3 Analytical Techniques 
Another problem raised by the majority of existing studies is that most of them, to some extent, 
are targeted to identify specific glycation products rather than mapping all possible glycation 
products in a model system, due to the inherent limitations of the analytical techniques used in 
those studies. This section evaluates the advantages and disadvantages of the main analytical 
techniques used to date to measure glycation products of collagen. [116][117]  
Liquid Chromatography-Mass Spectroscopy (LC-MS) 
AGEs are mostly identified by a combination of chromatography and mass spectroscopy, 
traditionally LC-MS and more advanced HPLC-MS/MS. These techniques require the least 
amount of sample (around 10µg protein) compared to other techniques discussed below and 
can produce quantitative results. However, these LC-MS-based techniques require standard 
compounds of each glycation product of interests to be made and examined before testing a 
complex biological mixture. However, concerns exist regarding preanalytical sample 
processing associated with this technique. Even though enzyme digestion is replacing 
traditional acid hydrolysis of collagenous tissues, revealing some acid-labile glycation products 
previously unidentified, there is no verified protocol to prepare protein samples to map all 
glycation products. Insufficient release of glycation products can be a problem when glycation 
products hinder proteolysis sites. Moreover, errors can be introduced during ionisation in the 
MS step, because the ionisation of some glycation products can cause oxidation and/or 
dehydration. For example, fructose-lysine (FL) can degrade to CML during ionisation [118].  
Immunohistochemical staining by antibodies 
Immunohistochemical staining has been used to map spatial distribution of some specific 
glycation products in native tissues [101].  
 
This technique has a few drawbacks. First, the antibodies used are often not standardised, and 
different laboratories tend to raise their antibodies. Second, the specificity of antibodies against 
the targeted glycation product is questionable. Antibodies can cross-react with substances that 
share similar molecular structures with their targets. For example, an antibody against CML, 
6D12, is found to react with CEL as well. [118][119] Third, the detection also depends on the 
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penetration depth of the antibody into the tissue sample, which can result in unreproducible 
results. Moreover, quantification methods relying on antibodies, such as ELISA assays, often 
do not offer an absolute concentration of substrate but only relative comparisons between 
samples, which makes it difficult to compare its results with results from other techniques.  
Fluorescence 
Some AGEs are fluorescent, offering the opportunity to monitor their presence by relatively 
simple and non-invasive fluorescence detection.  
 
However, most AGEs are not fluorescent and therefore cannot be detected. Moreover, 
fluorescence emission from different fluorescent AGEs overlap with each other extensively so, 
fluorescence spectra are not able to identify nor quantify specific glycation products, but only 
able to follow some part of the glycation process qualitatively. Other fluorophores, such as 
oxidation products like dityrosine, may coexist in biological samples, further interfering with 
glycation fluorescence measurement.  
Nuclear Magnetic Resonance (NMR) Spectroscopy 
Some AGEs are identified by solution-state NMR spectroscopy. Chemical structures of AGEs 
are analysed based on their 1H or/and 13C chemical shifts. Most of the AGEs generated in in 
vitro incubation are characterised by solution-state NMR spectroscopy; some AGEs in vivo 
tissues are purified by HPLC and then identified by solution-state NMR spectroscopy.  
 
In addition, solid-state NMR spectroscopy is considered as an emerging technique in this field 
and has the advantage of simplicity and minimal sample preparation – lyophilisation.  
3.5 Summary: A Novel In vitro Glycation Model System 
The glycation reaction and the accumulation of AGEs in tissues are widely accepted to 
associate with ageing, the development of diabetic complications and cancer genesis. A huge 
amount of work has been done aiming to unveil the mechanism behind AGE accumulation and 
disease pathologies, but the relationship between the accumulation of AGEs and disease 
genesis and development is still not fully understood.  
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Most research to date has focused on measuring only one or two AGEs under diseased 
conditions with special attentions on glycation crosslinks. However, all the deleterious effects 
caused by glycation cannot possibly be attributed to one or two AGEs. Considering the 
complex chemistry of the glycation process, a variety of glycation products can be generated 
at different stages of the glycation process, intermediates and endproducts, and are likely to all 
be present at some concentration in aged and diseased tissues, and therefore, consequences of 
glycation are probably caused by a collective effect of all AGEs and glycation intermediates 
present at glycation equilibria.  
 
However, little is known about the glycation intermediate products in biological systems, not 
to mention the relative amount of different AGEs and different glycation intermediates. One 
or two AGEs present in minor quantities are not likely to cause all the detrimental effects 
described in the previous sections. More studies are needed to identify glycation intermediate 
products, study the effects of glycation intermediate products and assess the relative 
significance between AGEs and the glycation intermediates.  
 
In order to mimic the glycation reaction and identify biologically relevant glycation products 
in vitro, the glycation model system needs to be optimised to best represent in vivo situation. 
Therefore, a novel model system is used in this work in order to produce glycation products 
that are more representative of in vivo situations, and solid-state NMR spectroscopy is used to 
profile all glycation products present at the glycation equilibria, with a focus on glycation 
intermediate products generated in this model system.  
Choice of the Glycation Substrate 
Collagen dominated in vitro ECMs are used as the primary glycation substrate in this project. 
It has been shown that in vitro ECM from osteoblasts mimic in vivo bone tissues [120]. The in 
vitro ECM bridges the gap in understanding of glycation chemistry between amino acid 
mixtures and small proteins and native tissues.  
Choice of the Glycating Agent 
In theory, any chemical with a carbonyl functional group, ketones or aldehydes, can potentially 
react as a glycating agent. However, two factors need to be taken into consideration. The first 
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one is the biological relevance of the carbonyl species, i.e. whether they are generated by 
metabolism and likely to be present in ECMs in vivo. The second one is their glycation rates. 
Glycating agents with rapid glycation rate are more likely to generate detrimental effects in a 
short time scale. It is also desirable to use an in vitro model glycating agent where the product 
equilibrium distribution is reached within a manageable timescale.  
 
Glucose is clearly the most biologically relevant glycating agent; however, glucose glycates 
very slowly and takes long time to reach the equilibrium distribution of glycation products, and 
is therefore, not amenable to study in this project. Ribose-5-phosphate (R5P), in the end, is 
chosen as the primary glycating agent in this project. R5P glycates faster than glucose, fructose 
and ribose [121] so that it can give access to the glycation equilibrium within reasonable 
timescales. It is a less studied but versatile metabolite involved in multiple metabolic pathways, 
and its production is suggested to be upregulated in cancerous tissues to support rapid 
proliferation of cancer cells [91], and so we propose that R5P will be an important glycating 
agents where there is cell necrosis in cancer.  
Choice of the Major Analytical Technique 
SSNMR spectroscopy is chosen as the primary tool to assess collagen glycation product 
distribution for several reasons. First, it requires minimal sample preparation – only 
lyophilisation and best preserves proteins in their native states. This feature minimises the risks 
of introducing artefacts in the results. Second, SSNMR allows observation all glycation 
products generated in a single sample and therefore clear assessment of major glycation 
products in each case.  
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4 Solid-State Nuclear Magnetic Resonance 
(SSNMR) Spectroscopy 
Solution-state NMR spectroscopy has become a routine characterisation technique for small 
molecules and soluble proteins, while SSNMR spectroscopy is far less exploited. SSNMR and 
latest developments in dynamic nuclear polarisation (DNP)-coupled SSNMR pose significant 
advantages for studying insoluble macromolecules.  
 
In this project, SSNMR is the major analytical tool, and a large component of this project is 
analysing SSNMR spectra to identify glycation products and explore atomic-level structural 
changes of insoluble collagenous materials.  
 
Essential concepts of SSNMR are briefly reviewed in this chapter, followed by principles of 
routine SSNMR experiments, focusing on SSNMR spectra interpretation. Complete 
understanding of NMR spectroscopy can be found in textbooks, Understanding NMR 
Spectroscopy by James Keeler [122], Introduction to Solid-State NMR spectroscopy by 
Melinda Duer [123] and Solid-State NMR: basic principles & practice by David Apperly, 
Robin Harris and Paul Hodgkinson [124], etc.  
4.1 The Vector Model 
When a sample is placed in a magnetic field, 𝐵#, a bulk magnetisation, 𝑴, will be generated 
under the effect of 𝐵#, as shown in Figure 4-1. 𝑴 is a vector sum of all individual magnetic 
moments, 𝜇&, arising from each nucleus in that sample. 𝑴 = ∑ 𝝁𝒊&      (Equation 4-1) 
 
The individual magnetic moment is related to the nuclear spin, 𝐼&, of the ith nucleus and the 
gyromagnetic ratio of the nuclear, 𝛾.  𝝁𝒊 = 𝛾𝑰𝒊     (Equation 4-2) 
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Figure 4-1 Spins in a sample are randomly orientated without an external magnetic field, and 
become more organised and generate a bulk magnetisation, 𝑴, under the effect of 
the applied magnetic field, 𝐵#. 𝑴 is parallel to 𝐵#.  
 
Nuclear spins precess about the static magnetic field, 𝐵#, at a constant rate, called Larmor 
frequency, 𝜔#. This is determined by the magnitude of 𝐵# and the gyromagnetic ratio, 𝛾, of the 
nuclear.  𝜔# = −𝛾𝐵#     (Equation 4-3) 
 
In pulsed NMR experiments, radiofrequency (rf) pulses, oscillating along the direction 
perpendicular to 𝐵# , flips 𝑴 away from equilibrium. Considering a simple case when the 
frequency of the rf pulse is the same as the Larmor frequency of the nuclear (𝜔01 = 𝜔#), 𝑴 
will flip an angle of 𝜃01 during time 𝜏01.  𝜃01 = 𝜔01𝜏01 = 	−𝛾𝐵01𝜏01   (Equation 4-4) 
where 𝐵01 is the rf field and 𝜔01 is the frequency of 𝐵01.  
 
Conventionally, a 90° pulse in NMR experiments means turning the magnetisation 90° away 
from the vertical axis, where 𝐵# lies, to the transverse plane (Figure 4-2). The magnitude of the 
transverse magnetisation during its recovery to equilibrium is what detected over time in pulsed 
NMR experiments.  
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Figure 4-2 A 90° pulse generated by a rf pulse oscillating along the x axis and perpendicular 
to 𝐵#, along the z axis, flips the bulk magnetisation, represented by the filled grey 
arrow, from equilibrium to transverse plane, along the y axis.  
4.2 Types of Interactions 
In a spin system, nuclear spins interact not only with the static magnetic field, but also with 
each other. For a spin system containing interacting spins, the overall interactions include but 
are not limited to the Zeeman interaction, the shielding interaction and the dipolar interactions, 
including both homonuclear and heteronuclear dipolar interactions. All three interactions will 
be discussed separately in detail in the following sections as all are relevant to the experiments 
presented in this thesis.  
 
For spins with 𝐼 > :;, there are also quadrupolar interactions, as such nuclei possess a non-zero 
electric quadrupole moment which interacts with surrounding electric field gradients. However, 
nuclei studied in this project are spin half nuclei, 𝐼 = :;, and thus, quadrupolar interactions will 
not be discussed in this thesis. Scalar coupling (or J coupling) is a further nuclear spin 
interaction in which pairs of nuclear spins are coupled via through-bond interactions, it is not 
exploited in the solid-state NMR experiments used in this project; therefore, it will not be 
discussed in detail either.  
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4.2.1 Zeeman Interaction 
The Zeeman interaction is the interaction between the spin system and the applied field, which 
is the dominant interaction in a spin system. It is determined by the magnitude of 𝐵#  and 
gyromagnetic ratio,	𝛾, of the nuclei, meaning it is the same for all spins of the same nuclei in a 
given field.  
4.2.2 Shielding Interaction  
The shielding interaction describes the interaction between the static magnetic field, 𝐵#, and 
the local magnetic field generated by surrounding electrons of a nucleus, ∆𝐵 , which is 
proportional to 𝐵#. The nucleus is shielded from 𝐵# by ∆𝐵 and therefore, experiences a net 
magnetic field, 𝐵# − ∆𝐵 . As the electron cloud around nuclei is general not spherically 
symmetric, ∆𝐵 is different depending on the relative orientation of the electron distribution 
with respect to 𝐵#, resulting in so-called shielding anisotropy. The anisotropy of the shielding 
interaction is described mathematically by the shielding tensor, 𝝈, a second rank tensor whose 
three principal values are designated 𝜎::, 𝜎;; and 𝜎??.  
 
In modern NMR spectrometers, chemical shifts are introduced, converting from the absolute 
frequencies (in Hz) of NMR signals to chemical shift (in ppm, parts per million) to remove the 
field strength dependence of the shielding interaction:  𝛿(𝑝𝑝𝑚) = DEFGDH	1IJGIKEL	(MN)OPFDKQD0Q	0I1I0IKEI	10IJGIKEL	(MN)PFDKQD0Q	0I1I0IKEI	10IJGIKEL	(MN) × 10T  (Equation 4-5) 
 
Within a solid sample, molecules, and thus their associated electron distributions, are in all 
possible orientations, so that the shielding anisotropy results in a different chemical shift for 
each molecular orientation. All chemical shifts arising from different molecular orientations 
combine together as a “powder pattern” spectrum (Figure 4-3), which the width of the power 
pattern being related to the chemical shift anisotropy (CSA). CSA is used to describe the 
orientation dependence of chemical shifts.  
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Figure 4-3 A typical powder pattern spectrum showing three principal values of the shielding 
tensor where 𝜎:: ≥ 𝜎;; ≥ 𝜎??. The actual shape of the powder pattern depends on 
the symmetry of the nuclei.  
4.2.3 Dipolar Interaction 
As mentioned previously, each nucleus in a molecule can generate a local magnetic field. Apart 
from interacting with 𝐵#, these local fields also interact with fields generated by nearby nuclei. 
This interatomic interaction is called the dipolar or dipole-dipole interaction, which occurs 
through space and is independent of bonds between dipoles.  
 
Similar to the shielding interaction, the strength of the dipolar interaction also depends on 
orientation, more specifically, the angle between the internuclear vector and 𝐵# , 𝜃. It also 
depends on gyromagnetic ratios of both spins involved, 𝛾V and 𝛾W, and internuclear distance, 𝑟VW (Figure 4-4). The dipolar interaction, 𝑑VW, between spin 𝐼 and spin 𝑆 can be calculated by 𝑑VW = ℏ\]^_ :0` ab 𝛾V𝛾W ? EcPd eO:;     (Equation 4-6) ℏ is reduced Planck constant, 𝜇# is the permeability of free space.  
 
Figure 4-4 The dipolar interaction between spin 𝐼 and spin 𝑆 depends on their internuclear 
distance, 𝑟VW and their orientation relative to B0, 𝜃.  
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The dipolar interaction is very useful in determining interatomic distances. However, the 
dipolar interaction also causes extensive signal broadening and potential signal overlapping, 
especially in biological samples where there are too many 1H-1H and 1H-13C interactions with 
various internuclear distances and orientations. Therefore, decoupling techniques (will be 
described in Section 4.3.2) are often used in SSNMR experiments to decouple undesired 
dipolar interactions and selectively observe informative dipolar interactions.  
4.3 Techniques in SSNMR 
4.3.1 Magic Angle Spinning (MAS) 
In solution-state NMR, above-mentioned anisotropic interactions are averaged, due to rapid 
isotropic molecular motion in solution, to their isotropic value resulting in sharp signals in 
solution-state NMR spectra. However, in the solid-state, molecular motion is much slower, and 
typically, not isotropic, diminishing this averaging effect observed in solution-state NMR. 
Therefore, SSNMR spectra generally contain broad and overlapping signals from the effects 
of anisotropic interactions.  
 
A useful averaging effect can be achieved in SSNMR by mechanically spinning samples at an 
angle of 54.74°  relative to the applied magnetic field, called the magic angle, which is 
equivalent to the body diagonal of a cube (Figure 4-5). At the magic angle, the 3 cos; 𝜃 − 1 
orientation dependence of nuclear spin interactions is averaged to zero. Therefore, spinning at 
the magic angle can remove the effects of anisotropic interactions. In practice, the spinning 
rate should be at least three times bigger than the magnitude of the broadening interaction to 
fully remove its effects from the spectrum. Otherwise, spinning sidebands, a set of signals on 
both sides of a central signal with multiples of the MAS rate apart, appear on SSNMR spectra 
with MAS (Figure 4-6).  
 
Rotational resonance occurs when 𝜔Q&Pc = 𝑛𝜔0 , where 𝜔Q&Pc  is the difference in isotropic 
frequencies of two signals, 𝜔0  is the MAS rate and 𝑛  is an integer. Under the effects of 
rotational resonance, the dipolar interaction averaged out by MAS is reintroduced, causing 
signal broadening and splitting. In two-dimensional SSNMR experiments, it is used to 
reintroduce the dipolar interactions in order to detect homonuclear dipolar coupled spin pairs.  
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Figure 4-5 Samples are packed in rotors and spun at an angle of 54.74°, called the magic angle, 
relative to the direction of 𝐵#, along z-axis to remove anisotropic interactions. This 
angle is at the body diagonal of a cube. 
 
Figure 4-6 13C SSNMR spectra of glycine. Top: static spectrum. Bottom: MAS at 10 kHz, with 
asterisks indicating spinning sidebands with 10 kHz apart from the central signal.  
Choice of MAS Rate 
In this project, a MAS rate at 10 kHz is used on most samples, unless otherwise stated. A MAS 
rate is carefully chosen to avoid overlapping between spinning sidebands and signals of interest 
and rotational resonance effects. Moreover, it has to be reasonably fast to remove some effects 
of anisotropic interactions but is limited by the diameter of the probe used, 4 mm, to a 
maximum of 15 kHz. Although this MAS rate is not sufficient to remove the effect of 1H-1H 
homonuclear dipolar interactions or dipolar couplings of 13C spins with large pools of 1H spins, 
 42 
because of 1H’s large gyromagnetic ratio, good quality 13C SSNMR spectra can be acquired 
from 1H-rich biological samples.  
4.3.2 Decoupling 
Biological samples typically suffer large 1H-1H homonuclear dipolar coupling and 1H-X, eg. 
1H-13C, heteronuclear dipolar couplings, causing significant signal broadening in 1H and 13C 
spectra respectively. To reduce the effects of these interactions and improve spectral resolution, 
decoupling techniques are commonly used in SSNMR. Due to 1H’s large gyromagnetic ratio, 
it can be challenging to remove 1H-1H homonuclear dipolar coupling in 1H spectra; however, 
decoupling 1H-X heteronuclear dipolar interactions is relatively straightforward to achieve in 
SSNMR.  
 
Briefly, decoupling 1H from other less abundant nuclei requires high power rf pulses applied 
close to 1H resonance frequency. The effect of those rf pulses is continuously flipping proton 
magnetisation, resulting in the time-averaged heteronuclear dipolar coupling to be zero.  
 
There are a number of decoupling sequences widely used in SSNMR, e.g. continuous wave 
(CW), two pulse phase modulation (TPPM) [125] and small phase incremental alteration 
(SPINAL64) [126]. The latter two schemes are extensively used in experiments described in 
this thesis.  
4.3.3 Cross Polarisation (CP) 
CP experiments are more commonly used than direct polarisation (DP) experiments in SSNMR 
where the observed spin is a low abundance nucleus such as 13C, and where there are abundant 
spins with large gyromagnetic ratios, such as 1H. In CP experiments, magnetisation from the 
abundant spin, mostly 1H, is transferred to a less abundant or dilute spin X, such as 13C or 15N, 
via their mutual heteronuclear dipolar coupling, resulting in enhanced signal intensity for the 
low abundance nucleus. A theoretical signal intensity enhancement is a factor of 𝛾M/𝛾p; for 
example, in 1H-13C CP, the theoretical 13C signal intensity enhancement is 𝛾M 𝛾q⁄ ≈ 4 times. 
However, this cannot be achieved in actual SSNMR experiments due to relaxation of both the 
spin-locked proton transverse magnetization and the developing 13C transverse magnetization 
during the contact pulses (more specifically, T1r; discussed in Section 4.4).  
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Dilute nuclei tend to have long T1 relaxation time (explained in Section 4.4), meaning the 
waiting time between consecutive scans, called the recycle delay, in DP experiments is long. 
However, in CP experiments, recycle delay depends on the 1H T1 rather than X T1, which is 
typically much shorter. This shortens the required recycle delay and allows more acquisitions 
per unit time. This plus the increased signal intensity for each scan results in shorter experiment 
times to reach a desired S/N ratio.  
 
Pulse sequence of CPMAS is shown in Figure 4-7. The abundant spin, 𝐼, is firstly excited using 
a 90° pulse. Then a pair of cross polarisation pulses, also called contact pulses, is applied on 
both spins for a length of time, known as the contact time. Until an optimal contact time, signal 
intensity of S builds up with contact time, and afterwards signal intensity starts to decline due 
to T1r relaxation. Finally, signals are acquired on the dilute spin, 𝑆, with decoupling pulses on 𝐼.  
 
Effective magnetisation transfer between two spins, spin 𝐼 and spin 𝑆, only happens when they 
are dipolar-coupled, and the Hartmann-Hahn condition for the nutation frequency of the 
contact pulses is matched: [127]  𝜔V = 𝜔W     (Equation 4-7) 𝛾V𝐵V = 𝛾W𝐵W                                                       (Equation 4-8) 
 
CPMAS experiments, i.e. CP under MAS conditions, are routinely carried out on all samples 
in this project to show basic molecular structural information on collagenous samples, such as 
amino acid composition and protein secondary structure. However, information provided by 
CPMAS experiments is not quantitative in that the CP signal intensity depends on not only the 
number of nuclei but also the efficiency of magnetisation transfer during CP and the rate of T1r 
relaxation. For example, in 1H-13C CP, 13C in close spatial proximity to low-mobility 1H 
benefits from high CP efficiency and gives intense signals, while 13C in high-mobility groups, 
such as methyl groups with rapidly rotating 1H, can suffer low CP efficiency, because the 
methyl group motion partially averages the methyl 13C-1H dipolar coupling and results in weak 
signals. So, it needs longer contact time to build up signal intensities. More importantly, CP 
works as an essential step for many 2D SSNMR MAS experiments to generate the initiate e.g. 
13C transverse magnetisation in the experiment (will be described in Section 4.5).  
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Figure 4-7 A typical CPMAS sequence. Transverse magnetisation is generated by a 90° pulse 
on the abundant spin 𝐼. Then, contact pulses are applied on both spins to transfer 
magnetisation from spin I to dilute spin 𝑆. A ramp pulse is usually used to broaden 
Hartmann-Hahn condition and gain signal intensity [128]. Finally, 𝑆 spectrum is 
acquired with decoupling on 𝐼.  
4.4 Relaxation  
After transverse magnetization is generated, whether by DP or CP, the spontaneous process of 
restoring the equilibrium along 𝐵# is called relaxation. Relaxation is caused by fluctuations of 
local fields experienced by nuclei, under the influence of molecular motion and interactions 
described in Section 4.2. The restoration of the z-component of 𝑴 is through longitudinal 
relaxation, also known as spin-lattice relaxation, with time constant T1. T1 determines the 
necessary recycle delay in NMR experiments. An additional relaxation time becomes relevant 
in pulsed SSNMR experiments, which is T1r. This describes the relaxation under the influence 
of the RF pulses.  
 
The restoration of the equilibrium transverse component of 𝑴, i.e. 0, is through transverse 
relaxation, also known as spin-lattice relaxation, with time constant T2. T2 is related to the 
broadness of signals. Slower T2 is, narrower the signal is. Therefore, relaxation can be seen as 
an indicator of molecular motion.  
4.5 Dynamic Nuclear Polarisation (DNP) coupled SSNMR 
DNP-SSNMR overcomes the intrinsic limitation of SSNMR, low sensitivity, and gives 
significant signal enhancement comparing to conventional SSNMR, which can dramatically 
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shorten the experiment time and allow signals to be observed for chemical species that would 
be too low in abundance to be observed in conventional SSNMR. In this work, it enables 2D 
heteronuclear correlation experiments between two dilute nuclei, e.g. 13C-15N, with 
significantly reduced experiment time and allows detection of minor 13C species beyond the 
detection limit of conventional SSNMR.  
 
DNP is achieved by transferring spin polarisation from unpaired electrons in so-called 
polarising agents to nearby nuclei in the sample of interest. The polarisation transfer is driven 
by microwave irradiation near the electron spin resonance frequency [129] [130]. The 
polarising agent used in this project is AMUPol [131], which has two unpaired electrons; its 
structure is shown in Figure 4-8. Typical DNP enhancement factors using AMUPol on in vitro 
ECM samples are between 20-60 on the 400 MHz SSNMR spectrometer used in this project. 
DNP experiments need to be carried out at very low temperature to enable the polarisation 
transfer and avoid unwanted side reactions involving the unpaired electrons. This low operating 
temperature, resulting in slow molecular motion, typically causes significant line broadening 
for biological samples.  
 
Figure 4-8 Structure of AMUPol, the polarising agent used in this project.  
4.6 Two-Dimensional SSNMR Experiments 
1D SSNMR spectra often lack the resolution needed for structure determination due to signal 
overlap, especially where signals are broad due to sample inhomogeneity as is the case for 
many samples in this work. 2D SSNMR experiments give more detailed structural information 
by resolving overlapping signals and correlating nuclei pairs according to their spatial 
proximity in the sample.  
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A typical 2D NMR experiment consists of four stages (Figure 4-9). It starts from a preparation 
period, usually a 1H 90° pulse or 1H-X CP, and then evolution. The evolution period, 𝑡:, is not 
a fixed time period but incremented in a series of 1D experiments. Each 1D experiment, called 
a slice, is repeated with different increment delays, 𝑡, 𝑡 + ∆𝑡, 𝑡 + 2∆𝑡, ⋯. This incrementation 
creates the second spectral dimension, called the indirect dimension or F1 dimension, in 2D 
NMR experiments. In practice, quadrature detection is achieved in the F1 dimension. The 
States-TPPI method is the most commonly used quadrature detection method in this project. 
Next, the mixing period is a period during which spins are allowed to communicate via 
different interactions. Interactions deployed in this period, mostly the dipolar interaction, 
determine what structural information is contained in 2D NMR spectra. More details about 
possible interactions and available structural information will be covered in later sections. 
Finally, signals are acquired during 𝑡;.  
 
 
Figure 4-9 A general scheme for 2D SSNMR experiments, containing four stages, preparation, 
evolution, mixing and acquisition.  
 
2D data acquired in 2D NMR experiments is Fourier transformed in both dimensions to 
generate 2D spectra as contour plots with chemical shifts on each dimension. In 2D NMR 
spectra, each signal has one chemical shift on each dimension, direct or F2 dimension and 
indirect or F1 dimension. Chemical shifts on F2 dimension are exact chemical shifts of 
observed nuclei, indicating their chemical environments; while chemical shifts on F1 
dimension can mean different things depending on experiment types or interactions involved 
during the mixing period. Several frequently used 2D SSNMR MAS experiments will be 
introduced in more detail in the following sections, focusing mostly on 2D SSNMR spectra 
interpretation.  
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4.6.1 Homonuclear Correlation Experiments 
13C-13C Proton-Driven Spin Diffusion (PDSD) and Dipolar-Assisted 
Rotational Resonance (DARR) Experiments 
The dipolar interaction is distance-dependent and therefore can reveal structural information 
on internuclear distance. However, the dipolar interaction is averaged to zero by MAS, so this 
interaction needs to be reintroduced to study the 13C-13C dipolar interactions.  
 
One of common experiments to reintroduce the dipolar coupling and correlate the spin pairs 
close in space is the 2D PDSD [132] and DARR [133] experiments. Their pulse sequences 
(Figure 4-10) begin with an initial CP step between 1H and 13C, and follow a decoupling pulse 
applied on 1H channel while 13C magnetisation evolves during 𝑡:. Prior to the mixing period, 
a 90° pulse is applied on 13C channel to prepare for spin diffusion. During the mixing time, the 
decoupling is switched off to allow spin diffusion involving 1H-1H and 1H-13C dipolar coupling. 
The mixing time determines the observable range of inter-13C distances. At the end of the 
mixing period, a 90° pulse is applied on 13C channel in order to acquire 13C signals with 1H 
decoupling.  
 
The DARR experiment is a simple variant of the PDSD experiment. The only difference is that 
during the mixing time, a weak decoupling pulse is applied on 1H channel. It has been shown 
that DARR experiments yield more intense cross peaks of long-distance spin pairs than PDSD 
experiments [134]; however, this effect has not been observed at our SSNMR spectrometer 
field strength and typical MAS rates used in this work.  
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Figure 4-10 Pulse sequence for 2D 13C-13C PDSD and DARR experiments. During the mixing 
time, the 1H decoupling (the grey rectangle) is switched off for PDSD experiments; 
for DARR experiments, the nutation frequency of this weak decoupling pulse is set 
to the MAS rate.  
 
The 2D PDSD or DARR spectrum (Figure 4-11) is symmetrical about a diagonal (solid dark 
grey line in Figure 4-11) and has chemical shifts of the same nuclei, i.e. 13C chemical shifts in 
this project, on both dimensions. Signals observed in 2D PDSD or DARR spectra are derived 
from dipolar-coupled nuclei pairs. Peaks on the diagonal are called diagonal peaks (bigger blue 
dots in Figure 4-11), indicating self-correlations between the same nuclei or environmentally 
similar nuclei, considering the broadness of peaks in SSNMR; peaks off the diagonal are called 
cross peaks (smaller blue dots in Figure 4-11), which originate from correlations between two 
environmentally different 13C and thus give different chemical shifts on each dimension. A 
cross peak with chemical shift 𝛿: on F1 dimension and 𝛿; on F2 dimension means that a 13C 
spin, 13C1, giving chemical shift at 𝛿: is dipolar-coupled to a 13C spin, 13C2, giving chemical 
shift at 𝛿;. In other words, 13C1 and 13C2 are dipolar-coupled 13C pairs and close in space.  
 
2D PDSD or DARR spectra allow identification of dipolar-coupled nuclei pairs, which can 
provide essential structural information, including chemical shifts and 13C spatial proximity, to 
determine molecular structures. Previously, experiments have been performed by former group 
members, Dr. Wing Ying Chow and Dr. Veronica WC Wong, showing a mixing time of 20 ms 
at a MAS rate of 10 kHz, the commonly used experimental condition in this project, can detect 
13C correlating pairs up to 7	Å apart [135][136].  
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Figure 4-11 A schematic 2D PDSD or DARR spectrum showing two peaks on the diagonal 
and two cross peaks symmetrical to the diagonal. This spectrum shows that the 
nuclei giving rise to the chemical shift at 𝛿: on F1 dimension are close in space to 
those giving the chemical shift at 𝛿; on F2 dimension.  
13C-13C Single Quantum-Double Quantum (SQ-DQ) Experiments 
Another experiment to reintroduce the dipolar coupling under MAS is to generate double 
quantum magnetisation between dipolar-coupled spin pairs by symmetric homonuclear dipolar 
recoupling sequences (SHDRSs). SHDRSs are used to selectively recouple homonuclear 
dipolar-coupled spin pairs of interest, e.g. 13C-13C, so, unlike PDSD/DARR experiments, it is 
vital to avoid any magnetisation transfer from or to 1H and requires a high level of 13C isotope 
enrichment.  
 
Several SHDRSs has been developed to date, such as C7 [137], POST-C7 [138] and SPC-5 
[139]. They can be applied in 1D experiments, after CP and before acquisition, as a DQ filter 
to filter out natural abundant components of samples. This experiment will be referred to as 
1D PC7 in the following texts. DQ filtration causes an intensity loss between normal CP and 
DQ-filtered CP. The extent of retaining signal intensity, or DQ efficiency, is used as a 
measurement of isotope enrichment level. For 13C labelled ECM samples used in this project, 
DQ efficiency is around 20-30%.  
 
Pulse sequence used in this project is a modified version of POST-C7 with large sweep width 
(LSW) on the DQ or indirect dimension [140] (Figure 4-12) to increase the spectral width on 
the DQ dimension to include the full chemical range. This 2D SQ-DQ LSW-POST-C7 
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experiment will be referred as 2D PC7 in the following text for simplification. After the initial 
1H-13C CP step, a 13C 90° pulse is applied to put the magnetisation back to the direction of 𝐵#. 
Then, a rotor synchronised LSW-POST-C7 pulse train excites the magnetisation to double 
quantum and converts back to zero quantum after evolution period, t1, for acquisition. Each 
LSW-POST-C7 pulse train contains seven elements, and they finish in 2 rotor periods. Then a 
final 90° pulse generates transverse magnetisation from the zero quantum magnetisation for 
observation.  
 
 
Figure 4-12 Pulse sequence for the 2D 13C-13C PC7 experiment. Above is a generic illustration 
of 2D SQ-DQ experiments. Specially designed SHDRSs are used to excite and 
convert magnetisation between SQ and DQ. POST-C7 sequence shown below is 
used in this project for SQ-DQ transitions. Each sequence contains 7 elements, 𝐶&, 
and length of each element is 𝜏E. Each element contains 3 pulses in an order of 90°, 360° and 270°. The excitation period, 𝜏IzE  and the conversion period, 𝜏0IE  are 
equal and include a multiple of pulse trains, 𝜏IzE = 𝜏0IE = 𝑛𝜏E	(𝑛 = 7, 14,⋯). 𝑡: 
needs to be a multiple of 𝜏E, 𝑡: = 𝑚𝜏E	(𝑚 = 0, 1,⋯ ).  
 
2D SQ-DQ experiments using SHDRSs, after Fourier transformation on both dimensions, give 
rise to 2D spectra with SQ chemical shifts on the F2 dimension and DQ chemical shifts on the 
F1 dimension, meaning signals are no longer symmetrical about a diagonal. A schematic 2D 
SQ-DQ spectrum is shown in Figure 4-13. Chemical shifts on those two axes give very 
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different information. If two signals share the same DQ chemical shift on F1 dimension, as 
(𝛿:+𝛿;) in Figure 4-13, which is also the sum of their SQ chemical shifts on F2 dimension, 𝛿: 
and 𝛿; separately, means the nuclei giving rise to these two signals are correlated by the pulse 
sequence and therefore are close in space.  
 
Inter-13C distances detected by 2D SQ-DQ experiments are relatively short. Experiments have 
also been performed by previous group members, Dr. Wing Ying Chow and Dr. Veronica WC 
Wong, showing 2D PC7 with n = 14 at a MAS rate of 10 kHz can detect 13C correlating pairs 
1-3	Å apart, roughly one bond distance away [135][136]. This is because the strength of dipolar 
coupling is highly dependent on inter-13C distances, proportional to :0b. In other words, dipolar 
coupling between directly bonded 13C pairs can be more than five times stronger than 13C pairs 
with two bonds apart. This strong distance dependence makes this type experiment resemble 
scalar coupling mediated experiments, and correlating spin pairs observed in its spectra can be 
interpreted as directly bonded 13C pairs [140]. This feature allows the establishment of 13C 
bond connectivity within a molecule. For example in Figure 4-13, assuming it is a 13C-13C SQ-
DQ spectrum, 13C1 (𝛿:) is close to 13C2 (𝛿;) because their DQ chemical shift equals the sum of 
their SQ chemical shifts, and 13C2 (𝛿; ) is close to 13C3 (𝛿? ). Therefore, it reveals 13C 
connectivity information about this three-carbon molecule, 13C1-13C2-13C3.  
 
 
Figure 4-13 A typical 2D SQ-DQ spectrum, showing four signals. Signals on the same 
vertically dotted line share the same F2 chemical shift, meaning they are the same 
13C; while signals are horizontally connected and have a DQ chemical shift equal 
to the sum of their SQ chemical shifts meaning they are correlating with each other. 
Grey dash line is the DQ diagonal.  
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2D SQ-DQ experiments also separate correlation signals from self-correlated spin pairs or 
dipolar-coupled spins with similar chemical shifts, which would have been overlapped by the 
strong diagonal in 2D PDSD/DARR spectra.  
 
SPC-5 sequences [139] used in DNP-SSNMR are variants of 2D PC7. They share the same 
principles but contain different number of elements in DQ magnetisation excitation and 
conversion sequence blocks. Interpretation of both 2D SQ-DQ SPC-5 and PC7 spectra is the 
same, and thus, the SPC-5 sequence will not be explained in detail.  
4.6.2 Heteronuclear Correlation Experiments  
1H-13C Heteronuclear Correlation (HETCOR) Experiments  
The 2D 1H-13C HETCOR pulse sequence [141] used in this project can be seen as a 2D variant 
of CP sequence, shown in Figure 4-14. 1H magnetisation is prepared by a 90° pulse. A t1 
evolution period is inserted prior to a CP contact pulse, during which decoupling pulses are 
applied on the 1H channel to remove 1H-1H homonuclear interactions. 1H-1H homonuclear 
decoupling ensures the resolution on 1H or indirect dimension. Also, shorter contact time, than 
normal CP, is used to limit 1H-1H interactions within that period. Varying contact time changes 
the observable range of 1H-13C distances.  
 
Figure 4-14 2D 1H-13C HETCOR pulse sequence. It begins from turning 1H magnetisation 90° 
to prepare it for evolution in t1. Afterwards, short CP pulses are applied on both 
channels for the final acquisition on 13C with 1H decoupling.  
 
High resolution in the 1H dimension is required in this experiment to extract 1H chemical shifts, 
which is achieved by employing 1H-1H Frequency-Switched Lee-Goldburg (FSLG) decoupling 
sequence [142] on 1H channel during the evolution period. FSLG decoupling sequence contains 
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a series of 360°  pulses with alternating frequency to limit 1H-1H homonuclear dipolar 
interactions but allow 1H-13C heteronuclear dipolar interactions.  
 
2D 1H-13C HETCOR experiments are achieved by CP, making it difficult to detect 1H-13C 
correlations in mobile environments. Free 1H without any stabilisation factor, e.g., hydrogen 
bonds, is not likely to be detected by 1H-13C HETCOR parameters used in this project.  
13C-15N Double Cross Polarisation (DCP) and DARR assisted DCP 
Experiments 
Detecting correlations between 13C-15N is more challenging and time consuming than 1H-13C 
and 13C-13C correlations because of the small gyromagnetic ratio of 15N. It also requires a high 
level of both 13C and 15N enrichment in samples. So 2D 13C-15N correlation experiments are 
only performed using DNP-SSNMR spectroscopy. Usually, 2D 13C-15N correlation 
experiments begin with 1H-15N/13C CP, and then allow 15N spins to interact with 13C spins via 
dipolar interactions. Different pulse sequences have been designed to measure selective or non-
selective 13C-15N interactions in biological samples.  
 
A simple form of 2D 13C-15N correlation experiments is double cross polarisation (DCP), 
whose sequences (Figure 4-15) begin from magnetisation transfer from 1H to 15N and then from 
15N to 13C and eventually acquire on 13C channel [143][144]. However, the 13C-15N internuclear 
distance detected in DCP experiments is limited because the dipolar interaction is distance-
dependent (explained in section 4.2.3). So, sometimes 13C-15N CP is followed by 13C-13C 
DARR mixing to obtain 13C-15N correlations with multiple bonds apart, as in DARR assisted 
13C-15N DCP experiments. Its pulse sequence is shown in Figure 4-15. The inter-13C-15N 
distance detected in 13C-15N DCP DARR experiments is primarily determined by the DARR 
mixing time.  
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Figure 4-15 The pulse sequence of the 2D 13C-15N DCP followed by DARR mixing. The part 
included in the red rectangle is a simple DCP sequence, which starts from a CP 
between 1H-15N and is followed by a second CP between 15N and 13C. The 13C-13C 
DARR sequence has been explained in section 4.6.1.  
Heteronuclear Correlation Spectra Interpretation  
All the above-mentioned 2D heteronuclear correlation experiments generate 2D spectra with 
two dimensions showing chemical shifts of different nuclei separately, and therefore 2D 
heteronuclear spectra are not symmetric about a diagonal as some homonuclear correlation 
spectra. A schematic 2D heteronuclear spectrum is shown in Figure 4-16 with 13C chemical 
shifts on the direct dimension (the horizontal axis in the figure) and X, 1H or 15N, on the indirect 
dimension (the vertical axis in the figure).  
 
In addition, all heteronuclear correlation experiments described here are mediated via dipolar 
coupling, meaning that they can be interpreted in the same way, to some extent. For example, 
if the 2D spectrum in Figure 4-16 is acquired from a 2D 1H-13C HETCOR experiment, the 
vertical axis will show 1H chemical shifts; and the correlation signal between 13C1 and d2 means 
that 13C spins giving a chemical shift at 13C1 is dipolar coupled to 1H spins giving a chemical 
shift at d2, and they are close in space. If the 2D spectrum in Figure 4-16 is acquired from a 2D 
13C-15N correlation experiment, the vertical axis will show 15N chemical shifts; and the 
correlation signal between 13C1 and d2 means that 13C spins giving a chemical shift at 13C1 is 
dipolar coupled to 15N spins giving a chemical shift at d2, and they are close in space.  
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Figure 4-16 A schematic 2D 13C-X heteronuclear correlation spectrum, showing three 
correlating 13C-X pairs (indicated by blue dots). All above-mentioned heteronuclear 
experiments acquire on 13C channel, so the direct dimension (horizontal axis) shows 
13C chemical shifts and the indirect dimension (vertical axis) shows X chemical 
shifts. In 2D 1H-13C HETCOR experiments, the indirect dimension will be 1H 
chemical shifts and in 2D 13C-15N correlation experiments, the indirect dimension 
will show 15N chemical shifts.  
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5 Experimental Details 
5.1 In vitro Extracellular Matrix Preparation 
Cells were cultured in a T-175 flask containing 25 mL complete Dulbecco’s Modified Eagle 
Medium (DMEM with 1 g/L glucose; Invitrogen). Complete DMEM was composed of 10% 
foetal calf serum (First Link), 30 μg/mL L-ascorbic acid 2-phosphate (Sigma) and 10 mL/L L-
glutamine-penicillinstreptomycin (200 mM L-glutamine, 10,000 units/ml penicillin, and 10 
mg/ml streptomycin in 0.9% sodium chloride; Sigma). Cell culture flasks were incubated at 
37°C in a humidified atmosphere of 95% air and 5% CO2, and the culture medium was renewed 
every 2 days. 
 
L-ascorbic acid 2-phosphate solution was prepared in phosphate buffered saline (1X PBS, 
Invitrogen) from powder and added in cell culture medium after filter sterilisation (0.22 μm 
syringe filter, Appleton Woods). 
 
ECM was harvested when cells produced a dense matrix which started to peel off the surface 
of the tissue culture flask. This usually takes about 10-15 days from seeding cells. Medium was 
removed, and cells were washed twice with 10 mL PBS to remove the cell culture media 
residual before any decellularization procedure.  
Freeze-thaw lysis 
The flask was placed in a freezer at -80°C for overnight and was allowed to thaw at room 
temperature for 30 minutes. The ECM was dislodged by gently swirling the flask in the 
presence of PBS. The ECM collected in PBS was transferred to a fresh 50 mL centrifuge tube. 
The ECM was further washed repeatedly by PBS to remove cell debris. Samples were stored 
at -20°C prior to any further procedure.  
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Detergent lysis 
10 mL of working detergent solution (0.5% Triton X-100, 20 mM NH4OH in 1x PBS) was 
added into each T-175 cell culture flask. The flask was incubated at 37°C for 10 mins. The 
decellularised ECM was dislodged by gently swirling the flask in the presence of detergent 
working solution. Then it was collected and transferred to a 50 mL centrifuge tube containing 
10 mL PBS. This tube was left in a 4°C fridge for overnight.  
 
The ECM was washed by PBS three times to remove remaining detergent, and was incubated 
with DNAse (Thermo Fisher Scientific, 10 ug/mL, 1:1000 dilution in its reaction buffer) at 
37°C for 30mins to remove residual DNA left by cells. DNAse solution was aspirated and 
matrix was thoroughly washed before transferring to a fresh 50 mL centrifuge tube. Samples 
were stored at -20°C prior to any further procedure.  
Introducing Isotope Labelling 
When isotope labelled matrix was needed, stock isotope labelled amino acids solution was 
prepared in PBS from powder and filter sterilised (0.22 μm syringe filter, Appleton Woods). 
U-13C, 15N-amino acids (Cambridge Isotope Laboratories) solution was added in cell culture 
medium to a final concentration of double the initial concentration in the DMEM, after cells 
were confluent. They were refreshed every 2 days together with cell culture medium until ECM 
is ready to harvest.  
 
Table 5-1 Concentrations of U-13C, 15N-amino acids in cell culture medium.  
Amino Acid Concentration /mM 
L-Arg 0.8 
L-Lys 1.6 
L-Pro 0.8 
Gly 0.8 
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5.2 Collagen Extraction from In vitro Extracellular Matrix 
To remove minor matrix proteins and extract collagen from in vitro extracellular matrix, one 
flask of freshly decellularised ECM was incubated with chymotrypsin (0.1 mg, Sigma, in 2 mL 
buffer, 100 mM Tris-HCl, 10 mM CaCl2, pH=7.8 in water) at 37°C for overnight and washed. 
Then it was incubated with Tween-20 solution (0.25% in 2 mL PBS) at 37°C for another 
overnight and washed. The sample was stored at -20°C in a centrifuge tube until further 
procedure.  
5.2.1 Transmission Electron Microscopy (TEM) Imaging 
ECM samples are gentled sonicated in water using a probe sonicator at a power about 10 W 
for 5-10 seconds, depending on the amount of the ECM sample, to better disperse sample in 
solution. Sonication can be repeated if the ECM sample is not well-dispersed. 5 µl of solution 
was adsorbed onto glow-discharged 400 mesh copper/carbon-film grids (EM Resolutions) for 
about 2 min. Grids were rinsed on two drops of DIW and negative staining was performed 
using a 2 % aqueous uranyl acetate solution. Grids were viewed in a FEI Tecnai G2 electron 
microscope run at 200 keV using a 10 µm objective aperture. Images were acquired using AMT 
Camera software.  
5.2.2 Fluorescence Spectroscopy 
All the fluorescence spectra were recorded on a Cary Eclipse fluorescence spectrophotometer 
(Agilent, former Varian). ECM was gently slided in a micro quartz cuvette with a pathlength 
of 10x2 mm and a chamber volume of 700 µL (Hellma Analytics). Voltage typically used were 
between 600 W – 750 W depending on sample volume. To acquire a spectrum with decent 
signal to noise, higher voltage was usually used when sample volume was small.  
 
Table 5-2 Excitation wavelength used, and emission spectra width acquired in this project.  
Excitation wavelength / nm Emission wavelength range / nm 
275 285-450 
285 295-450 
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5.2.3 Amino acid analysis 
Amino acid analysis service was provided by the Department of Biochemistry, University of 
Cambridge. Freeze-dried ECM samples were provided to the service for analysis. 
 
The procedure is modified from reference [145] for the ECM samples. Briefly, freeze-dried 
ECM samples were hydrolysed by a mixture of concentrated HCl, phenol (0.5 mL) and 
dodecanthiol (0.86 µL), with the presence of known amount of L-norleucine as an internal 
standard, under vacuum at 115 ℃ for 22 hours. Then the hydrolysed sample was dried and 
neutralised in a desiccator with solid NaOH and re-dissolved in buffer (sodium citrate, pH = 
2.2, Sigma) before injecting to a Pharmacia Alpha Plus series amino acid analyser (Biochrom 
Ltd, Cambridge, UK). Chromatography was performed and peak detection was achieved by 
mixing the eluate with ninhydrin at 135 ℃ and measuring the absorbance at 570 and 440 nm. 
The peak area from each amino acid was recorded and compared with the internal standard to 
give the ultimate mol% for each amino acid.  
5.3 Glycation  
Collagenous samples, either intact ECMs or collagen extracted from ECMs were incubated in 
50 mM U-13C5-Rib or -R5P or 100 mM U-13C6-Glc in 150 mM phosphate buffer at 37 ℃ for 8 
weeks. Often, ECM harvested from 2-3 flasks of cells were incubated in 6 mL solution. At the 
end of the glycation incubation, the collagenous sample was washed with deionised water to 
remove any excess glycating agents and phosphate buffer. The sample was freeze-dried for 
overnight and stored in -20 ℃ freezer before further analysis.  
5.4 Sample Preparation for SSNMR Experiments 
All SSNMR samples were thoroughly washed by water to remove possible salt content from 
PBS. Then they were freeze-dried overnight and stored at -20°C before SSNMR experiments.  
SSNMR 
Samples were packed in Kel-F inserts that fit in 4 mm zirconia rotors, unless they have 
sufficient amount to be packed directly in a rotor.  
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Generally speaking, sample mass varies between different sample types. Most samples 
included in this thesis weigh around 10-20 mg. Low sample mass can lead to low S/N ratio and 
thus less informative/desirable spectra. 
DNP-SSNMR 
For the DNP NMR experiments, 3.2 mm outer diameter zirconia rotors with Vespel caps were 
used. AMUPol was prepared as 20 mM solutions in D2O/H2O (75% D2O, 25% H2O), then 12.5 
μL of the radical solution was added to the sample-filled rotor. The rotors were closed with a 
Vespel cap, then spun in both vertical orientations (with the cap facing upwards and 
downwards) with a desktop mini centrifuge to distribute the radical solution within the rotor. 
The packed rotors were allowed to equilibrate with the radical solution overnight in the fridge 
before the start of DNP NMR experiments.  
5.5 SSNMR Experimental Parameters 
5.5.1 Spectrometer Used, MAS Rates and Chemical Shift 
Referencing 
SSNMR 
All experiments were performed on a Bruker AVANCE I 400 MHz wide bore spectrometer 
operating at a static magnetic field of 9.4 T, with 31P Larmor frequencies at 162 MHz, 13C at 
100 MHz and 15N at 40 MHz. A standard 4mm double resonance probe with a MAS rate limit 
of 15 kHz was used for all experiments.  
 
Chemical shifts reported in this thesis were referenced on different chemicals, as shown in the 
table below (Table 5-3), as well as MAS rates used to acquire different nuclei. All 2D spectra 
were acquired at a MAS rate of 10 kHz. Most experiments were performed under room 
temperature without temperature control/chilling; some were at 290 K.  
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Table 5-3 Chemical shift references and MAS rates for acquiring different nuclei.  
Nuclei MAS speeds Chemical Shift References  
31P 10 kHz Hydroxyapatite at 2.6 ppm with respect to 85 wt% H3PO4 at 0 ppm 
13C 10 kHz Glycine Ca at 43.1 ppm with respect to TMS at 0 ppm 
15N 6 kHz Glycine 15N at 32.3 ppm with respect to ammonia at 0 ppm 
1H 13 kHz Ethanol methyl carbon at 1.11 ppm with respect to TMS at 0 ppm 
 
DNP-SSNMR 
DNP-SSNMR experiments were performed on a Bruker Avance III wide-bore spectrometer 
operating at a static magnetic field of 9.4 T, with 1H Larmor frequencies of 400 MHz. For 
DNP-SSNMR, the 400 MHz spectrometer is equipped with a gyrotron operating at 9.7 T and 
a 3.2 mm (1H- 13C-15N) triple resonance low-temperature magic angle spinning (LTMAS) 
probe. DNP-enhanced experiments were carried out under 30 mA microwave irradiation. 
 
All spectra were acquired at a MAS rate of 8889 Hz. The sample temperature was set to 100 K 
using the LTMAS cooling cabinet. 
5.5.2 Typical Parameters for SSNMR Experiments  
Typical CPMAS SSNMR Experiments Parameters 
In this project, CPMAS SSNMR experimental parameters are usually optimised on solid-state 
collagen-like peptides, such as (GPO)10. Only if necessary, parameters are further optimised 
on individual samples. Typical 1H-X CPMAS parameters for this work are included in Table 
5-4. 1H’s natural abundance is 99.99%.  
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Table 5-4 Typical 1H-X CPMAS SSNMR experiments parameters used in this project to 
observe different nuclei. They are all obtained collagen-like peptides with a MAS 
rate at 10 kHz.  
Nuclei 
observed 
Natural 
abundance 
Recycle 
delay 
1H 900 pulse 
length 
Contact pulse 
length 
Decoupling 
13C 1.11% 2 s 2.5 µs 2.5 ms 104 kHz  
SPINAL64 15N 0.36% 2.5 ms 
31P 100% 10 ms 
 
Typical CPMAS DNP-SSNMR Experiments Parameters 
DNP-SSNMR parameters on the 400 MHz spectrometer were optimised on the specific sample 
but they usually are in a similar range: 1H 90° pulse length 2.2-2.5 μs, 1500 μs 1H- 13C ramped 
CP contact time, 80+ kHz 1H decoupling, with a recycle delay 1.5 s.  
Typical 2D 13C-13C PDSD MAS SSNMR Experiments Parameters 
1H-13C CP parameters have been included in the previous sections. 13C 90° pulse length is 3.57 
µs. 104 kHz CW-13 is used during the incremental delay and 104 kHz SPINAL64 decoupling 
scheme is used during acquisition periods.   
Typical 2D 13C-13C DARR MAS DNP-SSNMR Experiments Parameters 
1H-13C CP parameters under DNP conditions have been included in the previous sections. 13C 90° pulse length is usually between 4.1-4.75 µs. 1H decoupling pluses are typically between 
80-100 kHz.  
Typical 2D 13C-13C PC7 MAS SSNMR Experiments Parameters 
1H-13C CP parameters have been included in the previous sections. At our experimental 
condition, MAS rate of 10 kHz, 13C 90° pulse length is set to 3.57 µs to achieve the requirement 
on field strength, 𝜔01 = 7𝜔0 = 70	𝑘𝐻𝑧 . 𝑡:  is set to be 28.57	𝜇𝑠 = 𝜏E . With n=14, 𝜏IzE =𝜏0IE = 0.4	𝑚𝑠 . 104 kHz LG decoupling scheme [146] is used during C7, and 104 kHz 
SPINAL64 decoupling scheme is used during acquisition periods. LG decoupling scheme 
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introduces a scaling factor on 1H dimension, hampering 1H chemical shifts. This is taken care 
of post-acquisition.  
Typical 2D 13C-13C SPC-5 MAS DNP-SSNMR Experiments Parameters 
13C-13C 2D single quantum-double quantum (SQ-DQ) correlation spectra were carried out by 
1H-13C CP followed by a SPC-5 mixing sequence. The MAS rate was set to 8889 Hz. DQ 
coherence was excited by applying the SPC5 sequence for 1.2 ms (10 times).  
Typical 2D 1H-13C HETCOR MAS SSNMR Experiments Parameters 
Correlations between 1H and 13C are investigated using HETCOR experiments. Typical 
parameters are listed in the table below.  
 
Table 5-5 Typical parameters used in 2D 1H-13C HETCOR MAS SSNMR experiments for 
observing different nuclei. They are all obtained with a MAS rate of 10 kHz. 
Nuclei 
observed 
Recycle 
delay 
1H 9 𝟎°  pulse 
length 
Contact 
pulse length 
1H-1H Decoupling 
(evolution) 
1H-13C Decoupling 
(acquisition) 
13C 2 s 2.5 µs 0.5 ms 104 kHz 
FSLG 
104 kHz 
SPINAL-64 
 
Typical 2D 13C-15N Correlation DNP-SSNMR Experiments Parameters 
2D 13C-15N heteronuclear correlation  experiments were carried out with 90° pulse lengths of: 
1H 2.4 μs, 13C 4.33 μs, 15N 4.27 μs. In 13C-15N DCP-DARR experiments, magnetization was 
first excited by 1H-15N CP with a 450 μs contact pulse length, with a slight ramp shape on the 
15N channel, followed by indirect 15N evolution, during which 1H was decoupled at 80 kHz. 
Magnetization was then transferred by 15N-13C SPECIFIC-CP with a 4.5 ms contact pulse 
length, with a square shape on 15N and a tangential shape on 13C. At this point there was no 
indirect evolution on 13C, instead, a DARR sequence was immediately applied on the 13C 
channel, followed by 13C acquisition with 80 kHz 1H decoupling. A 219 ppm 15N sweep width 
was used here to ensure the full 15N range was recorded without aliasing. 60 indirect evolution 
increments were collected, with 1024 transients per increment. Thus, the signal averaging time 
was ~51 hours.  
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5.6 Cellular Metabolites Extraction 
Cells were cultured in a T-175 flask containing 25 mL Dulbecco’s Modified Eagle Medium 
(DMEM; Invitrogen) with 10% foetal calf serum (First Link) and 10 mL/L L-glutamine-
penicillinstreptomycin (200 mM L-glutamine, 10,000 units/ml penicillin, and 10 mg/ml 
streptomycin in 0.9% sodium chloride; Sigma). For K7M2, DMEM with 4.5 g/L glucose was 
used; while for VSMC, DMEM with 1 g/L glucose was used. The culture was incubated at 
37 °C in a humidified atmosphere of 95% air and 5% CO2, and the culture medium was 
renewed every 2 days until cells reached 90-95% confluency. Then medium was removed, and 
the cells were washed once with 10 mL saline (Invitrogen).  
 
Afterwards, cells were lysed by either freeze-thaw lysis or liquid nitrogen lysis:  
Freeze thaw lysis (FT)  
Cell culture flasks were placed in -80°C freezer for overnight and thawed the next day under 
room temperature for 30 minutes. Initially, cells were scraped off with the presence of 5-8 mL 
water; later, cells were scraped off with the presence of cold 80% MeOH (8 mL, pre-cooled in 
-80 °C freezer) to extract metabolites. Then, the mixture was transferred into a fresh centrifuge 
tube and it was centrifuged at 4 °C, 4500 RPM for 15 mins. Cell debris was washed again with 
cold 80% MeOH (8 mL, pre-cooled in -80 °C freezer) to achieve better extraction.  
Liquid nitrogen lysis (LN)  
Liquid nitrogen was poured into cell culture flasks to freeze cells. Pre-cooled 80% MeOH (8 
mL, -80 °C) was added to a flask to extract cell metabolites. Cells were scraped off with the 
presence of cold 80% MeOH, and transferred to a fresh centrifuge tube. Later, cell mixture was 
gently sonicated in ice to break more membranes. The tube was vortexed for better extraction, 
and centrifuged down at 4500 RPM for 15 minutes. Cell debris was washed again with cold 
80% MeOH (8 mL, pre-cooled in -80 °C freezer) to achieve better extraction.  
 
Finally, clear supernatant was transferred into 50 mL centrifuge tube and freeze-dried 
overnight. Freeze-dried cell lysate was stored at -20 °C freezer before further experiments.  
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5.6.1 Poly-L-Lysine Incubation Experiments 
Freeze-dried cell lysate samples were reconstituted in 1.4 mL 150 mM phosphate buffer (PB). 
The mixture was then centrifuged at 4500 RPM at 2 °C for 5 minutes to remove undissolved 
precipitates. Poly-L-Lysine (PLL, Sigma) was dissolve in PB to make 1 mL of 100 mM PLL 
solution. Same with glucose and other sugar, 1 mL 100 mM solution was made in PB. 100 µL 
PLL and 100 µL reconstituted cell lysate were added into a well in a black 96-well-plate for 
fluorescence measurement. 5 replicates were made for each experimental group. Control 
groups were made by adding 100 µL PB together with 100 µL control samples to balance the 
concentration. Plates were incubated in a 37 °C incubator, and AGE fluoresecence was 
measured at different time points over incubation.  
AGE Fluorescence Measurement 
AGE fluorescence was measured using a FLUOstar Omega plate reader (BMG LABTECH). 
Fluorescence intensities were recorded at excitation 355 nm and emission 460 nm.  
 
Data processing: Within the same plate, data acquired at different time points are normalised 
on PLL, which is not supposed to be fluorescent; however always give a fluorescent reading 
around 10 times of PBS-noise level intensity.  
5.6.2 Solution-state NMR experiments 
700 µL D2O with TSP as internal NMR reference, was added into lyophilized cell lysate (from 
1 flask of cells). It was then centrifuged at 4500 RPM at 2 °C for 3 minutes to remove bubbles 
and precipitates. Clear supernatant was transferred into a 5mm solution state NMR tube.  
 
All the solution-state NMR spectra were acquired on a 500 MHz Bruker spectrometer equipped 
with a cryoprobe that can operate at 5 ℃.  
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5.6.3 HPLC-UV-MS Experiments 
Pre-column Derivatisation  
Derivatisation method was adapted from reference [147].  
 
Different reaction times, 1, 2, 3, 4 and 9 hours, were tested on 0.5 mg/mL R5P in 75% methanol 
in water with an internal standard solution of 0.2 mg/mL fucose in in 75% methanol in water 
at 70 °C, static. Optimal reaction time was found to be 1 hour.  
 
A calibration curve was established with R5P in 75% methanol in water of different 
concentrations: 1 mg/mL, 0.5 mg/mL, 0.25 mg/mL, 0.1 mg/mL and 0.05 mg/mL, with the same 
concentration of fucose as internal standard.  
 
100 uL 75% methanol in water was added in lyophilized cell lysate to dissolve as much as 
possible, and was transferred into a 1.5 mL tube. The tube was centrifuged at 10,000 rpm for 
5 mins, and the supernatant was taken out as sample A. Then, a further 100 uL 75% methanol 
in water was added in the remaining cell lysate to repeat the process. The second supernatant 
was regarded as sample B.  
 
50 uL reconstituted cell lysate was mixed with 50 uL internal standard solution (0.2 mg/mL 
fucose in 75% methanol in water) in a 2 mL Eppendorf tube, followed by the sequential 
addition of 100 uL of 25 mM AEC in methanol, 50 uL of 50 mM NaCNBH3 solution, and 20 
uL acetic acid. The mixture was heated at 70 °C for 1 hour in a heating block. After reaction, 
the tube was cooled on ice for 1 min, and then, 100 uL of water and 1 mL of a dichloromethane-
hexane (2:1, v/v) solvent were added. Each tube was vortexed and was then centrifuged at 
10,000 rpm for 5 mins in a microcentrifuge. A 100 uL aliquot of the upper aqueous phase was 
transferred to an LC autosampler vial for HPLC-UV-MS analysis.  
HPLC-UV-MS Detection and Quantification 
All LC separations were carried out using Thermofisher HPLC system with a Phenomenex 
Synergi C18 (250×4.6mm, 4µm, 80Å) column. The mobile phase was composed of water/0.1% 
formic acid (A) and acetonitrile/0.1% formic acid (B). The column flow rate was set at 1 
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mL/min, and the column temperature was maintained at 30 ℃. The elution gradient was 0% to 
35% B in 45 mins, to 100% B in another 5 mins, and then held at 100% for 5 mins before 
equilibrating at 100% A for a further 5 mins. UV absorption spectra were collected at 254 nm.  
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6 Collagen Extraction from In vitro ECM 
In vitro ECM is known to contain hundreds of proteins other than collagen (described in section 
2.3). Extracting collagen from uniformly isotope enriched in vitro ECM allows the production 
of uniformly isotope labelled collagen, which enables further studies of collagen and collagen 
glycation by SSNMR.  
 
However, removing non-collagenous (NC) ECM proteins and extracting intact collagen from 
in vitro ECM can be challenging, because commonly used proteolytic enzymes, such as trypsin, 
papain and pepsin, would digest collagen at the same time as NC proteins [148][149]. An ideal 
enzyme for collagen extraction from in vitro ECM requires (1) working best under 
physiological conditions, pH and temperature, to avoid the effects of extreme working 
conditions on collagen and (2) working exclusively or at least significantly more effectively on 
NC ECM proteins than collagen, in other words, preferable enzymatic cleave sites involving 
amino acids more abundant in minor proteins, less abundant or even absent in collagen.  
 
Chymotrypsin was eventually chosen, aiming to remove NC ECM proteins while keeping 
collagen intact. Its activity is maximal at pH=7.8-8, but it is effective enough to use at 
physiological pH=7.4 [150]. This gentle pH condition minimises the possibility of collagen 
hydrolysis under acidic conditions. Moreover, chymotrypsin cleaves preferentially at carbonyl 
side of amide bonds of large hydrophobic or aromatic amino acids, such as phenylalanine (F), 
tyrosine (Y), tryptophan (W) and leucine (L), unless the next amino acid is proline (P) 
[151][152]. Considering the amino acid composition of collagen versus other ECM proteins, 
there are far fewer aromatic amino acids in collagen, and thus providing far fewer cleavage 
sites. For example, in bovine collagen type I, about 2.3% of the amide bonds are theoretically 
cleavable, while in bovine fibronectin isoform 1 this number goes up to 12.6% (Table 6-1) 
[153]. Additionally, due to the complex organisation of ECM, collagen may not be directly 
exposed to surrounding enzymes, and therefore can be regarded as protected to some extent by 
collagen binding proteins. Thus, collagen may not be digested until these binding proteins are 
removed.  
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Thus, chymotrypsin appears an ideal enzyme to remove minor ECM proteins and extract intact 
collagen fibrils from in vitro ECM. Its candidacy was tested by different characterisation 
methods, designed to (1) investigate effective working conditions on two different types of 
ECMs, as composition of ECM from different cells can be different, to see if a generic and 
robust protocol can be established (2) evaluate the effectiveness of the protocol, if successfully 
established, and (3) examine the purity and intactness of the resultant extracted collagen fibrils. 
Results and experimental details will be presented in the following sections.  
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Table 6-1 Number of cleavable F, Y, W and L sites in Top: Bovine Collagen Type I. Middle: 
Bovine Fibronectin Isoform 1. Bottom: Bovine Elastin Isoform 1. Numbers of 
residues are calculated using sequences published on protein sequence database, 
UniProt [153]. Identifiers for Bovine Collagen Type I are P02453 and P02465, for 
Bovine Fibronectin Isoform 1 is P07589-1, for Bovine Elastin Isoform 1 is P04985-
1. Numbers of residues can vary from one isoform to another resulting from slightly 
different sequences between isoforms. For ease of demonstration, the calculation 
below assumes that chymotrypsin only works on the 4 amino acids mentioned here.  
Amino acid 
(percentage 
per molecule) 
Number in Collagen I a1 chain Number in Collagen I a2 chain 
Total Protected by P Digestible Total Protected by P Digestible 
F (1.3%) 13 7 5 16 5 11 
Y (0.4%) 5 0 5 3 1 2 
W (0) 0 0 0 0 0 0 
L (2.5%) 22 12 10 34 15 19 
                                                                  20 x2 =40 32 
Sum                                                                                                                               72 (2.3%) 
Amino acid 
(percentage 
per molecule) 
Number in Fibronectin 
Total  Protected by P Digestible 
F (2.1%) 51 7 44 
Y (4.1%) 101 4 97 
W (1.6%) 40 0 40 
L (5.8%) 143 12 131 
Sum                                                          312 (12.6%) 
Amino acid 
(percentage 
per molecule) 
Number in Elastin 
Total  Protected by P Digestible 
F (2.8%) 21 6 15 
Y (0.94%) 7 3 4 
W (0) 0 0 0 
L (6.7%) 50 12 38 
Sum                                                              57 (7.6%) 
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6.1 Effects of Chymotrypsin Digestion on In vitro ECM 
In vitro ECM was decellularised and incubated with chymotrypsin; four techniques were used 
to examine the efficacy of this extraction: TEM, fluorescence microscopy, amino acid analysis 
(AAA) and SSNMR microscopy.  
 
The decellularisation method is an important factor in determining ECM composition, 
therefore it was optimised at the beginning to obtain relatively “clean” ECM with as few as 
possible NC components [154][155]. Initially, ECM is subjected to freeze-thaw lysis here to 
lyse the cells, which preserves essentially all proteins as well as a significant amount of lipid. 
Then, a mild detergent is used to decellularize ECM by gently breaking lipid-lipid interactions 
and protein-lipid interactions, obtaining cleaner ECM than that obtained from freeze-thaw lysis.  
6.1.1 Transmission Electron Microscopy (TEM) 
TEM can visually and qualitatively demonstrate collagen quality and residual ECM 
components in differently processed ECMs. Collagen fibrils, under TEM, are long (typically 
longer than the field of view), relatively straight, i.e. not kinked, and have distinctive banding 
patterns (illustration in Figure 2-4). These unique characteristics of collagen fibrils enable 
accurate recognition of collagen fibrils and distinguish collagen from other ECM proteins in 
TEM images. Specifically, in this work, TEM is used firstly, to examine if chymotrypsin is 
able to remove NC proteins, and secondly, to decide an optimal chymotrypsin treatment 
condition for ECM that removes the most NC proteins and preserves collagen fibrils. In other 
words, TEM is used to assess the feasibility and effectiveness of using chymotrypsin to clean 
in vitro ECM.  
 
To start with, ECM without any post-cell lysis treatment was observed under TEM. A 
representative image of freshly decellularised ECM from in vitro cell culture of bovine vascular 
smooth muscle cells (VSMCs) is shown in Figure 6-1 A. Different decellularisation methods 
do not show significant differences; both methods, freeze-thaw lysis and detergent lysis, show 
a substantial amount of what appears to be small proteins. Some of them are adhered to collagen 
fibrils while some are spread in the background. Collagen fibrils can be recognised but are 
mostly buried underneath small ECM proteins. Fibril banding patterns cannot be observed.  
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Then, different chymotrypsin incubation times were tested on VSMC ECM, 30 mins, 2 hrs and 
overnight (between 18-24 hrs) at 37℃  (detailed procedure is included in section 0), and 
eventually, overnight incubation was decided to be optimal for producing clean, well-
structured collagen fibrils after comparing a considerable number of images obtained from 
different chymotrypsin incubation times (images are not shown here due to space limitation).  
 
After overnight incubation (Figure 6-1 B), significant protein removal is achieved compared 
to untreated ECMs (Figure 6-1 A), and collagen banding patterns begin to be observed. This 
indicates that NC proteins are removed from collagen surface, revealing better details of the 
collagen fibril itself, though there is still some extraneous material left either associated with 
or dissociated from collagen fibrils. Overall, collagen fibrils are observed with a negligible 
amount of proteins entangled after overnight chymotrypsin incubation. Thorough washings 
should be done afterwards to remove unbound proteins as much as possible.  
 
Figure 6-1 TEM images of VSMC ECM samples, negatively stained by uranyl acetate. A. 
Freshly decellularised VSMC ECM, showing a significant amount of NC ECM 
proteins. Some collagen fibrils are pointed by a red arrow, recognised by their long 
and straight shape. B. VSMC ECM after overnight incubation with chymotrypsin, 
showing collagen fibrils and their banding patterns (see enlargement on the left). 
Scale bars are shown underneath each image, and both of them are 500 nm long.  
 
It is evident from TEM images that chymotrypsin is effective in digesting NC ECM proteins. 
Without chymotrypsin digestion, collagen fibrils are mostly covered by NC proteins and only 
distinguished from other ECM proteins because of their length and straightness. After 
chymotrypsin treatment, a significant amount of NC ECM proteins is removed from ECM 
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samples, and collagen fibrils can be easily identified by not only their straightness and length 
but also their unique banding patterns. An adequate working condition is determined to be 
incubating ECM with chymotrypsin overnight at 37℃ (more detailed protocol is included in 
section 0). However, further washing is needed to better remove proteins disassociated or 
loosely associated with collagen.  
 
However, TEM has its limitations. It can be selective, because images taken can only represent 
the local area observed, and the information interpreted from those images may not be an 
appropriate representation of the whole sample. Therefore, multiple images should be taken 
per sample to give a more holistic understanding of the sample. Although TEM is enough for 
an initial assessment, a better representation and more general information are desired to study 
the change in chymotrypsin treated ECM samples and to make a solid conclusion about 
effectiveness of this treatment.  
6.1.2 Fluorescence Spectroscopy 
Fluorescence has long been used to study proteins because many proteins with Y, W or F 
residues can auto-fluoresce. It can be used to investigate a wide range of topics related to 
protein structure because fluorescence is sensitive and changes in response to protein structural 
changes, including conformational changes, altered binding activities, etc [156][157][158]. 
This sensitivity allows analysis of ECM component changes due to chymotrypsin treatment. 
More importantly, unlike TEM, fluorescence can reflect the overall features of the entire 
sample in favourable circumstances.  
 
Among these three fluorescent amino acids, F is not studied as extensively as the other two 
because its quantum yield is too low (Table 6-2), making it unlikely to be observed when W or 
Y are also present. Y gives simple emission spectra. When excited at 275 nm at neutral pH, its 
emission maximises at 305 nm. A band at 330-350 nm sometimes appears together with its 
main peak, which originates from Y oxidation and is assigned as tyrosinate [159]. Tyrosinate 
is weakly fluorescent and can be easily lost under other peaks. W is much more often used as 
a fluorescence probe of protein structure than F and Y because its emission is highly sensitive 
to its local environments, such as polarity and solvent exposure. Commonly, when excited at 
285 nm, W folded inside proteins in a non-polar environment gives a maximum emission 
around 330 nm; if the maximum emission wavelength is longer than 330 nm, W is in a more 
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polar environment, and in most cases, more exposed to surrounding solvent [160]. Because W 
is not present in collagen, W emission spectra are used in this project as measurements of 
whether chymotrypsin effectively removes W-containing proteins in ECM samples. 
Fluorescence experiments were developed in collaboration with Dr. Uliana Bashtanova and 
Ieva Goldberga.  
 
Table 6-2 Fluorescence properties of F, Y and W in aqueous solutions at neutral pH [156][158], 
and wavelengths used in experiment.  
Amino 
acid 
Quantum 
yield in 
water  
Excitation 
wavelength in 
literature /nm 
Excitation 
wavelength in 
experiments /nm 
Emission 
wavelength in 
literature /nm 
Emission 
wavelength in 
experiments /nm 
F 0.024 max at 260 - 260-340;  
max at 280 
- 
Y 0.14 max at 275 275 280-380;  
max at 305 
285-450 
W 0.13 max at 285 285 300-450;  
max at 350 
295-450 
 
The effectiveness of chymotrypsin treatment is measured by comparing fluorescence emission 
spectra of W and Y between differently treated ECM samples and pure collagen type I (from 
bovine Achilles tendon), in particular comparing parameters such as band shapes and 
wavelength shifts. Absolute fluorescence intensity cannot be used to quantify the amount of W 
or Y containing proteins in ECM, because measured intensity depends on many factors, the 
majority of which cannot be determined in this experiment. For example, a quantitative 
correlation between fluorescence intensity and the amount of fluorescent proteins requires at 
least sample homogeneity along the optical beam path through the sample; however, with ECM 
samples, it is difficult to guarantee the sample is homogenous across the entire sample; and 
therefore, fluorescence on ECM samples can only be interpreted qualitatively rather than 
quantitatively. Considering W is absent in collagen, fluorescence emission spectra of W - or 
lack of W emission - can indicate the purity of the collagenous ECM sample, in other words, 
the effectiveness of NC protein removal. Typical fluorescence emission spectra, both Y and W, 
of ECM samples before and after chymotrypsin treatment are shown in Figure 6-2, as well as 
emission spectra from pure collagen type I for comparison.  
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The same chymotrypsin digestion procedure was repeated on a different in vitro ECM 
harvested from foetal sheep osteoblasts (FSOBs) cell cultures to test if the procedure is generic 
and robust. When excited at 275 nm (to observe primarily Y) and 285 nm (to observe primarily 
W), emission spectra of both VSMC and FSOB ECM look very similar (all four black spectra 
in Figure 6-2), showing a broad emission peak with a maximum wavelength around 330 nm. 
This maximum implies that both ECM samples have a significant amount of folded W. The 
broadness of the emission peaks indicates that W distributes in a variety of different local 
environments in ECM. Signals from Y are presumably overlapped by this broad, intense peak 
from W.  
 
After incubating ECM samples with chymotrypsin, W emission spectra, i.e. spectra arising 
from 285 nm excitation, (two red spectra in Figure 6-2 on the right) change dramatically from 
the previously broad peak centred around 330 nm to a decay curve with no obvious maximum. 
This change suggests that a substantial amount of W-containing proteins is removed from this 
sample, changing the emission peak shape. Two humps are observed around 310 nm and 325 
nm, which might be from remaining W in different environments. In Y emission spectra, i.e. 
spectra arising from 275 nm excitation, (two red spectra in Figure 6-2 on the left), ECM 
samples start showing distinct Y peaks at around 300 nm after chymotrypsin treatment. 
Appearance of the Y peak can result from significant decreasing W-containing proteins/W 
emission, and thus, uncovering hidden Y signals, which are expected from collagen as well as 
other ECM proteins. Both effects, significant decline in W peak intensity and appearance of 
the Y peak, suggest successful removal of W-containing proteins and the effectiveness of 
chymotrypsin in digesting minor ECM proteins.  
 
A washing step was introduced after the overnight chymotrypsin treatment to better remove 
remaining proteins, using a gentle detergent Tween-20 [161]. This extra washing step further 
smooths the emission spectra of collagenous ECM samples (all green spectra in Figure 6-2) 
and makes their spectra more like the emission spectra of pure collagen (blue spectra in Figure 
6-2). This washing seems to be more effective to VSMC ECM than FSOB ECM: the line shape 
does not change as much in FSOB as in VSMC.  
 
However, information obtained from fluorescence emission spectra may not apply to the entire 
sample as whether chymotrypsin digestion is effective only on ECM surface or on the entire 
sample is still an open question. Concerns arise from the observation of reflected signals. The 
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light beam used for fluorescence excitation does not penetrate through ECM samples 
completely, and part is reflected via the sample surface, which is the limitation of detection for 
solid samples. Peaks at 360nm, 375 nm and 420 nm for lex=275 nm, and 360 nm and 390 nm 
for lex=285 nm appear in all spectra obtained (Figure 6-2), and are assigned as reflection peaks 
due to samples’ solid nature. This means (1) ECM samples are rigid enough to reflect light, (2) 
unlike homogeneous protein solutions, ECM samples may not experience the same beam 
strength equally across the sample – some parts are penetrable and some not. For areas causing 
reflection, the light beam only reaches sample surface and discloses structural information of 
the sample surface. So, it is possible that minor proteins are hidden behind the reflective areas 
and are undetected by fluorescence.  
 
To sum up, fluorescence emission spectra of chymotrypsin digested and detergent washed 
ECM samples show that this combination successfully removes the majority of ECM proteins. 
However, due to the intrinsic limitation of fluorescence measurement on solid samples, a 
question regarding whether chymotrypsin is able to penetrate the whole ECM structure and 
cleave all minor proteins is still left open.  
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Figure 6-2 Fluorescence emission spectra acquired at different excitation wavelengths on 
differently treated ECM samples. Top: emission spectra from differently treated 
VSMC ECM at excitation of 275 nm (for Y) and 285 nm (for W). Middle: emission 
spectra from differently treated FSOB ECM at excitation of 275 nm and 285 nm. 
Spectra in black are from untreated ECM; spectra in red are from chymotrypsin 
digested ECM; spectra in green are from chymotrypsin digested and Tween-20 
washed ECM. Bottom (blue): emission spectra of collagen at excitation of 275 nm 
and 285 nm.  
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6.1.3 Solid-State NMR (SSNMR) Spectroscopy  
SSNMR provides averaged structural information of the entire sample. It is able to reveal 
amino acid composition of protein samples, and is also sensitive to protein secondary structures, 
giving different chemical shifts for residue signals in different secondary structures [162]. In 
particular, Ca and C’ 13C chemical shifts of residues in the collagen triple helix conformation 
are characteristically lower than those in all other secondary structures. Therefore, NMR can 
tell not only whether there is an overall amino acid composition change but also if the 
secondary structure has changed, in this work, if collagen is still present in intact triple helices.  
 
Figure 6-3 compares 1D 13C CPMAS SSNMR spectra of pure collagen type I and differently 
treated ECMs. 13C signals from G Ca, P Ca, O Cd, G C’ and P C’ become more prominent after 
the clean-up procedure, and overall spectrum details look more like pure collagen. This trend 
indicates ECM samples become more like pure collagen as a result of removing the majority 
of NC ECM proteins. The top three spectra in Figure 6-3, acquired on pure collagen type I, 
“cleaned” FSOB ECM (called “FSOB Chymotrypsin + Tween-20” in the figure, and will be 
referred as “Col(FSOB)” in the following text) and “cleaned” VSMC ECM (called “VSMC 
Chymotrypsin + Tween-20” in the figure, and will be referred as “Col(VSMC)” in the 
following text) look almost the same with slightly better resolution in the spectra of Col(FSOB) 
and Col(VSMC). However, whether there is any NC protein left is difficult to tell because 
SSNMR may not be sensitive enough to spot remaining minor proteins. It is also interesting to 
see the bottom four spectra in Figure 6-3, acquired on detergent lysed FSOB ECM (called 
“FSOB Detergent” in the figure, and will be referred as “ECM(FSOB)” in the following text), 
detergent lysed VSMC ECM (called “VSMC Detergent” in the figure, and will be referred as 
“ECM(VSMC)” in the following text), freeze-thaw lysed FSOB ECM (called “FSOB Freeze-
thaw” in the figure, and will be referred as “ECM(FSOB) FTL” in the following text) and 
freeze-thaw lysed VSMC ECM (called “VSMC Freeze-thaw” in the figure, and will be referred 
as “ECM(VSMC) FTL” in the following text), are very similar in terms of the overall signal 
shapes and signal relative intensities; even though some spectra are noisier than the other due 
to limited sample volume or fewer number of scans (consecutive acquisitions). This similarity 
also indicates SSNMR is not sensitive enough to distinguish ECM decellularised from different 
methods. 
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As mentioned earlier in Table 6-1, collagen has some cleaving sites which makes it also 
susceptible to chymotrypsin. An ECM sample was prepared by carrying out three cycles of 
chymotrypsin digestion and detergent wash to test if collagen is still intact. A positive control 
was also made using collagenase-digested collagen to show what the 13C NMR spectrum of 
denatured collagen looks like (Figure 6-4). 13C chemical shifts and peak widths of G Ca, P Ca, 
O Cd, G C’ and P C’ signals were inspected to see if there was any change correlating to 
secondary structure changes in the chymotrypsin treated sample compared to pure collagen or 
collagenases-digested collagen. Looking at black dotted lines in Figure 6-4, no obvious 
chemical shift changes are observed in the chymotrypsin-treated ECM sample (the olive green, 
middle spectrum in Figure 6-4), even after three cycles of chymotrypsin incubation, compared 
to pure collagen (the blue, top spectrum in Figure 6-4), indicating the majority of collagen triple 
helices are still intact. However, in the collagenase-treated collagen sample (the purple, bottom 
spectrum in Figure 6-4), significant signal shifts of G Ca and P Ca as well as signal broadening 
of all G Ca, P Ca, O Cd, G C’ and P C’ signals are observed, indicating the disruption of collagen 
triple helix.  
 
To sum up, the major protein left in ECM samples after the clean-up procedure is collagen. 
Based on the conserved 13C chemical shifts and the linewidth of G Ca and C’ and P Ca and C’ 
signals, collagen is still in triple helical form. However, the sensitivity of SSNMR can be 
arguable; not observing a species under SSNMR does not mean absolute absence. CP SSNMR 
experiments can be selective in terms of detecting proteins; for instance, CP is very inefficient 
for mobile molecules, and so signals from such molecules are unlikely to be observed in CP 
spectra.  
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Figure 6-3 13C CPMAS SSNMR spectra of, from top to bottom, pure collagen type I (ns = 
4096), Col(FSOB) (FSOB ECM chymotrypsin + Tween-20, ns = 32468), 
Col(VSMC) (VSMC ECM chymotrypsin + Tween-20, ns = 6144), ECM(FSOB) 
(FSOB ECM detergent, ns = 8192), ECM(VSMC) (VSMC ECM detergent, ns = 
8192), ECM(FSOB) FTL (FSOB ECM freeze-thaw, ns = 8192) and ECM(VSMC) 
FTL (VSMC ECM freeze-thaw, ns = 8192). Black dash lines connect P C’, G C’, 
O Cd, P Ca, and G Ca signals across all spectra.  
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Figure 6-4 A comparison of 1D 13C CPMAS SSNMR between pure collagen type I (top, blue, 
ns = 4096), detergent lysed VSMC ECM with 3 cycles of chymotrypsin digestion 
and detergent wash (middle, olive green, ns = 8192) and collagenase denatured 
collagen type I (bottom, purple, ns = 10240). Denatured collagen shows observable 
signal shifting and the sample was prepared by Dr. Sneha Bansode.  
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6.1.4 Amino Acid Analysis (AAA) 
Knowing G is every third residue in collagen triple helix, the molar ratio of G in collagen 
should be around 33%. This number can vary slightly in different types of collagen and 
collagen from different animal species. A second special feature of collagen is the presence of 
O, a unique post-translational modification (PTM) in collagen (and elastin). Considering the 
ECM as a whole, where G and O are rarer, the presence of other proteins dilutes the molar ratio 
of G and O. This means removing NC proteins in ECMs should result in increased molar ratio 
of G and O and decreased molar ratio of L, F and Y, which are relatively less abundant in 
collagen compared to other ECM proteins, towards their molar ratios in collagen. AAA is able 
to measure the molar ratio of individual amino acids in ECM samples and provides a more 
quantitative perspective on amino acid composition in collagenous ECM samples, compared 
to the above-mentioned techniques. AAA is provided as a service by the Department of 
Biochemistry, University of Cambridge; raw data were sent to us in the form of molar ratio of 
each amino acid and were further processed for the purpose of the work by Ieva Goldberga and 
me.  
 
Results from AAA (partial) are present in Table 6-3 and Figure 6-5. Pure collagen type I has 
almost 35% G, similar to the theoretical value of 33%, and 11% O. In terms of FSOB ECM, 
each step of treatment, except for the last washing step, results in growing G% and O% from 
14.6%, 23.3% to 31.8% and 2.4%, 6.3% to 9.8% separately and declining L%, F% and Y% 
from 7.4%, 5.0% to 3.1%, 3.2%, 2.2% to 1.6% and 2.5%, 1.4% to 0.6% respectively. 
Reconciling these results with fluorescence data (Figure 6-2in section 6.1.2), this final 
detergent washing does not seem to make a difference to FSOB ECM composition. For VSMC 
ECM, the G% and O% barely changes with different decellularisation methods, freeze-thaw or 
detergent lysis, both around 18% and 3.8%; while, VSMC ECM respond well to the final 
detergent wash, giving final G and O molar ratios of 32.8% and 9.8%.  
 
After all treatments, both FSOB and VSMC ECM samples are very similar to each other and 
to pure collagen type I, regarding G, O, L, F and Y molar ratios. Small differences are observed 
between ECM samples and pure collagen type I. This difference can be from a number of 
factors, in addition to the possibility of incomplete removal of ECM NC proteins. For example, 
ECM contains different types of collagen, and therefore, depending on the composition of 
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collagen types, amino acid molar ratios can be different. The pure collagen is derived from 
tendon, expected to be very largely collagen type I; that from osteoblast ECM, similarly mainly 
collagen type I; while that from muscle cell ECM, expected to contain significant amounts of 
collagen type III in addition to collagen type I. Also, tendon and muscle cell ECM are from 
bovine whilst the osteoblast ECM here is from sheep. Therefore, small differences in amino 
acid compositions between collagen in the three samples compared above are expected. It is 
worth mentioning here that VSMC ECM suffers more significant sample volume loss than 
FSOB ECM due to the clean-up procedure, indicating VSMC ECM has more NC proteins or 
FSOB ECM is less penetrable to the clean-up process. 
 
Overall, the proposed clean-up procedure using chymotrypsin digestion and Tween-20 
washing is effective in removing NC ECM proteins and extracting pure collagen from in vitro 
ECMs. Considering the sample volume involved in each measurement, usually less than 1 mg 
per measurement, assessment of the “cleaned” ECM samples can only represent a small portion 
of the total material obtained after the clean-up process. Therefore, when performing AAA, 
more repeats per sample are recommended to make an average and standard deviation to assess 
if differences in molar ratios between samples are significant or negligible, especially if the 
extraction product is not homogenous.  
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Table 6-3 Molar ratio of G, O, L, F, Y from pure collagen type I and differently-treated ECM 
samples, measured by AAA. Theoretical values are calculated from bovine collagen 
type I sequence published on UniProt [153]. 1This O% is deducted from chicken 
collagen type I and can be different from bovine collagen type I.  
Sample Type G% O% L% F% Y% 
Theoretical Value 33.05 6.061 2.48 1.33 0.41 
Collagen 34.97 11.16 2.74 1.45 0.44 
FSOB 
Freeze-thaw 14.57 2.41 7.36 3.15 2.48 
Detergent 23.33 6.31 5.02 2.23 1.44 
Chymotrypsin 31.83 9.79 3.05 1.60 0.60 
Chymotrypsin + Tween-20 31.71 9.15 3.08 1.60 0.61 
VSMC 
Freeze-thaw 17.91 3.85 6.38 2.91 2.19 
Detergent 17.95 3.80 6.42 2.60 2.10 
Chymotrypsin 31.61 9.64 3.25 1.56 0.66 
Chymotrypsin + Tween-20 32.75 9.75 2.76 1.42 0.39 
 
 
Figure 6-5 Molar ratio of G, O, L, F, Y from pure collagen type I and differently treated ECM 
samples, measured by AAA. Colour code is consistent with Table 6-3.   
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6.2 Summary  
ECM is known to have many proteins in minor quantities other than collagen. Extracting 
collagen from integral in vitro ECM can be complicated because ECM has a complex 
organisation and common proteolytic enzymes may denature collagen at the same time as 
digesting minor ECM proteins. Here, a protocol using a combination of detergent cell lysis, 
chymotrypsin digestion and detergent washing is proposed, and successful extraction of pure 
and intact collagen from complex in vitro ECM is achieved. The effectiveness of the clean-up 
protocol was examined by four analytical techniques, including TEM, fluorescence 
spectroscopy, SSNMR spectroscopy and AAA.  
 
TEM images offer a direct and visual examination of chymotrypsin treated ECMs. It is clear 
from the TEM images that as a result of the clean-up procedure, less NC proteins are present 
in ECM samples, and less proteins are bound to collagen fibrils, and collagen fibrils are more 
clearly defined as a result. Additionally, TEM images can be used to assess whether collagen 
fibrils left are intact. However, TEM can be selective because TEM images only cover a very 
limited area, relative to a whole TEM grid and a tiny fraction of the sample, relative to the total 
sample. This limitation can be overcome by (1) preparing more TEM grids per sample (2) 
taking images across the whole grid and (3) analysing as many images as possible before 
making a conclusion.  
 
Fluorescence emission spectra were acquired on ECM samples with and without chymotrypsin 
treatment and compared with spectra acquired on pure collagen type I were also used to assess 
the effectiveness of the clean-up protocol on eliminating ECM proteins. It is clear that after the 
clean-up protocol, the fluorescence emission spectra of ECM samples become more like those 
of pure collagen, suggesting the success of extracting collagen and removing NC proteins. 
However, it is uncertain whether ECM samples are homogenous across a measuring cuvette 
along the beam pathway in the fluorimeter. Therefore, it is possible that information obtained 
on solid ECM samples only reflects a specific portion of the sample, such as on the sample 
surface, rather than the whole sample.  
 
Of all techniques used, SSNMR spectroscopy is the only one able to disclose structural and 
compositional information of an entire ECM sample. Though the sensitivity of SSNMR 
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spectroscopy is lower than other techniques, it is not difficult to conclude from the comparison 
of SSNMR spectra obtained from differently treated samples that chymotrypsin successfully 
removes ECM proteins and the majority protein left after the series of treatments is intact triple 
helical collagen.  
 
AAA is the most quantitative analysis involved compared to the other three. It reveals 
information on amino acid compositions of ECM samples, showing that molar ratios of certain 
amino acids in cleaned-up ECM become closer to those of pure collagen. Its results can also 
be selective due to the small volume used per measurement. Therefore, information obtained 
may not be truly reflective of the whole sample. This limitation can be controlled by measuring 
multiple portions from one sample and taking an average value and examining the standard 
deviation to understand the degree of compositional heterogeneity in the sample.  
 
Though each technique has its limitations, a combination of all techniques assembles a full 
picture of the ECM sample after the clean-up steps. Therefore, a final conclusion is made that 
the designated clean-up procedure is effective in extracting collagen from in vitro ECM. This 
extraction method will be used to generate isotope enriched collagen, and study specific amino 
acid behaviour in glycation reactions.  
It is noticed from this work that (1) as assessed by the AAA results, VSMC ECM composition 
is not affected by decellularisation methods, either freeze-thaw lysis or detergent lysis, as much 
as FSOB ECM, giving ECMs that are slightly different composition after detergent lysis. AAA 
offers a more sensitive and different perspective from SSNMR spectra in this regard. (2) The 
final detergent washing step does not clean FSOB ECM as much as it does VSMC ECM, which 
is seen from the analysis of fluorescence spectra and AAA, and thus, may not be necessary for 
FSOB ECM. (3) More significant sample volume loss was observed on VSMC ECM than 
FSOB ECM, indicating VSMC ECM has smaller initial collagen content or is more penetrable 
by chymotrypsin. These different trends between two different types of ECM might be a 
reflection of their intrinsic differences in architecture and composition because they are from 
two different cell types.  
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7 Identification of Major Glycation Products in 
Model Systems 
The glycation reaction has been studied for almost a century because of its association with 
different pathologies. Many glycation products have been identified in in vivo tissues and 
different in vitro model systems, ranging from protected amino acids to collagen. However, a 
bridge between in vitro models and in vivo tissues is lacking to justify the biological relevance 
of glycation products detected in in vitro models. In this project, in vitro extracellular matrix 
(ECM) is used as the bridging in vitro model to mimic native tissues. The resemblance between 
the in vitro ECM models used here and native tissues has already been established [120].  
 
A number of characterisation techniques, including fluorescence spectroscopy, mass 
spectroscopy coupled with high performance liquid chromatography or gas chromatography 
and immunohistochemical staining, have been deployed to study the glycation chemistry and 
to identify glycation products in model systems. However, those techniques intensively used 
so far have their intrinsic disadvantages and potentially introduce artefacts into the study and 
reveal information not representative to the physiological conditions. SSNMR spectroscopy 
can overcome some of those disadvantages as it only requires minimum sample preparation so 
largely preserves biological samples in their native states. Therefore, SSNMR spectroscopy is 
used as the primary characterisation technique in this project. In order to overcome the 
sensitivity problem experienced by SSNMR, isotope enrichment is heavily used in this work.  
 
Ribose-5-phosphate is used as the main glycating agent in this project because firstly its 
glycation rate is faster than glucose and ribose and therefore able to generate more AGEs over 
the same period of time, and secondly it is an important metabolite in nucleic acid metabolism. 
Glucose and ribose are also used in this project as benchmarks for comparing glycation rates 
and glycation products with ribose-5-phosphate.  
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7.1 Glycation Products Derived from Pure Collagen Type I with 
U-13C6-Glucose and U-13C5-Ribose-5-Phosphate 
Collagen type I, as the major component of the ECM, plays a crucial role in ECM structure 
integrity and functions (reviewed in section 2.1). Pure collagen type I has been used as a 
simplified model of native tissue ECM to study the effects of glycation and used in this project 
as a starting point for further exploration of more complicated glycation models.  
 
This section will discuss possible glycation products derived from pure collagen type I (from 
bovine Achilles tendon) with U-13C6-glucose (U-13C6-Glc) and U-13C5-ribose-5-phosphate (U-
13C5-R5P). Collagen glycation using U-13C5-ribose (U-13C5-Rib) has been studied by other 
colleagues before [163][136], and some results have been published [163]; therefore, the 
experiment will not be repeated here.  
7.1.1 U-13C6-Glc  
Glucose is the most bio-relevant glycating agent because it is circulating in human bodies all 
the time. The concentration of circulating glucose can fluctuate in non-diabetic human bodies 
between 3.9-5.6 mM, and to above 10 mM in hyperglycaemia [164]. It is known to be a slow 
glycating agent [121][165] as the glycation rate is proportional to the relative concentration of 
glucose open chain aldehyde (0.004% [166]) form versus cyclic form in solution (Figure 7-1).  
 
Pure collagen type I was incubated with 100 mM U-13C6-Glc for four months (details are 
included in section 5.3) SSNMR analysis. It is clear from Figure 7-2 that new species are 
generated over the incubation and give 13C NMR signals at 180 ppm, 165 ppm, 96 ppm, 93 
ppm, 75 ppm, 70 ppm and 63 ppm (see the black dotted lines in Figure 7-2). In addition, 
glycation products are generated, giving a broad signal in the amide region around 170 ppm 
(shown in the purple spectrum in Figure 7-2). Signals between 60-100 ppm are likely to be 
from hydroxylated carbons in sugar adducts, in other words, early glycation products. More 
specifically, signals at 96 ppm and 93 ppm share similar chemical shifts as glucose C1 in b- 
and a- pyranose conformations (structures b and a in Figure 7-1). These two signals are likely 
to be from unreacted glucose remaining in the sample or possibly from carbon atoms in very 
similar structures. The broadness of all the sugar-like signals observed within the 60-100 ppm 
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region possibly indicates that glucose adducts are in multiple conformations and environments. 
The observation of sugar-like glycation intermediates after four months incubation reflects the 
slow reaction rate of glucose as a glycating agent. 
  
Figure 7-1 Isomers of glucose detected in solution-state NMR, their relative concentrations and 
C1 13C chemical shifts. a. a-pyranose (37.64%). b. b-pyranose (61.96%). c. a-
furanose (0.11%). d. b-furanose (0.28%). e. open chain aldehyde (0.004%) and f. 
its hydrate form (0.0059%). [166] 
 
Figure 7-2 Stacking of 1D 13C CPMAS SSNMR spectra of pure collagen type I (blue, ns = 
4096) and U-13C6-Glc glycated collagen type I (red, ns = 5472) and 1D 13C PC71D 
SSNMR spectrum, only revealing 13C-enriched species, of U-13C6-Glc glycated 
collagen (bottom, purple, ns = 10240). Dotted line connects glycation products. 
This glycated sample was prepared by Miss Holly Chetwood.  
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The observation of sugar-like glycation intermediates as the dominant glucose glycation 
products suggests that other signals might also come from early stage glycation products rather 
than AGEs. Thus, we propose that the 13C signal at 165 ppm might be from carbon-13 nuclei 
in Schiff base like structures (>13C=N-), and the signal at 180 ppm might be from the ketone 
functional group in Amadori products or other intermediates with aldehyde functional groups. 
These two signals indicate that glycation in this model system might still be at the reversible 
stage, but the generation of ketone/aldehyde functional groups should lead to further glycation 
reactions and eventually form AGEs.  
 
In order to assign the 13C signals from U-13C6-Glc derived glycation products more definitively, 
a 2D 13C-13C PDSD experiment was carried out. 2D 13C-13C PDSD experiments can detect 13C-
13C correlation pairs close in space, and thus 13C connectivity and ultimate molecular structure 
can be deducted from 2D 13C-13C PDSD spectra. Apart from 13C-13C correlation signals seen 
in the so-called “sugar region” of the 13C NMR spectrum (60-100 ppm), four 13C-13C 
correlation signals are detected in the 2D 13C-13C PDSD spectrum (Figure 7-3), 13C (45 ppm) 
-13C (173 ppm), 13C (50 ppm) -13C (170 ppm), 13C (71 ppm) -13C (180 ppm) and 13C (74 ppm) 
-13C (178 ppm) (chemical shifts are rounded to integers and included in Table 7-1). Based on 
their F1 chemical shifts, signals 1 (173 ppm) and 2 (170 ppm) in the 2D 13C-13C correlation 
spectrum (Figure 7-3 and Table 7-1) are probably carbonyl carbons in carboxylate groups (-
13COO--) or amide groups (-13CONH-), which are not likely to react further, and thus 
potentially from AGEs; while signals 3 and 4 (both ~ 180 ppm) could be carbonyl carbons in 
aldehyde groups (-13COH) or ketone groups (>13CO), which are still reactive and likely to be 
from glycation intermediates. However, without observing further connectivities to other 13C 
in the 2D 13C-13C PDSD spectrum, it is difficult to conclude what exact products they are and 
their chemical structures.  
 
Overall, it does not seem that AGEs are generated in a significant amount in the U-13C6-Glc 
glycated collagen sample during this incubation time, and the amount of glycation products 
generated is not sufficient to be observed and identified by SSNMR in this model system. 
Although AGEs crosslinks have been detected in collagen and glucose incubation systems by 
more sensitive techniques such as mass spectroscopy and fluorescence spectroscopy within a 
similar time scale, they are in extremely low concentration, for example, 1 pentosidine 
molecule per 200 collagen molecules [167] and this low concentration is below the detection 
limit of SSNMR.    
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To facilitate the glycation reaction and accumulate enough glycation products to characterise 
more fully by SSNMR within a reasonable time frame, U-13C5-Rib and U-13C5-R5P are used 
henceforth as the primary glycating agents in this project, unless otherwise specified.  
 
Figure 7-3 2D 13C-13C PDSD spectrum of U-13C6-Glc glycated collagen type I (20 ms mixing 
time, ns = 720, 218 F1 slices), showing a group of overlapping signals in the sugar 
region and four signals in the bottom right region. Signals included in blue 
rectangles are the Glc C1 signals. All correlation signals included in the right top 
panel fall in the “sugar region”.  
 
Table 7-1 13C-13C cross peaks detected by the 2D PDSD experiment on U-13C6-Glc glycated 
collagen type I sample (indicated by red dotted lines and numerals in Figure 7-3), 
excluding correlation signals in the sugar region.  
Signal Number 
in Figure 7-3 
Cross Peak Correlations 
Signal 1/ ppm Signal 2/ ppm 
1 45 173 
2 50 170 
3 71 179 
4 74 178 
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7.1.2 U-13C5-R5P 
Ribose-5-phosphate (R5P, structure shown in Figure 7-4) is an essential intermediate in nucleic 
acid synthesis and energy metabolism and a vigorous endogenic glycating agent. R5P generates 
over 5 times more fluorescent glycation products than Glc at the same concentration and within 
the same incubation period [165]. Apart from its reactivity towards proteins, R5P is susceptible 
to slow degradation at physiological temperature and pH, potentially generating many other 
reactive species, better mimicking the pool of various glycating agents in vivo. Figure 7-5 
shows 1D 13C solution state NMR spectra of 6-week incubated U-13C5-R5P and U-13C6-Glc in 
phosphate buffer respectively. Much more intense signals in the carbonyl region are observed 
in the U-13C5-R5P incubation. Those signals are attributed to R5P in its open chain form and 
R5P degradation products, indicating that R5P can glycate faster than Glc and potentially 
generate other reactive glycating agents. 
 
Pure collagen type I was incubated with 50 mM U-13C5-R5P for two months. Even though both 
concentration and incubation time are halved compared to what was used in making the 
previous U-13C6-Glc glycated collagen sample, a bigger variety of glycation products are 
generated after R5P incubation than Glc incubation (Figure 7-6). In addition to 13C signals 
already seen in the U-13C6-Glc glycated collagen, new signals are observed at around 190 ppm. 
This signal has previously been observed in U-13C5-Rib glycated collagen [163][136] and 
assigned as norpronyl-lysine. Also, a number of 13C signals are observed below 60 ppm, which 
are likely to be from sp3 carbons, such as carbon atoms in methyl or methylene groups.  
 
 
Figure 7-4 Isomers of ribose-5-phosphate. a. open chain form. b. furanose form. It can adopt 
either a- or b-furanose conformation. There is an equilibrium between the two 
forms in solution.  
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Figure 7-5 13C solution-state NMR spectra of 6 week-incubated 50 mM U-13C5-R5P (top) and 
U-13C6-Glc (bottom) in phosphate buffer alone. Both spectra are referenced against 
TSP with respect to both chemical shift and intensity.  
 
Figure 7-6 1D 13C CP-MAS (top, red, ns = 1024) and PC71D (bottom, purple, ns = 2048) 
SSNMR spectrum of U-13C5-R5P glycated pure collagen type I, showing more 
glycation products than U-13C6-Glc glycated collagen presented in previous section 
(Figure 7-2). Dotted lines indicate glycation products generated in this incubation 
period.  
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The phosphate group on R5P is considered a good leaving group, so R5P is not expected to 
retain its phosphate group in the glycation products. 1D 31P CPMAS SSNMR experiments were 
performed on the U-13C5-R5P glycated sample to measure phosphorus content in this sample 
to confirm the reaction behaviour of the phosphate group on R5P during the glycation reaction. 
Figure 7-7 shows that little 31P content is detected after glycation. 31P signals ranging between 
0-5 ppm are more likely to be from inorganic phosphate left from the phosphate buffer solution 
used in the incubation than sugar-bonded organic phosphate monoester. Therefore, the majority 
of the phosphate groups originally in R5P are not present in R5P derived glycation products. 
When R5P reacts with proteins, the fructosellysine-equivalent Amadori product called 5-
phosphono-ribuloselysine (5-PRL) forms. The negatively-charged 5-PRL might then affect the 
extent of glycation because of the potential repulsion with negatively-charged glycating agents, 
R5P. However, 5-PRL can go through further elimination to remove the terminal phosphate 
group and make the terminal carbon a methyl group (mechanism proposed in [163]), which 
generates a charge-neutral diketone intermediate. If the phosphate group is hydrolysed at any 
stage, R5P becomes a Rib as the “effective glycating agent”, and therefore, R5P probably 
generates a very similar set of glycation products compared to Rib.  
 
Figure 7-7 1D 31P CPMAS SSNMR spectrum of R5P (red, ns = 5384) and U-13C5-R5P glycated 
collagen type I (blue, ns = 800). “ns” stands for “number of scans”, meaning the 
number of consecutive scans acquired on the samples. More “ns” accumulates more 
signal intensity and, in general, can give spectra with better signal to noise ratio.  
 
Two different types of 2D 13C-13C correlation experiments were performed on this U-13C5-R5P 
glycated collagen sample to gain more detailed information on the glycation products generated 
over incubation. All signals observed in 2D 13C-13C spectra are from species derived from U-
13C5-R5P with signals from collagen invisible as 2D 13C-13C experiments require carbon-13 
and carbon-13 interactions which are rare in non-isotope labelled collagen (natural abundance 
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of 13C is around 1.1%). 2D 13C-13C PC7 experiments are good at detecting directly bonded 
carbon-13 pairs and revealing structural information on carbon-13 connectivity. 2D 13C-13C 
PDSD experiments detect 13C-13C correlations via the intervening 1H network in the sample, 
not necessarily directly bonded, so they can detect correlated 13C pairs with different distances 
apart, by varying an experimental parameter – the so-called mixing time (NMR terms are 
explained in section 4.6.1). Longer mixing time allows detection of correlated 13C pairs with 
longer distances apart. (up to a limit; more details in chapter 4) Therefore, a combination of 
these two different experiments should be able to elucidate more structural information than 
using any of them alone.  
 
Looking at the 2D PC7 spectrum first (Figure 7-8), it is clear to observe 13C-13C correlation 
signal pairs at, from top to bottom, 17-57 ppm, 37-59 ppm, 22-91 ppm, 21-173 ppm, 50-172 
ppm, 57-176 ppm, 57-193 ppm and 165-165 ppm. The two poorly-resolved signals circled out 
in the centre of the spectrum are likely to be from 13C-13C correlations within sugar-like 
glycation intermediates, such as between hydroxylated carbons and hemiacetal carbons. 13C-
13C correlation signals observed in this 2D PC7 spectrum are compared with those observed 
for U-13C5-Rib glycated collagen, and most signals are found in both spectra (Table 7-2).  
 
Figure 7-8 2D 13C-13C PC7 SSNMR spectrum of U-13C5-R5P glycated collagen (m = 30 mg, 
ns = 1024 and 70 F1 slices). Correlated signals are linked, and chemical shifts are 
indicated. The DQ diagonal is shown as a grey dotted line.   
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To gain more structural information and confirm assignments, 2D 13C-13C PDSD experiments 
with two different mixing times were performed on this sample. In theory, a variation in mixing 
time offers an opportunity to distinguish the spatial proximity between two correlated 13C. For 
example, if the intensity of the cross peak is stronger in the spectrum acquired with longer 
mixing time than in the spectrum acquired with shorter mixing time; or in some cases, if some 
cross peaks are only observed in spectra acquired with longer mixing times, this pair of 
correlated carbon-13 giving rise to the cross peak is relatively far apart and needs a longer time 
to accumulate signal intensity. However, in this case, the PDSD spectra (Figure 7-9) acquired 
with shorter, 20 ms, and longer, 100 ms, mixing time are not very different. Most signals seen 
in the 100 ms spectrum (the blue spectrum in Figure 7-9) are also observed in 20 ms spectrum 
(the red spectrum in Figure 7-9), except for 24-180 ppm, 69-193 ppm and 158-166 ppm 
(indicated by black dash lines in Figure 7-9).  
 
Figure 7-9 An overlay of 2D 13C-13C PDSD SSNMR spectra for U-13C5-R5P glycated collagen 
recorded with different mixing times. Red: 20 ms (ns = 816, 300 F1 slices). Blue: 
100 ms (ns = 800, 250 F1 slices). Black dash lines indicate the correlation signals 
only observed with the longer mixing time.    
 97 
To summarise the information we gained from this U-13C5-R5P glycated collagen sample, 
Table 7-2 includes all 13C-13C correlation signals observed in 2D spectra, both PC7 and PDSD, 
ignoring the overlapping correlations in the sugar region. Observed correlation signals are also 
compared with previously published data on U-13C5-Rib glycated collagen, and it is apparent 
that U-13C5-R5P glycated collagen contains a wider variety of glycation product signals than 
U-13C5-Rib glycated collagen. Possible assignments for the correlation signals are also 
suggested in Table 7-2 based on published structures and chemical shifts (some are included 
in Appendix).  
 
Table 7-2 All 13C-13C correlation signals observed in both 2D PC7 and PDSD spectra in Figure 
7-8 and Figure 7-9, and their suggested assignments based on literature (see 
Appendix). Chemical shift pairs underlined are also observed from U-13C5-Rib 
glycated collagen.  
Cross Peak Correlations  
PC7 
PDSD 
(20 ms) 
PDSD  
(100 ms) 
Suggested Assignments or Fragments Signal 1 
/ppm 
Signal 2 
/ppm 
17 57 Yes Yes Yes CEL and/or MG-H and/or MODIC 
17 193 - Yes Yes  
19 52 - Yes Yes CEL and/or MG-H and/or MODIC 
22 91 Yes - - CH3-CH(OH)NH-R 
22 173 Yes Yes Yes N-Acetyl- 
24 180 - - Yes N-Acetyl- 
37 59 Yes Yes Yes Pentosinane and/or DOPDIC 
37 69 - Yes Yes DOPDIC 
50 170 Yes Yes Yes CML 
52 177 - Yes Yes  
54 176 Yes Yes Yes CEL and/or MG-H and/or MODIC 
57 193 Yes Yes Yes Norpronyl Lys 
59 69 - Yes Yes  
59 175 - Yes Yes  
69 193 - - Yes  
88 169 Yes - -  
158 166 - - Yes  
165 165 Yes - - -NH-C(=O)-C(=O)-NH- 
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Correlated 13C pairs observed in the 2D PC7 spectrum can be interpreted as directly bonded 
13C pairs, and hence are expected to be observed in PDSD spectra. However, three correlated 
13C pairs are only observed in the PC7 spectrum, including 22-91 ppm, 88-169 ppm and 165-
165 ppm. The correlation signals at 22-91 ppm observed in the 2D PC7 spectrum (Figure 7-8) 
is attributed to a methyl carbon (-CH3), whose C-H single bonds are expected to rotate freely 
at room temperature. This movement can compromise the efficiency of 1H assisted spin 
diffusions, making correlations involving methyl groups difficult to observe in PDSD 
experiments. In terms of the signal at about 165 ppm on F2 dimension and 330 ppm on F1 
dimension in the PC7 spectrum, it is likely to be from a self-correlation between two 
environmentally similar and directly-bonded carbon-13 and is assigned to be oxalamide, -NH-
C(=O)-C(=O)-NH-. This kind of self-correlations or correlations between structurally-similar 
carbon-13 is not likely to be resolved in PDSD spectra as it would fall on the diagonal like all 
other self-correlated carbon-13 pairs. However, looking carefully at the PDSD spectrum for 
this U-13C5-R5P glycated collagen sample in Figure 7-9, it seems that there is some off-
diagonal intensity around 165-165 ppm, indicating the presence of a correlation signal. Taking 
into consideration the broadness of this signal, with half-height width over 3 ppm (measured 
by extracting slices from the 2D PC7 spectrum), the signal potentially covers slight chemical 
shift differences between the two correlated carbon-13 due to the special local environment 
they are in and their conformations. For instance, it could be a carbon-13 at 164.6 ppm 
correlating with another carbon-13 at 165.4 ppm. This might explain the off-diagonal intensity 
seen in the PDSD spectrum around 165-165 ppm.  
 
Apart from the main signal centred at 17 ppm and 57 ppm (in both 2D PC7 and PDSD spectra), 
it seems that there are some weaker signals with similar chemical shifts, such as 19-52 ppm 
and 17-54 ppm. The 13C signal at 54 ppm seems to correlate with another 13C at 176 ppm 
(indicated by the vertical orange dotted line in Figure 7-8). They could be from CEL or MG-H 
or MODIC in different conformations or environments, resulting in slightly different chemical 
shifts for each conformation/ environment. Alternatively, these three pairs of correlated signals 
could be from CEL, MG-H and MODIC respectively. Considering the fact that Hyl reacts with 
sugar faster than Lys [78] but is present less in numbers in collagen, there could also be a 
contribution from CE-Hyl. All these possibilities might explain the broadness of the main 17-
57 ppm correlating signal in addition to the presence of weaker signals around.  
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A third 2D experiment was done on this U-13C5-R5P glycated collagen sample, the spectrum 
from which, shown in Figure 7-10, supports the assignment of the oxalamide-like structure. 
The experiment, called the HETCOR experiment, detects the through space heteronuclear 
correlation between 1H and 13C, which is much more abundant in biological samples compared 
to 13C and 13C interactions (natural abundance of 1H is around 99.99%). It also means, signals 
observed in this experiment are a combination of 13C-enriched glycation products derived from 
U-13C5-R5P and non-isotope labelled collagen. The signal at around 165 ppm on the F2 
dimension and 8.4 ppm on the F1 dimension (highlighted in a red rectangle in Figure 7-10) 
means this carbon-13 giving rise to a signal at 165 ppm is correlating with proton spins with 
chemical shifts around 8.4 ppm, which falls into the nitrogen bonded proton (1H-N-) region. 
Therefore, this 1H-13C HETCOR spectrum in Figure 7-10 confirms that the 13C at 165 ppm is 
close to a protonated nitrogen like what is in the oxalamide-like structure, -N1H-13C(=O)-
13C(=O)-N1H-.  
 
Figure 7-10 2D 1H-13C HETCOR SSNMR spectrum of U-13C5-R5P glycated collagen (ns=256 
and 50 F1 slices). Correlation between 1H (8.4 ppm) - 13C (165 ppm) is highlighted 
in a red rectangle, suggesting the presence of oxalamide-like structure, -N1H-
13C(=O)-13C(=O)-N1H-. 1H-13C correlations within G are connected by blue dash 
lines.  
 
Combining information extracted from all spectra enables a better chance of assigning 
glycation products. A 13C signal at 193 ppm, assigned as norpronyl lysine before [163], from 
the 2D PC spectrum, is directly bonded to a carbon-13 giving the signal at 57 ppm, and this 
carbon-13 bonds to a third one at 17 ppm (13C connectivities indicated by solid orange lines in 
Figure 7-8). From the 2D PDSD spectrum, the correlation between 17 ppm and 193 ppm is 
observed, together indicating these three carbons are within one molecule in order of 13C (17 
ppm) - 13C (57 ppm) - 13C (193 ppm), which seems to be contradictory to the original 
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assignment as norpronyl lysine. Also, it is possible that this three-carbon fragment has 
contributions from more than one glycation product. For example, the cross peak at 17-57 ppm 
might be from CEL, MG-H or MODIC, and the cross peak at 57-193 ppm might be from 
norpronyl-lysine, and a third glycation product contains the 13C (17 ppm) - 13C (57 ppm) - 13C 
(193 ppm) fragment. From 2D PC7 spectrum in Figure 7-8, it seems that there is also a three-
carbon fragment, 13C (173 ppm) - 13C (22 ppm) - 13C (91 ppm) (indicated by solid orange lines 
in Figure 7-8), which could be from structures like -HNO13C-/13COOH-13C(?)-13CH(OH)NH. 
However, the interaction between 13C (22 ppm) - 13C (91 ppm) is not observed in PDSD, 
indicating this 13C (22 ppm) is more likely to be a terminal methyl group rather than a bridging 
methylene group. Plus, a methylene carbon bridging between a carboxylic group or an amide 
group and a hydroxylated carbon is expected to have a higher chemical shift than 22 ppm. 
Therefore, these three signals are likely to be from two two-carbon fragments, 13C (173 ppm) 
- 13C (22 ppm) and 13C (22 ppm) - 13C (91 ppm), rather than the initially expected three-carbon 
fragment.  
 
Assignments of all observed signals are attempted by comparing literature and experimental 
chemical shifts, but possible structures are not limited to the suggestions made in the above 
paragraphs. Because of the broadness of SSNMR signals and the similarities of glycation 
product structures, signals can easily overlap with one another, such as the CEL, MG-H or 
MODIC situation explained in the earlier paragraph. Unless a full 13C connectivity within a 
molecule is identified, it is hard to confirm a specific structure; therefore, more possible 
structures are suggested based on 13C chemical shifts revealed in 1D SSNMR experiments 
(Figure 7-11)
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Figure 7-11 Suggested glycation products: structures and chemical shift ranges. Left: 13C 
PC71D SSNMR spectra of U-13C6-Glc, U-13C5-Rib and U-13C5-R5P glycated pure 
collagen type I. Possible assignments for each signal or range of signals are 
indicated with coloured circles. Dotted lines compare chemical shifts of 13C signals 
across three spectra. Right: possible glycation products with expected 13C chemical 
shifts indicated with coloured circles, corresponding to the colour schemes used in 
the spectra on the left. Figure credit to Prof. Melinda Duer.  
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7.2 Glycation Products Derived from Collagen extracted from In 
vitro Extracellular Matrix with U-13C6-Glucose, U-13C5-
Ribose-5-Phosphate and U-13C5-Ribose 
In vitro ECM harvested from mammalian cell culture was cleaned by chymotrypsin to remove 
as many non-collagenous (NC) proteins as possible, leaving only collagen fibrils (more details 
in Chapter 6). Though the ECM primarily consists of collagen type I, other collagen types are 
present in minor quantities in the ECM and are resistant to chymotrypsin, and therefore are 
likely to remain after chymotrypsin digestion. This means compared to the pure collagen type 
I described in the previous section (section 7.1), samples described in this section contain a 
mixture of collagen types, such as type I, III, IV and V. Different collagen types are not 
expected to give very different glycation products, especially those monovalent amino acid 
sidechain modification products. The extent of glycation and glycation induced crosslinks for 
different collagen types might be different, depending on their unique sequences and tertiary 
structures. For instance, the number of sugar-accessible reactive residues and distance between 
two reactive residues along the collagen sequence will affect the potential to form crosslinks.  
 
Differences between pure collagen type I and cell-culture produced collagen also arise from 
possibly different developmental stages of collagen, including differences in fibril sizes and 
maturity of enzymatic crosslinks. Observed under TEM, the diameter of pure mature collagen 
type I (from bovine Achilles tendon) tends to be around 100 nm, while the diameter of collagen 
extracted from in vitro ECM varies between 40-60 nm (images are not shown here). In other 
words, there is a surface area/volume (S/V) ratio difference between the two materials. Higher 
S/V ratio potentially exposes more reactive residues on collagen surface to ambient glycating 
agents, which might lead to different extents of glycation and possibly different glycation 
products. In terms of maturity, cell culture produced collagen is probably less mature than the 
pure collagen type I extracted from bovine Achilles tendon, and therefore less Hyl/Lys is 
enzymatically crosslinked, and more Hyl/Lys is available for glycation. In addition, early stage 
enzymatic crosslinks or allysine might also involve in the glycation reaction.  
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7.2.1 U-13C6-Glc Glycated Col(FSOB) 
The ECM harvested from foetal sheep osteoblast (FSOB) culture was cleaned by chymotrypsin 
treatment and then incubated with 100 mM U-13C6-Glc for six months before SSNMR analysis. 
This prolonged incubation time was determined because the previous pure collagen type I 
sample made from four months incubation does not generate many AGEs signals under 
SSNMR.  
 
Figure 7-12 (A) compares 1D 13C CPMAS SSNMR spectra of U-13C6-Glc glycated pure 
collagen type I (the red spectrum in Figure 7-12 (A)) and collagen extracted from FSOB ECM 
(Col(FSOB)) (the green spectrum in Figure 7-12 (A)), in which much more intense peaks, 
relative to the collagen C’ signal, are observed in the “sugar region” in the Col(FSOB)-Glc 
sample than the U-13C6-Glc glycated pure collagen type I sample (described in section 7.1.1), 
suggesting the higher extent of glycation in Col(FSOB). This could be due to the longer 
incubation period, less mature fibrils in Col(FSOB), greater fibril surface area/volume ratio, or 
a combination of these. However, not dissimilarly to the glycated collagen type I sample (the 
red spectrum in Figure 7-12 (A)), most glycation species generated in this sample are sugar-
like intermediates.  
 
A weak 13C signal around 193 ppm is observed in the Col(FSOB)-Glc sample (the green 
spectrum in Figure 7-12 (A)), which is a characteristic signal of AGEs and also seen in all U-
13C6-Glc, U-13C5-Rib and U-13C5-R5P glycated collagen. However, this signal is too weak to 
be observed in the 2D 13C-13C PDSD spectrum, shown in Figure 7-12 (B). Only 13C-13C 
correlations between hydroxylated sugar-like carbons (60-100 ppm) are detected in the 2D 
PDSD spectrum (Table 7-3). 
 
The observations for this Col(FSOB)-Glc sample leads to the same conclusion as from section 
7.1.1: though glucose is the most biologically relevant glycating agent, its reaction rate is too 
slow to be investigated as the primary glycating agent in this project. More reactive glycating 
agents need to be used to generate enough glycation products for SSNMR characterisation.  
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Figure 7-12 (A) An overlay of 1D 13C CPMAS SSNMR spectra of U-13C6-Glc glycated pure 
collagen type I (red, ns = 5472) and collagen extracted from in vitro FSOB ECM 
(Col(FSOB)) (green, ns = 2048). 13C signal intensity is normalised on the collagen 
13C’ signal. The green spectrum shows a weak peak at 193 ppm (pointed by an 
arrow) which is absent in the red spectrum. (B) 2D 13C-13C PDSD SSNMR 
spectrum of U-13C6-Glc glycated Col(FSOB) (Col(FSOB)-Glc) (ns = 352 and 309 
F1 slices). 13C-13C correlation signals are only observed in the “sugar region”, and 
their chemical shifts are listed in the Table 7-3 below.  
 
Table 7-3 Correlated 13C-13C pairs detected by 2D PDSD experiments in the Col(FSOB)-Glc 
sample. All signals are in the “sugar region” and are likely to be from hydroxylated 
carbons in glucose or glucose adducts in different conformations. 13C signals at 
d(C1), d(C4) and d(C6) of glucose are more distinctive than d(C2), d(C3) and d(C5) 
of glucose, so, the latter three signals are not distinguished and assigned as Cx 
because of the uncertainty in signals assignment.  
Signal Number in 
Figure 7-12 (B) 
Cross Peak Correlations 
Assignments 
Signal 1/ ppm Signal 2/ ppm 
1 60 76 a-pyranose C6-C4 
2 63 72 b-pyranose C6-Cx 
3 63 76 b-pyranose C6-C4 
4 72 93 a-pyranose Cx-C1 
5 71 97 b-pyranose Cx-C1 
6 76 97 b-pyranose C4-C1 
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7.2.2 U-13C5-R5P Glycated Col(FSOB) and Col(VSMC) 
In vitro ECMs produced by two different cells, foetal sheep osteoblasts (FSOBs) and adult 
bovine vascular smooth muscle cells (VSMCs), were cleaned by chymotrypsin and then 
incubated with 50 mM U-13C5-R5P for two months separately (This concentration and 
incubation time apply to all samples described afterwards, unless otherwise specified). Both 
materials are mainly composed of collagen type I, and minor components include collagen type 
III, IV and more, as described above, though exact protein compositions in each ECM is 
unknown. Results to identify glycation products in both materials are compared in this section 
and also compared with U-13C5-R5P glycated pure collagen type I described in section 7.1.2.  
 
1D 13C CPMAS SSNMR spectra of both Col(FSOB) and Col(VSMC) are compared in (Figure 
6-3 in section 6.1.3), which shows great similarities in signal frequencies and relative 
intensities, suggesting highly similar molecular structures and environments. So, the collagen 
fibrils from both sources are expected to react with R5P in a very similar manner and produce 
very similar glycation products. Though differences in composition between Col(FSOB) and 
Col(VSMC) are expected, including in their native enzymatic crosslinking, the minor collagen 
types that differentiate the two types of tissues they represent, i.e. bone and blood vessels, may 
not be abundant enough to make an observable difference in SSNMR spectra.  
 
To characterise R5P derived glycation products and decide whether R5P reacts differently with 
Col(VSMC) and Col(FSOB), i.e. collagen models for two different tissues, SSNMR 
experiments were performed on U-13C5-R5P glycated Col(VSMC) and Col(FSOB) to further 
study glycation chemistry and products. Figure 7-13 and Figure 7-14 compare U-13C5-R5P 
glycated Col(VSMC) and Col(FSOB) by their 1D 13C CPMAS spectra and 2D 13C-13C PDSD 
and PC7 spectra. No significant difference is observed in their 13C 1D CPMAS SSNMR spectra 
(Figure 7-13), regarding 13C chemical shifts of signals. Only some signal intensity variations 
are observed between those two samples, Col(VSMC)-R5P and Col(FSOB)-R5P (some are 
indicated by black arrows in Figure 7-13). These slight intensity variations could relate to the 
amount of a particular product generated in the two samples or different CP efficiencies, which 
can vary with sample conditions, such as hydration level and molecule stiffness.  
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Figure 7-13 An overlay of 1D 13C CPMAS SSNMR spectra of U-13C5-R5P glycated Col(FSOB) 
(blue, ns = 4096) and Col(VSMC) (red, ns = 2048), showing great similarities 
between them, regarding 13C chemical shifts of different signals. Some signal 
intensities vary between the two spectra, pointed by black arrows; however, signal 
intensities are not the focus of this investigation.  
 
Common correlation signal pairs observed in both samples are connected by red dash lines 
across both 2D PC7 and PDSD spectra (Figure 7-14), and their chemical shifts are summarised 
in Table 7-4. Overall, both types of 2D spectra show very similar 13C-13C correlation signals 
from 13C-enriched glycation products to each other as well as to the equivalent spectrum for 
U-13C5-R5P glycated pure collagen type I. So, correlation signals that discussed in previous 
sections will not be repeated here.  
 
A three-carbon fragment, 13C (59 ppm) - 13C (37 ppm) - 13C (69 ppm), is clearly detected in 
the Col(VSMC)-R5P sample (Figure 7-14 A and C, indicated by green solid lines), but only 
the partially seen in U-13C5-R5P glycated pure collagen type I (will be referred to as ColI-R5P 
in the following text) and Col(FSOB)-R5P sample. In ColI-R5P, even though all three 13C 
signals, at 37 ppm, 59 ppm and 69 ppm are observed in PDSD spectra with both mixing times 
(20 ms and 100 ms) (Figure 7-9), their connectivities are not revealed in its PC7 spectrum 
(Figure 7-8); while in Col(FSOB)-R5P, only the correlation between 13C (37 ppm) - 13C (69 
ppm) is observed in the PDSD spectrum (Figure 7-14 D). The chemical shifts of this three-
carbon fragment are very similar to C2, C3 and C4 in DOPDIC (structure and 13C chemical 
shifts are shown in Appendix), suggesting the presence of DOPDIC analogue or structurally 
similar AGEs in R5P glycated samples.  
 107 
 
 
Figure 7-14 2D 13C-13C correlation SSNMR spectra of U-13C5-R5P glycated Col(VSMC) (A: 
PC7, ns = 2048 and 79 F1 slices. C: PDSD, 20 ms mixing time, ns = 768 and 160 
F1 slices) and Col(FSOB) (B: PC7, ns = 2048 and 103 F1 slices. D: PDSD, 20 ms 
mixing time, ns = 624 and 319 F1 slices). Signals connected by red dash lines across 
spectra are common correlations observed in both samples; signals connected by 
green dash or solid lines mean they are observed only for one sample.  
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Three pairs of correlation signals are only detected in the Col(FSOB)-R5P sample: 24 ppm-
180 ppm (present in ColI-R5P), 62 ppm-179 ppm and 71 ppm-179 ppm (Figure 7-14 B and D, 
indicated by green solid lines). The latter two could be from a hydroxylated carbon (60~80 
ppm) correlating to an aldehyde carbon (~180 ppm), which could be from glycation 
intermediates, such as Amadori products, similar to signals 3 and 4 observed in U-13C6-Glc 
glycated pure collagen I shown in Figure 7-3. Glycation intermediates with aldehyde groups 
can react further and form more advanced glycation products.  
 
The 13C-13C correlation signals at 24-180 ppm and 22-173 ppm are preliminary assigned to Ne-
acetyl- moieties on lysine and hydroxylysine. 1D 13C solution-state NMR spectra were 
acquired on model compounds, Ne-acetyl-lysine hydroxylysine and bis-acetyl-hydroxylysine 
(structures and experimental 13C chemical shifts are shown in Figure 7-15), to measure their 
13C chemical shifts before confirming these assignments. It is worth noting that the 24-180 
ppm correlation signal is observed in the PDSD spectrum of ColI-R5P with a mixing time of 
100 ms but not the spectrum with 20 ms mixing time (Figure 7-9), which may result from the 
slow magnetisation transfer between methyl (24 ppm) and carbonyl (180 ppm) carbons due to 
the rotation of the methyl group.  
 
Overall, the glycation products from R5P glycation of Col(FSOB) and Col(VSMC) are very 
similar, and they show great similarity to the products in U-13C5-R5P glycated pure collagen 
type I (described in Section 7.1.2).  
 
Compound C1 C3 C2 C4 C’ Ca Cb Cg Cd Ce 
Ne-Acetyl-Lys 24.6 - 176.9 - 177.7 57.6 24.7 33 31 42 
Bis-Acetyl-Hyl 24.5 or 24.8 177.2 or 177.3 178.7 55.8 29.8 32.8 72.4 47.8 
Figure 7-15 Structures and 13C chemical shifts of Ne-acetyl-lysine and bis-acetyl-
hydroxylysine measured by solution-state NMR spectra. Their 13C chemical shifts 
(in ppm) are referenced against TSP at 0 ppm.   
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Table 7-4 A list of 13C-13C correlations observed in 2D 13C-13C PC7 and PDSD SSNMR spectra 
of U-13C5-R5P glycated Col(FSOB) and Col(VSMC) samples and their suggested 
assignments. Signals not observed for the ColI-R5P sample are in bold. 1Observed 
in U-13C6-Glc glycated pure collagen type I in Figure 7-3.  
Cross Peak Correlations 
PC7 
PDSD 
(20 ms) 
Notes Suggested Assignments or Fragments Signal 1 
/ppm 
Signal 2 
/ppm 
17 57 Yes Yes Both 
samples 
CEL and/or MG-H and/or MODIC 
21 98 Yes Yes  
22 173 Yes Yes N-Acetyl-Lys 
50 170 Yes Yes CML 
54 176 Yes Yes CEL and/or MG-H and/or MODIC 
57 193 Yes Yes Norpronyl Lys 
88 169 Yes -  
165 165 Yes - -NH-C(=O)-C(=O)-NH- 
 
24 180 Yes Yes Col(FSOB)  N-Acetyl-Hyl 
62 179 Yes Yes Glycation intermediates, such as 
Amadori products 71 1791 Yes Yes 
 
22 91 Yes Yes Col(VSMC) CH3-CH(OH)NH-R 
37 59 Yes Yes DOPDIC 
37 69 Yes Yes DOPDIC 
59 69 - Yes DOPDIC 
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7.2.3 U-13C5-Rib Glycated Col(FSOB) and Col(VSMC) 
Ribose (structure and chemical shifts shown in Figure 7-16) is the second most abundant 
carbohydrate in blood, at concentrations around 100 µM [168], after glucose. Ribose, a five-
carbon reducing sugar, reacts faster than glucose but slower than R5P [165]. Its glycation 
products with pure collagen type I [163] and amino acids [169] have been published before.  
 
Figure 7-16 Tautomers of ribose and their C1 chemical shifts measured by 13C solution-state 
NMR. a. a-pyranose. b. b-pyranose. c. a-furanose. d. b-furanose. e. open chain 
aldehyde and f. its hydrate. [170] 
 
A 13C solution-state NMR spectrum was acquired on 6-week incubated 50 mM U-13C5-Rib 
(Figure 7-17, top) to decide whether it is subject to degradation and generates similar 
degradation products as R5P. It is clear from the spectrum that ribose degrades during the 
incubation and produces fragments giving 13C signals between 170-190 ppm, similar to U-13C5-
R5P (Figure 7-17, middle). However, fragmentation products from U-13C5-Rib, though not 
assigned, are not exactly the same as those of U-13C5-R5P. Many sugar fragmentation products 
are proposed in reference [69], including different carboxylic acids.  
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Figure 7-17 13C solution-state NMR spectra of 6-week incubated 50 mM U-13C5-Rib (top, ns 
= 1024), U-13C5-R5P (middle, ns = 1024) and U-13C6-Glc (bottom, ns = 1024) in 
150 mM phosphate buffer. 13C chemical shifts are referenced against TSP at 0 ppm.  
 
Samples described in this section were prepared by incubating collagen extracted from in vitro 
FSOB and VSMC ECM with U-13C5-Rib. Different SSNMR experiments, including 1D 13C 
CP, 2D 13C-13C SQ-DQ, 2D 13C-13C PDSD, were then performed on these two U-13C5-Rib 
glycated samples to study their glycation products and compare the glycation chemistry 
between Rib and R5P. 
 
1D 13C CPMAS SSNMR spectra (Figure 7-18) of both U-13C5-Rib glycated Col(VSMC) and 
Col(FSOB) samples look very similar in terms of signals arising from 13C-enriched glycation 
products, except slight variations in relative signal intensities. The similarities in glycation 
products and variations in signal intensities are consistent with the observation in the 
corresponding spectra of the U-13C5-R5P glycated Col(VSMC) and Col(FSOB) samples shown 
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in Figure 7-13. Intense 13C signals around 180 ppm and between 60-80 ppm indicate the 
presence of glycation intermediates. These glycation intermediate signals are resolved into a 
number of cross peaks in 2D 13C-13C correlation spectra (Figure 7-19), including cross peaks 
at 179-74 ppm, 179-72 ppm, 179-65 ppm and 179-62 ppm.  
 
Figure 7-18 An overlay of 13C CPMAS SSNMR spectra for U-13C5-Rib glycated Col(FSOB) 
(blue, ns = 4096) and Col(VSMC) (red, ns = 3072), showing intense signals 
assigned to glycation intermediates. 
 
Compared with glycation products derived from U-13C5-R5P, most products detected for U-
13C5-Rib glycated Col(FSOB) and Col(VSMC) appear to be very similar (see Figure 7-19 and 
Table 7-5). Most correlation signals observed in Figure 7-19 have been observed for previous 
samples before, meaning R5P and Rib generate very similar glycation products simply with 
different glycation rates. However, some new signals are observed in Rib glycated samples 
compared with R5P glycated samples, such as the correlated 13C pairs at 169-169 ppm in Figure 
7-19 (A) and (B), the cross peak at 51-191 ppm in Figure 7-19 (C).  
 
Nevertheless, different products observed here, between Rib-glycated samples and R5P-
glycated samples, does not necessarily mean that Rib and R5P have different glycation reaction 
pathways and could simply be caused by differences in their glycation rates. Rib is known to 
glycate more slowly than R5P, which means Rib glycated samples and R5P glycated samples 
are probably at different glycation stages when SSNMR spectra were acquired. Then, the 
difference in glycation products observed reflects the difference in glycation stages, more or 
less advanced glycation. In other words, in this model system, glycation products derived from 
Rib might be less mature/advanced than those derived from R5P. Therefore, it is hypothesised 
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that the 13C-13C correlation between 169-169 ppm might be from a structurally similar 
precursor (or previous phase or less mature) to a more advanced product giving rise to the 165-
165 ppm correlation as well as the cross peak at 51-191 ppm versus 57-193 ppm.  
 
Figure 7-19 2D 13C-13C correlation SSNMR spectra of U-13C5-Rib glycated Col(VSMC) (A: 
PC7, ns = 1344 and 70 F1 slices. C: PDSD, 20 ms mixing time, ns = 800 and 321 
F1 slices) and Col(FSOB) (B: PC7, ns = 2048 and 120 F1 slices. D: PDSD, 20 ms 
mixing time, ns = 1024 and 235 F1 slices). Signals connected by red dash lines are 
common correlations observed in both samples; signals connected by green dash 
lines are only observed in one spectrum. 
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Table 7-5 A list of correlated 13C-13C signal pairs observed in 13C-13C 2D SSNMR spectra 
shown in Figure 7-19 and their suggested assignments, excluding signals in the 
sugar region. 1This is not well resolved and overlapped with the 50-170 ppm 
correlation. Signals not observed in any of the previously described samples are 
marked in bold.  
Cross Peak Correlations 
PC7 
PDSD 
(20 ms) 
Notes Suggested Assignments or Fragments Signal 1 
/ppm 
Signal 2 
/ppm 
22 173 Yes Yes Both samples N-Acetyl-Lys 
24 180 Yes Yes N-Acetyl-Hyl 
45 173 Yes1 Yes  
50 170 Yes Yes CML 
57 193 Yes Yes Norpronyl Lys 
62 179 Yes Yes 
Glycation intermediates  
65 179 - Yes 
72 179 Yes - 
74 179 - Yes 
165 165 Yes - 
-NH-C(=O)-C(=O)-NH- 
169 169 Yes - 
 
17 57 - Yes Col(VSMC) CEL and/or MG-H and/or MODIC 
21 98 Yes Yes  
37 59 - Yes DOPDIC 
51 191 Yes -  
80 172 Yes -  
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7.3 Glycation Products Derived from In vitro Extracellular 
Matrix 
The above sections have shown that incubating Col(FSOB) or Col(VSMC) with U-13C5-R5P 
or U-13C5-Rib results in very similar glycation products in pure collagen model systems, 
regardless of the source of collagen.  
 
This section moves on to a more complicated model system, the integral ECM, to explore if 
the presence of non-collagenous (NC) proteins in the ECM would affect the glycation 
chemistry and generate more or different glycation products. Compared with the collagen-only 
systems described in the sections above, the integral mammalian ECM from in vitro cell culture 
has been proved to be a good in vitro model for native tissues [120] and is expected to show 
possible glycation products derived from NC ECM proteins.  
 
NC proteins in the ECM, usually residing on collagen fibril surfaces to achieve biological 
functions, might well protect collagen in the ECM from exposure to glycating agents and thus 
from being glycated [171]. Also, being much smaller and more mobile than collagen, NC 
proteins are expected to react faster and accumulate AGEs faster than collagen. However, for 
those NC proteins attaching to collagen fibrils via electrostatic interactions, a consequence of 
glycation might be their expulsion from collagen fibrils due to charge alterations with glycation, 
and this could cause their precipitation out of the ECM, for instance.  
 
VSMC and FSOB in vitro ECM were harvested by detergent lysis, and their similarities in 
structure and components have already been compared by their 1D 13C CPMAS SSNMR 
spectra shown in Figure 6-3 in section 6.1.3. Four glycated in vitro ECM samples, either by U-
13C5-R5P or U-13C5-Rib were prepared (see Table 7-6) and are referred to as ECM(VSMC)-
Rib, ECM(VSMC)-R5P, ECM(FSOB)-Rib and ECM(FSOB)-R5P in the following text.  
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Table 7-6 Glycated in vitro ECM samples prepared and SSNMR experiments performed on 
them. 1Also did 100 ms PDSD experiment on this sample.  
Sample Type 
Sample 
Made 
SSNMR Experiments Performed 
13C CP 
31P CP 
& DP 
13C PC7 
1H-13C 
HECTOR 
13C-13C 
PC7 
13C-13C PDSD 
(20 ms) 
ECM(VSMC) – detergent lysis 
U-13C5-Rib Glycation Yes Yes - Yes Yes Yes Yes 
U-13C5-R5P Glycation Yes Yes Yes Yes Yes Yes Yes1 
ECM(FSOB) – detergent lysis 
U-13C5-Rib Glycation Yes Yes - Yes Yes Yes Yes 
U-13C5-R5P Glycation Yes Yes - Yes Yes Yes Yes 
 
1D 13C CPMAS SSNMR spectra of glycated in vitro ECMs, ECM(VSMC)-Rib, 
ECM(VSMC)-R5P, ECM(FSOB)-Rib and ECM(FSOB)-R5P, are compared in Figure 7-20, 
showing similar glycation products (dash lines in Figure 7-20) and glycation intermediates 
signals. Glycation products accumulate in all samples and give signals between 160-200 ppm, 
as well as sugar-like glycation intermediates ranging between 60-90 ppm. It is also noticed that 
some unreacted U-13C5-R5P/-Rib remains in some samples. So even though four samples have 
been prepared and a variety of SSNMR experiments has been performed on them (Table 7-6), 
not all results will be presented here due to their extensive similarities to what has been 
observed for previous samples in the section above.  
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Figure 7-20 Overlays of 1D 13C CPMAS SSNMR spectra of, top: ECM(VSMC) before (black, 
ns = 8192) and after U-13C5-Rib (red, ns = 10240) or U-13C5-R5P (blue, ns = 158928) 
glycation, bottom: ECM(FSOB) before (black, ns = 8192) and after U-13C5-Rib (red, 
ns = 2048) or U-13C5-R5P (blue, ns = 8192) glycation.  
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Two representative 2D 13C-13C correlation SSNMR spectra, PC7 and PDSD, of one sample are 
shown in Figure 7-21, and 13C chemical shifts of correlation signals observed in the 2D spectra 
and possible assignments are summarised in Table 7-7. It is clear from Figure 7-21 and Table 
7-7 that all signals observed in these two spectra are observed in spectra of previous samples.  
 
Overall, glycation products detected in integral ECMs are not different from those for either 
collagen or ECM extracted collagen, regardless of glycating agent.  
 
 
Figure 7-21 (A) 2D 13C-13C PC7 SSNMR spectrum (ns = 2048, 101 slices) and (B) 2D 13C-13C 
PDSD SSNMR spectrum (20 ms mixing time, ns = 896, 320 slices) of U-13C5-Rib 
glycated FSOB ECM. Correlations in red are observed in both spectra. Correlations 
in green are only observed in (A).  
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Table 7-7 A list of 13C-13C correlated signal pairs observed in 2D PC7 and PDSD spectra of 
the ECM(FSOB)-Rib sample shown in Figure 7-21 and suggested assignments for 
the 13C-13C correlation pairs.  
Cross Peak Correlations 
PC7 
PDSD 
(20ms) 
Suggested Assignments or Fragments 
Signal 1/ ppm Signal 2/ ppm 
17 57 Yes Yes 
CEL and/or MG-H and/or MODIC 
19 52 Yes Yes 
21 98 Yes -  
22 173 Yes Yes N-Acetyl-Lys 
24 180 Yes Yes N-Acetyl-Hyl 
37 59 Yes Yes DOPDIC 
50 170 Yes Yes CML and/or G-H 
54 176 Yes Yes CEL and/or MG-H and/or MODIC 
57 193 Yes Yes Norpronyl-Lys 
62 179 Yes Yes 
Glycation intermediates 
72 179 Yes - 
165 165 Yes - 
-NH-C(=O)-C(=O)-NH- 
169 169 Yes - 
 
7.4 Summary 
The glycation reaction is a pure chemical reaction between amino groups in proteins and 
aldehyde groups in reducing sugars or reducing sugar phosphates; it is associated with many 
diseases and widely accepted as one of the causes of various pathologies. The glycation 
reaction is not regulated by cell processes or enzymes, but is a pure chemistry reaction 
governed, as for all chemical reactions, by complex thermodynamics and kinetics, generating 
many possible glycation intermediates and products. In addition, glycation products evolve on 
both short and long timescales, from early glycation products via numerous glycation 
intermediates to the eventual advanced glycation endproducts (AGEs), which adds to the 
difficulty of following the glycation chemistry. Complicated glycation pathways, many 
possible glycation products and lack of cellular/enzymatic regulation in the glycation reaction 
pose great challenges for studying the glycation chemistry and identifying glycation products 
in vivo using normal biological strategies.  
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Therefore, in this work, the glycation reaction is studied in an in vitro model system that mimics 
native tissues, using solid-state NMR (SSNMR) spectroscopy in order to establish a better 
understanding of glycation chemistry and the major glycation products potentially generated 
in vivo. Three glycation substrates, pure collagen type I (from bovine Achilles tendon), 
collagen extracted from in vitro ECMs and intact in vitro ECMs, and three glycating agents, 
U-13C6-glucose, U-13C5-ribose and U-13C5-ribose-5-phosphate, are used in this project to study 
the different glycation products derived from different glycating agents. Utilisation of isotope-
enriched glycating agents allows the glycation pathways to be followed from glycating agents 
to glycation products and the glycation products to be identified by SSNMR.  
 
Glucose is the most bio-relevant glycating agent as it is constantly circulating in human bodies. 
However, it fails to accumulate a sufficient amount of AGEs for SSNMR identification, and 
the glucose glycation seems to be still at the reversible stage in the model system described in 
this work, which is less likely to cause detrimental effects compared with the formation of 
irreversible advanced glycation products in the case of ribose and ribose-5-phosphate glycation. 
Therefore, ribose and ribose-5-phosphate are used as the primary glycating agents in this work 
as they glycate faster than glucose and are able to accumulate a significant amount and variety 
of intermediate glycation products and AGEs to be characterised by SSNMR spectroscopy. 
The glycation chemistry and glycation products determined from ribose and ribose-5-
phosphate glycation will represent at least to some extent the situation of other reducing sugars 
and reducing sugar phosphates respectively, since a number of other hexoses, hexose-
phosphates, pentoses and pentose-phosphates are also present in human bodies as essential 
metabolites. However, it is possible and likely that different glycating agents generate some 
different glycation products and different chemical equilibria. 
 
A number of glycation products have been identified by comparing AGE chemical shifts 
published in the literature and from new assignments made here by reference to model 
compounds, including N-acetyl-lysine and N-acetyl-hydroxylysine. Moreover, a fragment with 
oxalamide-like structure has been assigned, which could be derived from oxoaldehydes, such 
as glyoxal or methylglyoxal, originating from either fragmentation of glycation agents or 
glycation intermediates.  
 
The major glycation products generated in model systems are amino acid sidechain 
modifications, such as N-carboxylmethyl-lysine (CML), possibly N-carboxylmethyl-arginine 
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(CMR), and N-acetyl-lysine/-hydroxylysine, rather than AGEs crosslinks as widely believed. 
Some AGEs moieties (the fragments derived from glycating agents) share very similar 
structures and chemical shifts, such as CEL, MG-H1 and MODIC, so it can be difficult to 
decide whether some 13C signals are from AGE crosslinks or monovalent sidechain 
modifications without a complete 13C connectivity map for the entire molecule, rather than just 
the component derived from the 13C-enriched glycating agent.  
 
Among all the glycation products identified in the model system, some are observed in almost 
all samples, such as CML and norpronyl-lysine, while some are less frequently observed 
glycation products, such as the unassigned product giving rise to 13C-13C correlations at 22-91 
ppm (possible fragment: 13CH3-13C(OH)-N-). This variation in the glycation products observed 
is consistent with complex dynamics and equilibria of the glycation reaction, and some AGEs 
forming earlier or more readily than the others. For example, the correlated 13C signals at 50-
170 ppm, assigned to CML, are observed for most samples, indicating it might be one of the 
most facile and/ or early-forming AGEs.  
 
Though Rib- and R5P-glycated samples share many common glycation products, a small 
number of glycation products are only observed in one of the two glycated samples. For 
example, Rib glycated samples tend to show strong 13C-13C correlations associated with a broad 
13C signal around 180 ppm and 13C signals in the sugar region, as well as the 13C-13C correlation 
signal pair at 169-169 ppm in 2D SQ-DQ spectra. Possible reasons behind the differences of 
Rib and R5P glycation are: firstly, Rib reacts slower with amine groups than R5P, and hence, 
within the same incubation period, Rib probably accumulates relatively less AGEs but more 
glycation intermediates than R5P; secondly, R5P is negatively charged while Rib is neutral 
under physiological pH. This means initially R5P is more attracted to the positively-charged 
glycation-target residues than Rib due to charge-charge interactions; Rib can access glycated 
and charge-altered residues and neighbouring residues more readily due to the lack of 
electronic repulsion.  
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8 Glycation Studies in Model Systems with 13C 
and 15N Enrichment  
Uniformly 13C and 15N enriched ECMs can be prepared by cell culture; then, 13C, 15N-enriched 
collagen can be extracted from the isotope-enriched ECMs generated. Introducing isotope 
enrichment of specific amino acids into the in vitro ECMs allows further studies on the 
glycation behaviour of specific amino acids. Moreover, 13C and 15N enrichment enables the 
performance of SSNMR experiments observing 15N and 13C-15N correlations, to better 
characterise glycation products. The DNP-SSNMR technique can greatly enhance NMR 
sensitivity and was used on some glycated samples to detect glycation products present in 
minor quantities below the detection limit of conventional SSNMR. With the signal intensity 
enhancement of DNP, DNP-SSNMR is capable of detecting the rare Hyl and glycosylated Hyl 
in native ECMs [172].  
 
Different isotope-labelling schemes allow study of different aspects of glycation. K and R are 
the main residues involved in the glycation reaction because of their reactive amine/guanidino 
groups. Therefore, in this work, U-13C6, 15N2-K and U-13C6, 15N4-R enriched in vitro ECMs 
and collagen extracted from those ECMs are glycated using U-13C5-R5P or U-13C5-Rib to gain 
a better understanding of the chemistry of K and R in the glycation reaction. U-13C2, 15N-G and 
U-13C5, 15N-P enriched ECMs are also prepared to probe the effects of glycation on collagen 
structure at the atomic level. When U-13C5, 15N-P is fed into cell culture and incorporated into 
collagen, some U-13C5, 15N-P are post-translationally modified into U-13C5, 15N-O. Even 
though P and O do not participate directly in the glycation reaction, their chemical shifts (13C 
and 15N) are affected if the overall collagen molecular conformation is altered by the glycation 
reaction. Typically, an estimated isotope incorporation level of 60-70% can be achieved in in 
vitro ECMs (the 13C incorporation level of some U-13C6, 15N2-K enriched ECM samples were 
measured by MS; data not shown) under the cell culture conditions used in this work (details 
included in section 5.1). Slight variations of the isotope incorporation can occur, depending on 
the exact timeline of introducing isotope enrichment in relation to collagen biosynthesis by the 
cultured cells.  
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After glycation, the 13C, 15N-enriched collagenous materials are studied using SSNMR with a 
focus on studying whether 13C and 15N chemical shifts of enriched amino acids, K, R, G and 
P/O, change as an effect of glycation. For K and R, alterations in sidechain chemical 
environment and/ or sidechain conformation due to the attachment of glycation products at the 
end of their sidechains are expected to change their sidechain 13C and 15N chemical shifts, 
especially for the terminal carbons. For example, K d(13Ce) goes up 7 ppm from K to CML 
[173]; K d(15Ne) is also observed to be higher after glycation due to transition from a primary 
amine to a secondary amine. G and P/O are not directly involved in glycation reactions and so 
their 13C and 15N chemical shifts can be expected to report on any overall secondary structure 
changes to the collagen molecules as a result of the glycation reaction or AGE accumulation. 
In addition, the strength of the internal hydrogen bonding between G and X-position residues 
in neighbouring chains that stabilises the collagen triple helix is expected to be reflected in the 
G N-H 1H chemical shift, which here is measured in 2D 1H-13C correlation SSNMR 
experiments.  
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8.1 Glycation Products Derived from U-13C6, 15N2-K Enriched 
Model Systems with U-13C5-Ribose-5-Phosphate and U-13C5-
Ribose 
Lysine (K) is of special interest in studying glycation reaction, as it has a free amino group at 
the end of its sidechain. This free amino group of K potentially acts as a nucleophile to initiate 
the glycation reaction.  
 
There are 107 K residues in the bovine collagen type I sequence (from UniProt), some of which 
are expected to be post-translationally modified to 5-hydroxylysine (Hyl) and then 
glycosylated (13C and 15N chemical shifts of K and post-translationally modified K are included 
in Table 8-1 and Table 8-2). The extent of K post-translational modifications (PTMs), 
hydroxylation and glycosylation, changes with animal age and is different in different tissues.  
 
K glycation is dependent to some degree on the extent of K PTMs. As the collagen fibril 
matures, the extent and nature of enzymatic crosslinks also alter, which can also affect K 
glycation. For example, if collagen fibrils are less enzymatically crosslinked, more K will be 
available for glycation. We hypothesise that this might be the case for collagen produced in 
vitro in cell culture. However, it is worth mentioning that some latest research has shown that 
K glycation might interfere with the existing (reversible) enzymatic crosslinks (unpublished 
group data, not shown here).  
 
Table 8-1 13C and 15N chemical shifts for lysine (K), proline (P), hydroxyproline (O) and 
glycine (G) measured in collagenous samples in this work.  
AA 
d(13C)/ ppm d(15N)/ ppm 
C’ Ca Cb Cg Cd Ce N’ N 
K 173 53 30 23 27 40 122 32 
P 174 58 30 25 47 - 130 - 
O 172 58 38 70 55 - 130 - 
G 169 42 - - - - 106 - 
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First, a set of U-13C6, 15N2-K enriched samples were prepared, including Col(VSMC-K), 
Col(FSOB-K), ECM(VSMC-K) Detergent, ECM(FSOB-K) Detergent, ECM(VSMC-K) 
Freeze-thaw and ECM(FSOB-K) Freeze-thaw (nomenclature explained in Figure 8-1 caption), 
to compare the similarities and differences of their K environments and conformations in these 
collagenous samples. Then, those samples were glycated to study the chemistry of K glycation.  
 
Figure 8-1 compares 1D 13C CPMAS SSNMR spectra of differently treated U-13C6, 15N2-K 
labelled in vitro ECMs, including intact in vitro ECM harvested from freeze-thaw and detergent 
cell lysis and collagen extracted from detergent lysed in vitro ECM using chymotrypsin to 
remove non-collagenous (NC) proteins. Overall, no significant difference in K 13C chemical 
shifts is found between the different samples (indicated by the red dash lines in Figure 8-1), 
which aligns with the conclusion drawn from the previous chapter: molecular conformations 
in these collagenous samples are very similar. One general trend observed in Figure 8-1 is that 
when K-containing NC proteins are removed from the ECMs by chymotrypsin digestion, 13C 
signals from natural abundant G and P/O start to be observed in the SSNMR spectra (signals 
indicated by black dash lines Figure 8-1). In addition, some 13C signals are narrower, such as 
the K 13C’ and K 13Ca, indicating that the distribution of K conformations or environments in 
the samples are less heterogeneous after chymotrypsin digestion. In theory, some U-13C6, 15N2-
K residues in collagen should be post-translationally modified to U-13C6, 15N2-Hyl; however, 
Hyl in collagen is too rare to be observed by conventional SSNMR, and its signature signal, 
Hyl Cd, expected ~ 70 ppm, potentially overlaps with O Cg (~ 70 ppm).  
 
Due to the similarities between Col(VSMC-K) and Col(FSOB-K) regarding K composition 
and conformation, results from only Col(FSOB-K) are described and discussed in the following 
sections, unless otherwise stated.  
 126 
 
Figure 8-1 Comparison of 1D 13C CPMAS SSNMR spectra of, from top to bottom, Col(VSMC-
K) (U-13C6, 15N2-K enriched VSMC ECM, detergent lysed, cleaned up by 
chymotrypsin and Tween-20, ns = 8192), Col(FSOB-K) (U-13C6, 15N2-K enriched 
FSOB ECM, detergent lysed, cleaned up by chymotrypsin and Tween-20, ns = 
4096), ECM(VSMC-K) Detergent (U-13C6, 15N2-K enriched VSMC ECM, 
detergent lysed, ns = 4027), ECM(FSOB-K) Detergent (U-13C6, 15N2-K enriched 
FSOB ECM, detergent lysed, ns = 4096), ECM(VSMC-K) Freeze-thaw (U-13C6, 
15N2-K enriched VSMC ECM, freeze-thaw lysed, ns = 36666) and ECM(FSOB-K) 
Freeze-thaw (U-13C6, 15N2-K enriched FSOB ECM, freeze-thaw lysed, ns = 2048). 
Red dash lines indicate all the K 13C signals, and black dash lines indicate the 
natural abundant 13C signals from O Cg, P/O Ca (not resolved), P Cd and G Ca.  
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8.1.1 Col(FSOB-K) Glycated with U-13C5-R5P and U-13C5-Rib 
Glycated U-13C6, 15N2-K enriched collagenous samples are referred to as Col(FSOB-K)-R5P 
or Col(FSOB-K)-Rib in the following text. Figure 8-2 compares 1D 15N (top) and 13C (bottom) 
CPMAS SSNMR spectra of Col(FSOB-K)-R5P and Col(FSOB-K)-Rib with non-glycated 
Col(FSOB-K).  
 
When glycation products attach to K 15N, a subset of primary amine becomes secondary amine 
or amide, depending on the adducts, and therefore, the glycated K 15N signal is expected to 
shift towards higher chemical shifts than its original K 15N signal. This change from K to 
glycated K, i.e. primary amine to amide-like structure, possibly explains the broad 15N signal 
appearing around 105 ppm after glycation (Figure 8-2 top, pointed by an arrow).  
 
Similar 13C signals from glycation products are observed in both Rib and R5P glycated samples 
as shown in Figure 8-2 (bottom) to those in the samples discussed in the previous chapter, as 
expected, such as the 13C signals at 193 ppm, 180 ppm, 165 ppm and the many overlapping 
signals in the sugar region. It is also noticed from 1D 13C CPMAS SSNMR spectra that the U-
13C5-Rib glycated sample (the green spectrum in Figure 8-2 bottom) gives stronger (relative to 
the K C’ signal) and a more diverse range of sugar-like glycation intermediate 13C signals than 
the U-13C5-R5P glycated sample (the red spectrum in Figure 8-2 bottom). The strong 13C peak 
around 180 ppm for the U-13C5-Rib glycated sample (green spectrum in Figure 8-2 bottom) 
also indicates the presence of reactive carbonyl species, possibly from Amadori products or 
other glycation intermediates. This broad 13C signal at 180 ppm is resolved into several 13C-
13C correlation signals in 2D 13C-13C correlation SSNMR spectra (Figure 8-4 (B) and (D) in 
orange), which shows correlations between 13C signals at around 180 ppm and 13C signals 
ranging from 56 ppm to 73 ppm. These correlations could come from carbonyl carbons and 
hydroxylated carbons in sugar adducts. This observation of relatively strong and greater 
diversity of 13C signals from glycation intermediates in the Rib-glycated sample than the R5P-
glycated sample is likely due to their differences in glycation rates, as previously discussed.  
 
The change from K to glycated K is expected to shift a portion of the K 13Ce (40 ppm) signal 
to higher chemical shifts or broaden the K 13Ce signal because of the increase in heterogeneity 
in 13Ce environments; however, the shifting or broadening of K 13Ce (40 ppm) signal can be 
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difficult to extract from 1D 13C spectra (Figure 8-2 bottom) because K 13Ce overlaps with 
natural abundance G Ca signals (42 ppm) and potentially with 13C-enriched glycation products.  
For example, previously observed 13C-13C correlation signals (in non-isotope-enriched model 
system), 54-176 ppm (CEL and/or MG-H and/or MODIC) and 22-173 ppm can overlap K 
13Ca (53 ppm) - 13C’ (174 ppm) and 13Cd (23 ppm) - 13C’ (174 ppm), and hinder the possible 
chemical shift changes or signal broadening of K 13C signals due to glycation.  
 
Figure 8-2 Top: 1D 15N CPMAS SSNMR spectra of Col(FSOB-K) (blue, ns = 8192), U-13C5-
Rib glycated (green, ns = 38633) and U-13C5-R5P glycated (red, ns = 6201) 
Col(FSOB-K). Bottom: 1D 13C CPMAS SSNMR spectra of Col(FSOB-K) (blue, 
ns = 4096), U-13C5-Rib glycated (green, ns = 4096) and U-13C5-R5P glycated (red, 
ns = 2048) Col(FSOB-K). Signal intensities are normalised on the K C’ signal. 
Black dash lines indicate the successful enrichment of 13C and 15N in K residues in 
these samples.  
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The 2D PDSD SSNMR spectrum of Col(FSOB-K)-R5P in Figure 8-4 (C) show 13C-13C 
correlations between 13C (30 ppm), 13C (45 ppm), 13C (53 ppm), 13C (68 ppm) and 13C (75 ppm) 
(the cross peaks included in a purple dash rectangle). These 13C chemical shifts are very similar 
to those of previously reported PTMs of K signals, Hyl, Hyl-NH-R and GlcGal-Hyl, by DNP-
SSNMR (their 13C chemical shifts are summarised in Table 8-2) [172]. However, Hyl 
composes less than 2% of K residues in collagen, and only a small portion of Hyl is further 
modified into Hyl-NH-R and GlcGal-Hyl. Thus, PTMs of K are unlikely to be observed by 
conventional SSNMR and have never previously been observed in non-glycated samples 
without DNP. Thus, we instead assign these 13C correlation signals to glycated K and hence 
provide direct evidence on how 13C signals shift when K becomes glycated K to form K-NH-
sugar structures. A schematic of a K glycation molecular structure that can account for these 
13C signals is shown in Figure 8-3.  
 
Table 8-2 13C chemical shifts (in ppm) of three post-translation modifications (PTMs) of K, Hyl, Hyl-
NH-R and GlcGal-Hyl in collagen [172]. Chemical shifts in purple indicates signals with similar 
chemical shifts are observed in the 2D 13C-13C spectra of ECM(VSMC-K)-R5P in Figure 8-6.  
PTMs of K Ca Cb Cg Cd Ce 
Hyl-NH2 54 28 30 69 45 
Hyl-NH-R 54 30 28 71 56 
(Glc)Gal-Hyl 54 28 30 75 44 
 
 
Figure 8-3 A suggested structure of a K glycation intermediate/product giving correlation signals that 
include the observed signals of 13C (30 ppm), 13C (45 ppm), 13C (53 ppm), 13C (68 ppm) 
and 13C (75 ppm), i.e. the signals marked in purple or included in the purple dash rectangle 
in Figure 8-4. 13C correlation signals can be either from U-13C6, 15N2-K or U-13C5-Rib/-
R5P in these samples where both glycation substrate (K) and glycating agents are 13C-
enriched. 13C chemical shifts for R1 and R2 are not resolved in the 2D spectra.  
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Figure 8-4 2D 13C-13C PC7 (top row) and PDSD (bottom row) SSNMR spectra of Col(FSOB-
K)-R5P (left column; A: ns = 2048 and 120 F1 slices; C: ns = 800 and 266 F1 slices) 
and -Rib (right column; B: ns = 3424 and 60 F1 slices; D: ns = 912 and 180 F1 
slices). Correlation pairs observed in all samples are linked by red dash lines; 
correlating signals only observed in one spectrum are linked by green dash lines. 
Purple dash rectangle shows signals arising from Hyl-like and glycosylated Hyl-
like structures discussed above. Orange dash rectangle includes all signals 
correlated a broad 1D signal maxima at 180 ppm discussed in the text.  
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Table 8-3 A summary of 13C-13C correlation signals observed in 2D PC7 and PDSD spectra of 
Col(FSOB-K)-R5P and Col(FSOB-K)-Rib in Figure 8-4, excluding the overlapping 
signals in the sugar region and in the so-called glycation intermediates region (the 
orange rectangles). Chemical shifts in purple correspond to signals in the purple 
dash rectangles in Figure 8-4. Chemical shifts in bold are correlation signal pairs 
that have not been observed in any previous spectra; they might correspond to 
correlations between K sidechain and glycation adducts.  
13C-13C Correlations R5P Rib 
Suggested Assignments or Fragments Signal 1 
/ ppm 
Signal 2 
/ ppm 
PC7 
PDSD 
(20 ms) 
PC7 
PDSD 
(20 ms) 
17 57 Yes Yes Yes Yes CEL and/or MG-H and/or MODIC 
21 98 - - Yes -  
22 90 Yes - - -  
22 173 Yes Yes - Yes N-Acetyl-Lys 
24 180 - - Yes Yes N-Acetyl-Hyl 
25 47 - Yes - -  
34 58 - - - Yes  
50 170 Yes Yes Yes Yes CML 
51 191 - - - Yes  
52 70 Yes - - -  
57 193 Yes Yes Yes Yes Norpronyl-Lys 
59 174 - Yes - -  
88 168 Yes - - -  
165 165 Yes - Yes - 
-NH-C(=O)-C(=O)-NH- 
169 169 - - Yes - 
30 45 - Yes - - 
See the suggested structure in Figure 8-3 
30 68 - Yes - - 
30 75 - Yes - Yes 
45 68 Yes Yes - - 
53 75 - Yes - Yes 
56 70 - Yes - Yes 
66 70 - Yes - Yes 
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8.1.2 ECM(VSMC-K)-R5P and Col(VSMC-K)-Rib: A DNP-
SSNMR Study  
SSNMR spectroscopy is not a highly sensitive technique and thus signals from low abundance 
glycation species may not be observed. Low abundance of a glycation species does not mean 
those species are not important; indeed, we expect highly reactive intermediates – which are 
clearly important in the glycation reaction scheme – to be relatively low abundance. Similarly, 
glycation crosslinks, which have the potential to cause significant molecular structure changes 
as well as changes to molecular elasticity, are expected to be very low in abundance. DNP-
SSNMR generates significant sensitivity enhancement that allows observation of low abundant 
glycation products not observable by conventional SSNMR. More importantly, DNP-SSNMR 
allows acquisition of 2D 13C-15N correlation spectra in relative short experiment time, which 
were not performed on conventional SSNMR due to the excessive length of these experiments 
arising from the low sensitivity of 15N in NMR spectroscopy. However, sacrifice is made on 
spectral resolution because the low operating temperature of DNP (100 K) can cause significant 
line broadening (explained in section 4.5). For example, the 13C signals from K sidechain 
carbons, Cb, Cg and Cd, in the 1D DNP-SSNMR spectra of collagenous samples in Figure 8-5 
(A), are not as well resolved as in the spectra acquired at room temperature in Figure 8-1 (the 
third one from top). Figure 8-5 shows that all three signals “merge” into one broad signal under 
DNP conditions (Figure 8-5 (A)), and it seems that the resolution on these three sidechain 
carbons is further degraded after glycation (Figure 8-5 (B) and (C)). Discussion in this section 
will focus on signals not observed by conventional SSNMR.  
 
1D 13C DNP-SSNMR spectra of Col(VSMC-K)-Rib and ECM(VSMC-K)-R5P (Figure 8-5) 
show that in addition to the 13C glycation signals observed before, such as the 13C signals at 
193 ppm, 165 ppm and the overlapping signals in the sugar region, DNP-SSNMR captures new 
glycation product signals in the 13C chemical shifts region between 100-150 ppm than 
conventional SSNMR (Figure 8-5 (B) and (C)), which is where some of the aromatic crosslinks 
signals are expected. However, few correlation signals are observed in this region in 2D 13C-
13C spectra (Figure 8-6 and Figure 8-7), suggesting that the glycation products giving 13C 
signals between 100-150 ppm are either in really low quantities or not 13C enriched or not 
bonded to a 13C or have few 1H around.  
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Figure 8-5 1D 13C (the left column) and 15N (the right column) CPMAS DNP-SSNMR spectra 
of ECM(VSMC-K) (blue, ns = 128 for 13C 1D, ns = 16 for 15N 1D), Col(VSMC-
K)-Rib (green, ns = 2048 for 13C 1D, ns = 6144 for 15N 1D) and ECM(VSMC-K)-
R5P (red, ns = 1024 for 13C 1D, ns = 2048 for 15N 1D). Black dash lines indicate 
13C and 15N signals from K, and 15N signals of glycated K.  
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Previously in the Col(FSOB-K)-R5P sample, a group of Hyl-like 13C special correlations are 
observed in its 2D PDSD spectrum (in purple rectangles in Figure 8-4 with suggested 
assignments shown in Figure 8-3), while the 13C connectivity between them is not revealed in 
the corresponding PC7 spectrum. In the 2D 13C-13C SQ-DQ DNP-SSNMR spectrum of 
ECM(VSMC-K)-R5P (Figure 8-6), the 13C connectivity map in this glycated K molecule is 
observed (signals connected by red lines in Figure 8-6): 13C(30 ppm)-13C(69 ppm)-13C(45 ppm), 
13C(44 ppm)-13C (75 ppm)-13C(30 ppm) and 13C (71 ppm)-13C(55 ppm) or, 13C(44 ppm)-13C 
(75 ppm)-13C(30 ppm)-13C(69 ppm)-13C(45 ppm), if these signals all arise from a single 
molecular moiety, i.e. no accidental degeneracies between signals from different molecular 
species, which would lead to overlap of signal correlations. However, the 13C connectivity 
revealed by the 2D SQ-DQ DNP-SSNMR spectrum of ECM(VSMC-K)-R5P (Figure 8-6) does 
not match the deduced structure from the 2D 13C-13C PDSD SSNMR spectrum of Col(FSOB-
K)-R5P: 13C(30 ppm)-13C (45 ppm)-N-13C(53 ppm)-13C(75 ppm)-13C(68 ppm) (Figure 8-3); 
these SQ-DQ DNP-SSNMR signal chemical shifts and connectivities are more like the 
previously assigned Hyl, Hyl-NH-R and glycosylated Hyl (Table 8-2).  
 
Then, a question arises: whether the special Hyl-like 13C signals are from the three possible 
PTMs of K or glycated K and Hyl or a combination of all of these possibilities, because all 
these species can give 13C signals at around the above-mentioned chemical shifts. Because Hyl 
is widely accepted as a rare residue in collagen and not expected to be observed by SSNMR 
without DNP, the set of Hyl-like 13C signals observed by conventional SSNMR in the R5P 
glycated sample (in the purple rectangle observed in Figure 8-4) was proposed to arise 
predominantly from the sugar moieties on glycated K and glycated Hyl, such as 13C(~ 69 ppm) 
and 13C(~ 75 ppm) and the sidechain carbons of glycated K, such as 13C(~ 30 ppm) and 13C(~ 
45 ppm) (see Figure 8-3). However, DNP-SSNMR in principle is capable of observing 13C 
signals from the three PTMs of K, and therefore the PTMs of K are expected to contribute to 
the group of signals (marked in red in Figure 8-6). Therefore, the signals marked in red in the 
DNP-SSNMR spectrum (Figure 8-6) are assigned as a combination of three PTMs of K and 
glycated K and glycated Hyl and sugar adducts.  
 
The broadness of the 13C(~ 30 ppm) - 13C(~ 45 ppm) correlation signal observed in the 2D 13C-
13C DARR DNP-SSNMR spectrum in Figure 8-7 (in red rectangles) to some extent confirms 
the idea that there are multiple contributors to that correlation signal.  
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In addition, a 13C-13C correlation signal pair is observed at 175-30 ppm in the 2D 13C-13C SQ-
DQ spectrum of the ECM(VSMC-K)-R5P sample in Figure 8-6, whose chemical shifts are 
what would be expected for K 13C’ and 13Cb respectively; however, SQ-DQ experiments are 
not likely to detect non-directly bonded 13C pairs, and therefore, this correlation signal pairs is 
not from K nor PTMs of K but from glycation products. The 175 ppm 13C signal is likely to be 
from an amide carbon or carboxylate carbon, and such functionalities are not likely to proceed 
to further reactions and usually represent the end stage of glycation reactions, i.e. in this case, 
AGEs. 
 
The 13C-13C correlation signals, 47-26 ppm and 180-34 ppm (marked in pink in Figure 8-6 and 
Figure 8-7) are also observed in 2D DNP-SSNMR spectra of ECM(VSMC-K), but remain 
unassigned, so they are not the focus of this work. The correlation between 13C(87 ppm) and 
13C(53 ppm) seen in the 2D SQ-DQ DNP-SSNMR spectrum in Figure 8-6 is overlapped by 
spinning sidebands in the 2D DARR DNP-SSNMR spectrum in Figure 8-7; these signals are 
most likely derived from sugar moieties in glycation products.  
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Figure 8-6 2D 13C-13C SQ-DQ (SPC5) DNP-SSNMR spectrum of ECM(VSMC-K)-R5P (ns = 
64, 512 F1 slices).  
 
 
Figure 8-7 2D 13C-13C DARR DNP-SSNMR spectrum of ECM(VSMC-K)-R5P (ns = 64, 640 
F1 slices). Signals with green marks are spinning sidebands, except the 87-53 ppm 
correlation signal which overlaps with signals of glycation products.  
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Figure 8-5 (D, E and F) also compares 1D 15N CPMAS DNP-SSNMR spectra of ECM(VSMC-
K) (blue, top, (D)), Col(VSMC-K)-Rib (green, middle, (E)) and ECM(VSMC-K)-R5P (red, 
bottom, (F)). As for 15N species generated from U-13C6, 15N2-K in the glycation model system, 
four 15N signals are observed in glycated samples (Figure 8-5 (E) and (F)), 45 ppm, 57 ppm, 
75 ppm and 85 ppm, in addition to the two 15N signals arising from K, at 32 ppm (K 15N) and 
127 ppm (K 15N’). 15N signals with chemical shifts higher than 160 ppm (Figure 8-5 (E) and 
(F)) have been previously assigned to nucleotide bases [174] and therefore, we assign these 
signals as being from glycation species with similar chemical functionality to nucleotide bases, 
aromatic-like glycation products, such as argpyrimidine (structure is shown in Appendix). It is 
worth mentioning that sample weight of ECM(VSMC-K)-R5P is roughly 5 times more than 
ECM(VSMC-K)-Rib; this limited sample weight of ECM(VSMC-K)-Rib (~1-2 mg) might 
limit the observation of 15N and 13C-15N correlations.  
 
The 15N signal at around 45 ppm is observed in the 1D 15N CPMAS DNP-SSNMR spectra of 
Col(VSMC-K)-Rib (Figure 8-5 (E)) and also in the spectrum for ECM(VSMC-K)-R5P but 
weaker (Figure 8-5 (F)). Figure 8-8, 2D 13C-15N correlation DNP-SSNMR spectra, shows that 
this 15N signal (45 ppm) correlates with two 13C signals at 50 ppm and 170 ppm in spectra of 
both Col(VSMC-K)-Rib and ECM(VSMC-K)-R5P samples (Figure 8-8, correlation signals are 
connected by a black dash line), and therefore, is assigned to CML, 15N-carboxymethyl-lysine.  
 
The 13C-15N correlations involving the 15N signal at about 57 ppm are only observed for the 
ECM(VSMC-K)-R5P sample (Figure 8-8 (B), in red). This 15N signal correlates with two 13C 
signals at 47 ppm and 58 ppm. These two 13C chemical shifts are very similar to P Ca and Cd. 
So, these 13C-15N correlations might be from a P-like structure, possibly in a five-membered 
ring: 13C-15N-13C.  
 
The 15N signal at 85 ppm is observed in 1D 15N CPMAS DNP-SSNMR spectra of both 
ECM(VSMC-K)-R5P and Col(VSMC-K)-Rib samples, Figure 8-5 (E) and (F) (connected by 
a black dash line); however, it is only observed in the 2D 13C-15N correlation spectrum for 
ECM(VSMC-K)-R5P (Figure 8-8 (B), in red). The middle panel of the Figure 8-8 (B) shows 
that this 15N signal (85 ppm) is in fact composed of two 15N signals and which correlates with 
two different 13C signals, 15N (85 ppm)-13C (40 ppm) and 15N (86 ppm)-13C (54 ppm), 
suggesting there are in fact two glycation products with an 15N signal close to 85 ppm, but with 
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different carbon functionalities. A 13C chemical shift of 54 ppm is consistent with a carbon 
bonded to a nitrogen and so the 15N (86 ppm)-13C (54 ppm) correlation signal is assigned to K 
15N bonded to a carbon. However, a 13C chemical shift of 40 ppm is not consistent with a carbon 
bonded to nitrogen, so the 15N (85 ppm)-13C (40 ppm) correlation corresponds to a K 15N and 
a carbon further away from that nitrogen.  
 
A 15N signal at 135 ppm correlates with the 13C signal at 165 ppm, observed in 2D 13C-15N 
correlation spectra for ECM(VSMC-K)-R5P and Col(VSMC-K)-Rib in Figure 8-8, which is 
consistent with our previous assignment for this 13C signal, -15NH-13C(=O)-13C(=O)-15NH-.  
 
Table 8-4 The main 13C-15N correlations observed in 2D 13C-15N DNP-SSNMR spectra of 
Col(VSMC-K)-Rib and ECM(VSMC-K)-R5P in Figure 8-8.  
13C-15N Correlations Appearance in Figure 8-8 
Suggested Assignments or Fragments 
15N /ppm 13C /ppm (A) (B) 
46 50 Y Y CML 
170 Y Y 
57 47 - Y 13C-15N-13C in a five-membered ring 
structure 58 - Y 
85 40 - Y  
86 54 - Y  
135 165 Y Y -NH-C(=O)-C(=O)-NH- 
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Figure 8-8 2D 13C-15N correlation DNP-SSNMR spectra of (A) Col(VSMC-K)-Rib (green) 
and (B) ECM(VSMC-K)-R5P (red). The main 13C-15N correlations observed are 
summarised in Table 8-4.  
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8.2 Glycation Products Derived from U-13C6, 15N4-R Enriched 
Model Systems with U-13C5-Ribose-5-Phosphate and U-13C5-
Ribose 
Arginine (R) is also a target amino acid of protein glycation because it has a terminal guanidino 
group that can potentially participate in the glycation process. R glycation is studied in this 
section by examining U-13C5-R5P/-Rib glycated and U-13C6, 15N4-R enriched in vitro ECMs 
using SSNMR spectroscopy, similarly to the study of K glycation in the previous section.  
 
There are 161 R residues in the bovine collagen type I molecule (sequence is taken from 
UniProt), and R does not undergo complicated post-translational modifications as K does. So, 
in theory, all accessible guanidino groups on R are available for glycation. However, the 
guanidino groups on R is generally regarded to be less reactive towards glycating agents than 
the amine groups on K. So, U-13C6, 15N4-R enriched in vitro ECMs are produced and glycated 
to explore whether there is any glycation reactivity between R and U-13C5-R5P/-Rib.  
 
U-13C6, 15N4-R enriched ECMs were prepared by in vitro cell culture where U-13C6, 15N4-R is 
supplemented into cell culture media. Introducing U-13C6, 15N4-R into cell culture can generate 
extra NMR signals from cell metabolism of the labelled R and thus complications in assigning 
NMR spectra. Cells consume U-13C6, 15N4-R and metabolise to U-13C5, 15N-P, and U-13C5, 15N-
P can be post-translational modified to U-13C5, 15N-O in collagen. So, a combination of signals 
from 13C, 15N-labelled R, P and O can be observed in U-13C6, 15N4-R enriched in vitro ECMs 
in addition to the signals from glycation products of interest.  
 
Figure 8-9 compares 1D 13C CPMAS SSNMR spectra of differently treated U-13C6, 15N4-R 
enriched in vitro ECMs, including intact in vitro ECM harvested from freeze-thaw and 
detergent cell lysis and collagen extracted from detergent lysed in vitro ECM, to decide if 
different treatments would affect R conformations. R 13C signals (indicated by red dash lines 
in Figure 8-9) do not shift much as a consequence of chymotrypsin treatment. It seems that 
some minor shifts are observed on R sidechain carbons, which might result from the removal 
of non-collagenous proteins and thus, removal of their NMR signals to make the R 13C 
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chemical shifts more towards their chemical shifts for the triple helical conformation. The 
expected 13C and 15N chemical shifts of R in collagen are included in Table 8-5.  
 
Table 8-5 13C and 15N chemical shifts of arginine (R) observed in triple helical collagen.  
AA 
d(13C)/ ppm d(15N)/ ppm 
C’ Ca Cb Cg Cd Cz N’ Ne Nh 
R 174 54 28 26 42 157 120 84 72 
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Figure 8-9 Comparison of 1D 13C CPMAS SSNMR spectra of, from top to bottom, Col(VSMC-
R) (U-13C6, 15N4-R enriched VSMC ECM, detergent lysed, cleaned up by 
chymotrypsin and Tween-20, ns = 4096), Col(FSOB-R) (U-13C6, 15N4-R enriched 
FSOB ECM, detergent lysed, cleaned up by chymotrypsin and Tween-20, ns = 
4096), ECM(VSMC-R) Detergent (U-13C6, 15N4-R enriched VSMC ECM, 
detergent lysed, ns = 4096), ECM(FSOB-R) Detergent (U-13C6, 15N4-R enriched 
FSOB ECM, detergent lysed, ns = 31625), ECM(VSMC-R) Freeze-thaw (U-13C6, 
15N4-R enriched VSMC ECM, freeze-thaw lysed, ns = 4096) and ECM(FSOB-R) 
Freeze-thaw (U-13C6, 15N4-R enriched FSOB ECM, freeze-thaw lysed, ns = 4000). 
Red dash lines indicate all the R 13C signals, and black dash lines indicate the 13C 
signals from O Cg, P/O Ca (not resolved) and P Cd.  
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8.2.1 Col(FSOB-R) Glycated with U-13C5-R5P and U-13C5-Rib 
Glycated samples are referred to as Col(FSOB-R)-R5P or Col(FSOB-R)-Rib in the following 
text, and their 1D 13C and 15N CPMAS SSNMR spectra are shown in Figure 8-10.  
 
Minor 13C chemical shifts changes of R aliphatic carbons are observed in glycated samples 
compared to non-glycated samples (Figure 8-10 top), indicating R conformational changes 
associated with glycation. This conformational change might be related to R sidechain charge 
alteration due to glycation. However, the 13C chemical shift changes can also arise from the 
production of 13C enriched glycation products, giving 13C signals in the aliphatic carbon region 
and overlap with R 13C signals.  
 
In 1D 15N CPMAS SSNMR spectra of Col(FSOB-R)-R5P and Col(FSOB-R)-Rib samples 
(Figure 8-10 bottom), the intensities of R 15Ne and R 15Nh decrease after glycation, when 15N 
signal intensities are normalised on R 15N’, suggesting that these R N are directly involved in 
glycation reactions. In addition, new 15N signals, weak and broad, are observed for both 
Col(FSOB-R)-Rib and Col(FSOB-R)-R5P samples near 100 ppm (arrow in Figure 8-10 
bottom), indicating a small portion of R in those samples is glycated. Depending on the location 
of the R glycation site, sidechain R 15N with sugar moieties attached either transitions from a 
“primary-amine-like” to a secondary amine or from a secondary amine to a tertiary amine; 
under either circumstance, the glycated R sidechain 15N signal shifts are expected to result in 
higher 15N chemical shifts than the original R 15N chemical shifts.  
 
As mentioned earlier, R can be metabolised into P by cells, and P can be post-translational 
modified into O in collagen. This series of activities explains the 13C P and O signals observed 
in 2D 13C-13C correlation spectra (the grey solid squares and the blue dash rectangles in Figure 
8-11). The 13C-13C correlation signals from U-13C6, 15N4-R, U-13C5, 15N-P and U-13C5, 15N-O 
overlap with signals from AGEs, resulting in a group of poorly-resolved signals in the amide 
carbon spectral region. For example, signals in the blue dash rectangle (the amide carbon region) 
in Figure 8-11 (C) and (D) contain many overlapping signals, including correlations between 
amide carbons and aliphatic carbons in R, P and O residues as well as AGEs correlation signals 
50-170 ppm (CML) and 54-176 ppm (CEL and/or MG-H and/or MODIC) observed previously. 
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Figure 8-10 Top: 1D 13C CPMAS SSNMR spectra of Col(FSOB-R) (blue, ns = 4096), U-13C5-
Rib glycated (green, ns = 4096) and U-13C5-R5P glycated (red, ns = 4096) 
Col(FSOB-R). Intensities are normalised on R 13C’ signal. Bottom: 1D 15N CPMAS 
SSNMR spectra of Col(FSOB-R) (blue, ns = 10240), U-13C5-Rib glycated (green, 
ns = 10240) and U-13C5-R5P glycated (red, ns = 10240) Col(FSOB-R). Intensities 
are normalised on R 15N’ signal.  
 
However, many glycation product signals are observed and can be identified in 2D 13C-13C 
correlation spectra, PC7 and PDSD, in Figure 8-11, and 13C chemical shifts of correlated 
signals and their suggested assignments are summarised in Table 8-6, excluding signals in the 
sugar and the amide carbon spectral regions. Many of the glycation products assigned here 
have already been observed and assigned in previously described model systems, so will not 
be discussed further here.  
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13C-13C correlation signals are observed at 54-75 ppm and 28-75 ppm in the 2D PDSD spectrum 
for Col(FSOB-R)-Rib in Figure 8-11 D. These two pairs of correlation signals share similar 
13C chemical shifts with previously observed Hyl-like correlations in the 2D PDSD spectrum 
for Col(FSOB-K)-R5P in Figure 8-4 C. The fact that the molecule/moiety giving these 13C-13C 
correlations is still 13C-enriched without 13C-K means that the molecule/moiety those two 
correlation pairs are from 13C-Rib/-R5P.  
 
Correlation signals that have not been observed in non-isotope enriched model systems are of 
primary interest and are most likely from glycated R (R-sugar) (chemical shifts of these signals 
are in bold in Table 8-6). For example, the 13C PDSD correlation signal at 85-175.5 ppm seen 
in Figure 8-11 (D) is likely to derive from R 13Cz correlating with a hydroxylated carbon in the 
sugar adduct (R-N-13Cz-N-13Csugar(OH)), further substantiating that Rib and R5P, or by-
products of their glycation with K, react with R.  
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Figure 8-11 2D 13C-13C PC7 (top row) and PDSD (bottom row) SSNMR spectra of Col(FSOB-
R)-R5P (left column; A: ns = 2048, 100 F1 slices; C: ns = 560, 278 F1 slices) and 
-Rib (right column; B: ns = 1280, 120 F1 slices; D: ns = 1024, 151 F1 slices). 
Common correlation pairs are linked by red dash lines across spectra; correlation 
signals only observed in one spectrum are in green. Signals included in the orange 
dash boxes are likely from glycation intermediates with aldehyde groups. Grey solid 
boxes include signals from P and O aliphatic carbons, and the blue dash rectangles 
include overlapping signals in amide and carboxylate region.  
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Table 8-6 A summary of 13C-13C correlation signals observed in 2D 13C-13C correlation spectra 
(PC7 and PDSD) of Col(FSOB-R)-R5P and Col(FSOB-R)-Rib in Figure 8-11. 
Chemical shifts in orange correspond to signals in orange dash rectangle. Chemical 
shifts in bold are signals that have not been observed in non-isotope-enriched model 
systems and are discussed in the text.  
Cross Peak Correlations  R5P Rib Suggested Assignments or Fragments 
Signal 1 
/ppm 
Signal 2 
/ppm 
PC7 
PDSD 
(20 ms) 
PC7 
PDSD 
(20 ms) 
 
17 57 Yes Yes Yes Yes CEL and/or MG-H and/or MODIC 
22 173 Yes - Yes - N-Acetyl-Lys 
24 180 Yes Yes Yes Yes N-Acetyl-Hyl 
51 191 - - Yes Yes  
57 193 Yes Yes Yes Yes Norpronyl-Lys 
165 165 Yes - Yes - 
-NH-C(=O)-C(=O)-NH- 
169 169 - - Yes - 
21 68 Yes - - -  
28 75 - - - Yes R-sugar 
54 75 - Yes - Yes R-sugar 
57 71 - Yes - Yes R-sugar or sugar 
85 157.5 - - Yes Yes R-sugar 
156 160 - Yes - Yes  
51 179 - - - Yes 
Glycation intermediates 
62 179.5 Yes Yes Yes Yes 
65 179  - - Yes 
69 181 - Yes - - 
72 179 Yes  Yes  
73.5 179 - - - Yes 
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8.3 Glycation Studies in U-13C2, 15N-G and U-13C5, 15N-P 
Enriched Model Systems with Ribose-5-Phosphate: 
Conformation and Integrity of Collagen Triple Helix 
G and P/O are the most abundant amino acids in collagen and are critical to collagen triple 
helix structure and stability. Collagen triple helix is stabilised by interchain hydrogen bonding 
between G N-H group and X O=C group along the backbone and the special stereo stabilising 
effects of P and O (reviewed in section 2.1.2). G and P/O in collagen cannot directly participate 
in the glycation reaction as they do not have available amino groups; therefore, their chemical 
structures are not affected by glycation. However, their NMR chemical shifts can be affected 
if glycation has an impact on the conformation of the collagen triple helix which would be 
observed as changes in 13C chemical shifts of G and P/O, measured here in 1D 13C CPMAS 
SSNMR spectra; if glycation disrupts the collagen triple helix, the interchain hydrogen-
bonding would be affected, which leads to changes of 1H chemical shifts of the hydrogen-
bonded proton in G N-1H groups, measured here in 2D 1H-13C HETCOR SSNMR spectra. Due 
to the special roles they play in collagen structure stability and the sensitivity of 13C chemical 
shifts of G and P/O carbons to the molecular secondary structure, their NMR chemical shifts 
are used here to probe the effects of glycation on collagen and collagen dominated ECMs on 
collagen triple helix conformation and integrity.  
 
In vitro ECM with U-13C2, 15N-G and U-13C5, 15N-P and U-13C5, 15N-O enrichment is produced 
by cell culture with addition of the appropriately labelled G and P to the cell cultural media. 
Figure 8-12 compares 1D 13C CPMAS SSNMR spectra of freeze-thaw and detergent lysed U-
13C2, 15N-G, U-13C5, 15N-P and U-13C5, 15N-O enriched in vitro ECMs, as well as collagen 
extracted from detergent lysed U-13C2, 15N-G, U-13C5, 15N-P and U-13C5, 15N-O enriched in 
vitro ECMs to determine if G and P/O conformation changes in response to different treatments. 
13C chemical shifts of all G, P and O aliphatic carbon signals are consistent across spectra, as 
expected (indicated by black dash lines in Figure 8-12), except P 13Ca and O 13Ca are not 
resolved. Relative 13C signal intensity differences between G, P and O 13C in different spectra 
are likely to be resulted from different time points of feeding U-13C2, 15N-G and U-13C5, 15N-P 
into cell culture in relative to cell growth, utilisation rates of G and P and collagen biosynthesis.  
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Figure 8-12 A stacking of 1D 13C CPMAS SSNMR spectra of U-13C2, 15N-G and U-13C5, 15N-
P labelled, differently treated ECMs, from top to bottom, Col(FSOB-PG) (green, 
U-13C2, 15N-G and U-13C5, 15N-P/-O enriched FSOB ECM, detergent lysed, cleaned 
up by chymotrypsin and Tween-20, ns = 2048), ECM(FSOB-PG) Detergent (navy, 
U-13C2, 15N-G and U-13C5, 15N-P/-O enriched FSOB ECM, detergent lysed, ns = 
2048), ECM(VSMC-PG) Detergent (purple, U-13C2, 15N-G and U-13C5, 15N-P/-O 
enriched VSMC ECM, detergent lysed, ns = 4096) and ECM(VSMC-PG) Freeze-
thaw (brown, U-13C2, 15N-G and U-13C5, 15N-P/-O enriched VSMC ECM, freeze-
thaw lysed, ns = 4096). Black dash lines indicate the 13C chemical shifts of G, P 
and O signals. Arrows are pointing at a shoulder signal off the major G 13C’ signal 
with lower chemical shifts, originating from G in more tightly packed triple helical 
regions. This colour code will be applied to samples described in the sections below.  
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The 13C chemical shifts of P and O observed in collagenous samples shown in Figure 8-12 
reflect a weighted average 13C chemical shifts of P and O in different environments. 13C 
chemical shifts of G and P/O are sensitive to local structure which is likely to be different at 
different points along the collagen triple helix, their neighbouring residues (see Table 8-7), as 
well as effects of glycation.  
 
Table 8-7 13C chemical shifts (in ppm) of G and P/O in collagen and collagen-like model 
peptides. 13C chemical shifts of P and O can be affected by their locations and 
neighbouring residues in the G-X-Y triplets and the endo or exo conformation they 
adopt. Chemical shifts of collagen-like triple helical model peptides were measured 
by Dr. Wing Ying Chow and included in her PhD thesis [135], and some are 
published in [175][176].  
Residue Type d(13C')  d(13Ca)  d(13Cb)  d(13Cg)  d(13Cd)  
G in Collagen 170 42 - - - 
P in Collagen 
174 58 
30 25 47 
O in Collagen 38 70 55 
(GPO)11 171.5 58.2 27.9 25.3 46.8 
(GPO)11 172 58.3 38.2 70.4 55.3 
(GPP)11 173.7 58.9 29.5 25.5 47.5 
(GPO)5GPP(GPO)5  171.4 58.1 28.2 24.8 46.7 
(GPO)5GPP(GPO)5  173.9 58.9 29.5 25.9 47.6 
 
8.3.1 13C Chemical Shifts of G and P/O  
Glycated Col(FSOB-PG) and ECM(VSMC-PG) with R5P are prepared and studied by SSNMR 
to assess if there is any conformational changes of collagen triple helix in response to the 
glycation reaction. Figure 8-13 shows the 1D 13C CPMAS SSNMR spectra of two pairs of 
comparisons between glycated and non-glycated collagenous samples with 13C, 15N-enriched 
G and P/O, Col(FSOB-PG) versus Col(FSOB-PG)-R5PN (Figure 8-13 (A) green/bottom 
spectrum and black/top spectrum; nomenclature explained in figure caption) and ECM(VSMC-
PG) versus ECM(VSMC-PG)-R5P (Figure 8-13 (B) purple/bottom spectrum and black/top 
spectrum).  
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After glycation, 13C signals of G and P/O do not shift, indicating no significant changes in 
collagen secondary structure.  
 
Figure 8-13 13C CPMAS SSNMR spectra of (A) Col(FSOB-PG) before (green, U-13C2, 15N-G 
and U-13C5, 15N-P/-O enriched FSOB ECM, detergent lysed, cleaned up by 
chymotrypsin and Tween-20, ns = 1024) and after (black, ns = 1024) R5P (non-
isotope-enriched) glycation. Those two spectra are acquired on a 700 MHz SSNMR 
spectrometer at a MAS rate of 14 kHz. Both samples were prepared by Ieva 
Goldberga. (B) ECM(VSMC-PG) before (purple, U-13C2, 15N-G and U-13C5, 15N-
P/-O enriched VSMC ECM, detergent lysed, ns = 4096) and after (black, ns = 8192) 
U-13C5-R5P glycation. Black dash lines indicate the 13C chemical shifts of G, P and 
O signals.  
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8.3.2 Collagen Interchain Hydrogen Bonding 
A second SSNMR measurement was trialled on glycated versus non-glycated U-13C2, 15N-G 
and U-13C5, 15N-P and -O enriched ECM samples to examine the effect of glycation on 
intrahelix hydrogen bond strength. The 2D 1H-13C correlation experiment gives signal 
correlations between 1H and 13C nuclei close in space and generate 2D spectra in which one 
dimension contains a 1H spectrum and the other, a 13C spectrum (more details about this 
SSNMR experiment is explained in section 4.6.2).  
 
In the collagen triple helix, every G N’-H group proton is hydrogen-bonded to the carbon in 
the O=C’ group of the residue at X position (N’-H (G)⋯O=C’ (X)) on a neighbouring chain to 
stabilise the triple helix. From a SSNMR perspective, this hydrogen-bonded 1H in the N’-H 
group should give a distinctive 1H-13Ca(G) cross peak in the 2D 1H-13C HETCOR spectrum. 
The 1H chemical shift of the 1H-13Ca(G) signal depends on the strength of hydrogen-bonding: 
the longer/weaker the hydrogen-bond, the lower the 1H chemical shift. If the strength of this 
hydrogen-bond changes with glycation, the implication is that glycation has affected the triple 
helix stability/integrity. We aim here to detect any such changes in G N-1H 1H chemical shift 
through correlation between the G Ca 13C signal and the G N-1H signal in the 1H dimension of 
the 2D 1H-13C correlation spectra we record.  
 
2D 1H-13C HETCOR spectra of Col(FSOB-PG) before and after R5PN glycation are presented 
in Figure 8-14. The G Ca 13C signal correlates with its directly bonded 1H giving a correlation 
signal at 3.9 ppm on the 1H dimension and 42.3 ppm on the 13C dimension; in the meantime, 
the G Ca 13C signal correlates with 1H at higher chemical shift, 8.6 ppm from the G amide 1H. 
After glycation, the chemical shift of this G amide 1H does not appear to change, suggesting 
no significant change on the H-bonding of this amide 1H and thus glycation does not appear to 
affect the intrahelix hydrogen-bonding and stability of the helix from this bonding.  
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Figure 8-14 2D 1H-13C HETCOR spectra of (A) Col(FSOB-PG) (green, U-13C2, 15N-G and U-
13C5, 15N-P/-O enriched FSOB ECM, detergent lysed, cleaned up by chymotrypsin 
and Tween-20, ns = 256, 50 F1 slices) (B) Col(FSOB-PG)-R5PN (black, U-13C2, 
15N-G and U-13C5, 15N-P/-O enriched FSOB ECM, detergent lysed, cleaned up by 
chymotrypsin and Tween-20 and glycated with ribose-5-phosphate, ns = 256, 50 F1 
slices). Slices extracted at G Ca shown in red, and red dash lines indicate 1H 
chemical shifts of G Ca-1H and N’-1H. Both spectra are acquired on a 700 MHz 
SSNMR spectrometer at a MAS rate of 14 kHz. These two samples were prepared 
by Ieva Goldberga. 
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8.4 Summary 
K and R directly participate in the glycation reaction, and their chemical structures are expected 
to change due to glycation and glycation products adding to their sidechains. We explored 
changes of K and R conformation with glycation via 13C and 15N chemical shift changes from 
samples in which the collagen K and R was uniformly 13C, 15N labelled. 13C-labelled glycating 
agents were used in the glycation reactions in order to extract carbon and nitrogen 
connectivities between K and R sidechains and glycation additions to those sidechains. 15N 
chemical shifts of K or R are expected to change significantly with glycation, as the glycation 
chemistry occurs at these nitrogens, and thus 15N NMR spectra were used to assess the degree 
to which K and R each participate in glycation reactions.  
 
DNP-SSNMR spectroscopy compensates the intrinsic sensitivity problem of conventional 
SSNMR spectroscopy and allows observation of signals derived from minor glycation products 
that are not observable by the conventional SSNMR. 2D 13C-15N correlation DNP-SSNMR 
spectra confirms the assignments of N-carboxymethyl-lysine and the oxalamide-like structure 
in the previous chapter.  
 
G and P/O do not participate in the glycation reaction, but their chemical environments can 
change due to glycation if glycation affects more than simply the local structure of the glycated 
residue. We monitored any such effects here through the respective NMR 13C and G N-1H 
chemical shifts of G, P and O and concluded that glycation has little effect on any of these 
parameters. We thus suggest that, rather than causing gross changes to the collagen triple helix 
conformation, glycation predominantly affects local collagen structures, including K and R 
sidechain conformations. Modifications of K and R sidechains may lead to further 
consequences and eventually cause tissue failure. For example, charge alterations of K and R 
sidechains may also alter the electrostatic interactions between collagen molecules and cause 
misalignments of collagen molecules and therefore destabilise collagen fibrils. In addition, 
modifications of R involved in collagen-integrin binding might disrupt regular ECM-cell 
interactions, trigger abnormal cell behaviours and affect tissue function.  
  
 155 
9 Biogenic Glycating Agents in Cellular Models 
As reviewed in section 3.4.2, many carbonyl or dicarbonyl species have been used as model 
glycating agents in in vitro systems, such as GO and MGO, but not all the glycation products 
identified in vitro have been identified in in vivo tissues. The biological relevance of carbonyl 
species as in vitro glycating agents is needed to establish the in vivo relevance of their 
corresponding glycation products identified in in vitro systems.  
 
Cell metabolism can vary under different conditions, especially under diseased conditions, and 
therefore, cells can produce different compositions of metabolites. For example, the polyol 
pathway is known to be upregulated in diabetic conditions, and potentially generates excess 
glycating metabolites such as fructose and fructose-6-phosphate compared with healthy 
metabolism [177]. In order to explore what biological relevant glycating metabolites can be 
generated by cells, multiple cell models mimicking different metabolic conditions are tested in 
this work to see if altered metabolism alters the amount or nature of glycating metabolites.  
 
In terms of cellular metabolites, some metabolites are readily released outside cells (referred 
to as extracellular metabolites) while some only exit cells under certain conditions (referred to 
as intracellular metabolites), such as cell necrosis or impaired metabolism. This work mainly 
focuses on intracellular metabolites that can leak outside cells under necrosis. There is little 
known about the glycation consequences of cell necrosis, which is an inherent part of many 
diseases, such as cancer and inflammation.  
 
Intracellular metabolites are collected for analysis by cell lysis. Collecting the cell lysate is 
challenging because cell metabolism status can change very quickly in response to 
environmental changes; for example, cell metabolism can change immediately when cells are 
taken out of the incubator or when cell culture media is removed or even during the lysis 
process. This fast metabolic response poses challenges on collecting the cell lysate that 
accurately reflects the cell metabolism status before the cell lysis procedure and requires the 
whole cell lysis process to be conducted as fast as possible. Therefore, it is of priority to find 
an appropriate cell lysate extraction method to best represent cell metabolism status for the 
study of intracellular metabolites and their concentrations.  
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Performing cell lysis and subsequent procedures at low temperature can potentially slow down 
cell metabolism, enzymatic processes and possible secondary reactions between reactive, i.e. 
glycating, metabolites and surrounding proteins or lipids. To begin with, cell lysate was 
collected by freeze-thaw lysis, which involves cells to be frozen in a -80℃ freezer overnight 
then thawed at room temperature. A considerate amount of protein is collected together with 
cellular metabolites, even after repeated centrifugation (see section 5.6 for metabolite 
extraction procedure). This protein content makes the cell lysate itself a glycation system with 
both glycating agents and glycating substrates (protein) are present and can result in inaccurate 
and misleading results. In a second set of experiments, cell lysate was collected from liquid-
nitrogen-lysed cells, i.e. cell cultures flash frozen in liquid nitrogen, with extra steps to separate 
cellular proteins and metabolites (see section 5.6 for the detailed procedure), which resulted in 
more effective metabolites extraction: faster cell lysis and less protein content.  
 
The glycating capability of extracted metabolites is then investigated by two experiments. The 
first one is to incubate cell lysate with poly-L-lysine (PLL), where cell lysate works as a 
glycating agent, and PLL works as a glycation substrate. AGE fluorescence was measured at 
different time points over the incubation period to determine if glycation occurs and therefore 
if cell lysate contains glycating metabolites. This experiment provides an overall estimation of 
glycation capability of intracellular metabolites. The second experiment involves high-
performance liquid chromatography with UV absorbance detection (HPLC-UV) and mass 
spectroscopy (HPLC-UV-MS) to identify and quantify glycating metabolites in the cell lysate. 
A pre-column derivatisation of cell lysate is introduced to make reactive, i.e. glycating, 
metabolites UV active.  
 
Results obtained from above-mentioned experiments are presented and discussed in the 
following sections.  
9.1 Glycating Capacity of Cell Lysate - AGE Fluorescence 
The glycation capacity of cell lysate is first measured by incubating cell lysate with poly-L-
lysine (PLL), and AGE fluorescence is followed over time to study if glycation reactions 
happen and produce fluorescent AGEs during incubation. Positive controls, such as PLL with 
sugar or sugar phosphate, were also incubated to compare their glycation behaviours with the 
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cell lysate. The experiments are designed to estimate qualitatively the amount of glycating 
metabolites in the cell lysate. 
 
It is worth noting that (1) in this cell lysate and PLL glycation system the dominating glycation 
substrate, i.e. PLL, only contain K but cellular proteins remaining (explain later) in the cell 
lysate might contain both K and R that can also undergo glycation reaction that could skew the 
results (2) only a small portion of AGEs are fluorescent and therefore detected in this 
experiment; glucosepane, the major AGE crosslink from glucose glycation, is not fluorescent. 
Known fluorescent AGEs are list in the table below (Table 9-1). However, they may not all be 
generated in cell lysate and PPL incubation, depending on the carbonyl metabolites present in 
cell lysate and whether the incubation condition matches their synthetic requirement. 
 
Table 9-1 A list of fluorescent AGEs and their excitation and emission wavelengths (𝜆Iz and 𝜆I). The numbering in this table is corresponding to Table 3-3 and Table 3-4 in 
previous chapters. GA is glyceraldehyde; GA3P is glyceraldehyde-3-phosphate; 
MGO is methylglyoxal.  
Fluorescent AGEs  No. Glycating Agent 𝝀𝒆𝒙 /nm 𝝀𝒆𝒎 /nm Ref 
K Amino Acid Sidechain Modifications 
GA-pyridine 5 GA 326 406 [178] 
K Crosslinks 
Lysine-dihydropyridinium 
(K2P) 
17 - 343 410 [179] 
Lys-hydroxy-triosidine 33 GA 354 440 [111] 
Vesperlysines 27 Glc  380 440 [180] 
Crosslines 28 Glc  379 463 [181] 
K R Crosslinks 
Pentosidine 13 Pentose 
Rib, Glc, Fru and ascorbate 
Xylose 
335 385 [80][49] 
[105] 
[111] 
R Amino Acid Sidechain Modifications 
Argpyrimidine 9 MGO 
GA or GA3P 
320 380 [182] 
[111] 
R Crosslinks 
Arg-hydroxy-triosidine 26 GA or GA3P 331 380 [111] 
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9.1.1 Freeze-thaw Lysis (FTL) 
FTL, as the simplest and the most commonly used cell lysis method, was first surveyed for cell 
lysate collection and analysis.  
 
Vascular smooth muscle cells (VSMCs, from adult bovine) were exposed to different glucose 
concentrations for different time lengths, aiming to alter normal metabolism and mimic 
hyperglycaemia. Then, the cell lysate was collected by FTL and incubated with PLL. AGE 
fluorescence was measured regularly over a 24-day incubation period, and fluorescence 
intensity build-up curves from three cell lysate samples are shown in Figure 9-1. Cell lysate 
samples collected by FTL are coded for brevity (Table 9-2).  
 
Table 9-2 A list of cell lysate samples described in this section, and their relevant details. All 
samples were obtained from VSMCs. 1Day counting started after cells are confluent.  
Sample Code Cell Culture Condition Cell Lysis 
CL1-1g-F 1 g/L Glc 
Freeze-thaw Lysis 
CL2-9g-1d-F 1-day exposure to 9 g/L Glc1 
CL3-9g-6d-F 6-day exposure to 9 g/L Glc1 
CL4-1g-F 1 g/L Glc 
 
Sample CL1-1g-F (blue curve in Figure 9-1) was obtained from VSMCs cultured with 1 g/L 
glucose in its culture media, which is the usual cell culture condition for VSMCs; sample CL2-
9g-1d-F (orange curve in Figure 9-1) was obtained from VSMCs with 1-day exposure to 9 g/L 
glucose before cell lysis; sample CL3-9g-6d-F (grey curve in Figure 9-1) was obtained from 
VSMCs with 6-day exposure to 9 g/L glucose before cell lysis. All three fluorescence intensity 
build-up curves from the incubated cell lysate and PLL fluctuate with a similar trend (Figure 
9-1). It seems that at the beginning, these glycation systems already show some AGE 
fluorescence. Then, this initial fluorescence disappears and later recovered, which might 
indicate that fluorescent AGE formation is somewhat reversible, which is unexpected. This 
may indicate that the signal/noise level in this fluorescence measurement is poor or that there 
are some unknown fluorescent glycation intermediates generating and advancing to non-
fluorescent glycation products in the cell lysate and PLL incubation.  
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Figure 9-1 AGE fluorescence build-up curves of three different cell lysate samples and PLL 
over a 24-day incubation. Grey (top): CL3-9g-6d-F+PLL. Orange (middle): CL2-
9g-1d-F+PLL. Blue (bottom): CL1-1g-F+PLL.  
 
The fact that the AGE fluorescence recovers in different rates among three different CL 
samples and that all samples exhibit an overall increase of AGE fluorescence over the 
incubation period suggests the three CL samples might contain different amount of glycating 
metabolites. Different amounts or nature of glycating species can arise because of differences 
in metabolism. For example, glucose usually is metabolised via glycolysis to glucose-6-
phosphate (G6P), fructose-6-phosphate (F6P), fructose-1,6-biphosphate (F16P), 
glyceraldehyde-3-phosphate (GA3P), dihydroxyacetone-phosphate (DHAP), etc., which are all 
more reactive glycating agents than glucose; when excess glucose is provided to cells, 
glycolysis can be promoted and more of the reactive glucose-derived products can be produced.   
 
After the 24-day incubation period, CL3-9g-6d-F (the grey curve in Figure 9-1) generates more 
fluorescent AGEs than CL2-9g-1d-F (the orange curve in Figure 9-1) and CL1-1g-F (the blue 
curve in Figure 9-1). This difference in the amount of accumulated fluorescent AGEs between 
the three samples was speculated to be a result of insufficient cell washes before cell lysis, 
resulting in residual glucose from the cell culture medium in cell lysate and this glucose being 
primarily responsible for the observed AGE fluorescence, rather than intrinsic cell metabolism 
differences. However, in principle, CL2-9g-1d-F and CL3-9g-6d-F have the same medium 
glucose concentration before cell lysis. If the insufficient washing is the sole reason for the 
observed glycation and AGE fluorescence, CL2-9g-1d-F and CL3-9g-6d-F should give very 
similar fluorescence vs time curves. To strengthen the point, glucose is known to be a very 
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slow glycating agent, and a minor quantity of glucose leftover from the cell culture medium is 
unlikely to contribute to AGEs formation in this 24-day timescale. Thus, the difference in final 
fluorescent AGEs accumulation suggests that cells exposed to a high glucose environment for 
longer periods produce more damaging metabolites as glycating agents. The final dip in all 
curves might result from PLL aggregation and precipitation, compromising fluorescence 
measurement.  
 
Positive controls, PLL incubated with Glc, Rib and R5P, were measured in parallel to estimate 
the glycating capacity of cell lysate samples by comparing their AGE fluorescence intensity 
build-up curves (Figure 9-2). All three positive controls react significantly faster than cell 
lysate samples and display a higher magnitude of AGE fluorescence intensity at every time 
point so that they are plotted separately to show the details of the curves better. The massive 
difference in fluorescence intensity or AGE content of these samples is probably because the 
concentrations used for these sugars and sugar phosphate are too high to be comparable to the 
concentration of reactive metabolites in the cell lysate.  
 
Rib+PLL (the orange curve in Figure 9-2) accumulates the most intense AGE fluorescence 
during the 3-day incubation, followed by R5P+PLL (the grey curve in Figure 9-2) and then 
Glc+PLL (the blue curve in Figure 9-2). These differences in fluorescence intensity suggest 
that Rib generates the most fluorescent AGEs with PLL, compared to R5P and Glc. R5P+PLL 
exhibits the highest AGE fluorescence intensity at the beginning of the incubation, consistent 
with R5P reacting more rapidly than Rib or Glc, but the AGE fluorescence does not increase 
as much as Rib+PLL over the incubation. The lower fluorescent AGE accumulation of 
R5P+PLL compared to Rib+PLL is unexpected, because R5P is widely accepted to glycate and 
accumulate AGEs faster than Rib. It may be that the major products of R5P+PLL at the end of 
the incubation period are simply not fluorescent.  
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Figure 9-2 AGE fluorescence build-up curves from a 3-day incubation of 50 mM Glc, 50 mM 
Rib and 50 mM R5P with 50 mM PLL separately. Orange: Rib+PLL. Grey: 
R5P+PLL. Blue: Glc+PLL.  
Protein Content in Cell Lysate 
The results above and further analysis indicated that FTL resulted in a considerable amount of 
protein being collected together with the metabolites of interest. Consequently, the cell lysate 
collected by FTL contains both glycating agents, i.e. metabolites, and glycating substrate, i.e. 
cellular proteins, and thus results collected from above PLL incubation experiments do not 
reflect the glycation potential of cellular metabolites accurately. Evidence for protein in the 
cell lysates is presented below.  
 
1H solution-state NMR is used as a quick and crude measurement of protein presence. Protein 
molecules usually are much bigger than typical metabolites and have slower molecular 
tumbling, especially at the low temperature (5 ℃ ) at which the spectrum was acquired; 
therefore, proteins tend to give broad and poorly-resolved NMR signals while small molecules 
give sharp signals. Moreover, proteins have many characteristic nitrogen bonded protons (1H-
N) which are expected to give distinctive 1H signals between 6-10 ppm. Figure 9-3 shows a 1H 
solution-state NMR spectrum for a freeze-thaw lysed cell lysate sample, CL4-1g-F (sample 
code explained in Table 9-2). Broad and poorly-resolved 1H signals are observed in this 6-10 
ppm range, suggesting the presence of proteins in the cell lysate sample.  
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Figure 9-3 1H NMR spectrum of a freeze-thaw cell lysate sample (CL4-1g-F, ns = 1024), 
acquired at 5 ℃.  
 
To confirm that proteins in FTL CL samples interfere with AGE fluorescence measurements, 
CL4-1g-F was incubated with either the glycating substrate, i.e. PLL, or a glycating agent, R5P. 
If the cell lysate has both proteins and glycating metabolites, it is expected to react with both 
PLL and R5P, exhibiting AGE fluorescence intensity increase upon incubation. Figure 9-4 
clearly shows that cell lysate reacts with both R5P (the grey, blue and orange curves in Figure 
9-4) and PLL (the yellow curves in Figure 9-4), and accumulates fluorescent AGEs over a 15-
day incubation.  
 
Figure 9-4 AGE fluorescence build-up curves from a 15-day incubation of cell lysate from 
normally cultured VSMC (1 g/L Glc) with R5P or PLL. Grey: CL4-1g-F+3 mM 
R5P. Blue: CL4-1g-F+2 mM R5P. Orange: CL4-1g-F+1 mM R5P. Yellow: CL4-
1g-F+PLL. 
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Average protein content was quantified by bicinchoninic acid (BCA) assay to be 3.75 mg per 
flask cell (average over 4 flasks cells with each flask containing roughly 8 million cells).  
 
Above results showed that the cell lysate collected by FTL is not only a pool of glycating agents 
but also a pool of glycation substrates. It can potentially react with itself and therefore, cannot 
result in a reliable measure representing the cell lysate glycation capacity. Under this 
circumstance, reactive metabolites might have already reacted with surrounding proteins 
before the first measurement in the PLL incubation experiment. So, a method that captures 
metabolites before internal reactions in the cell lysate occur is needed for this project, in which 
reactive metabolites should be isolated from cellular proteins as fast as possible.  
9.1.2 Liquid Nitrogen Lysis (LNL) 
Extraction methods to isolate metabolites from cellular proteins were researched and 
introduced to achieve metabolites-proteins separation and effective metabolites extraction. A 
protocol is evaluated in this section, involving much faster cell lysis by liquid nitrogen freezing 
and an additional metabolites extraction by MeOH.  
 
In this protocol, LNL replaces the previous FTL, aiming at quenching cell metabolism and 
releasing intracellular metabolites immediately. Then, LNL is followed by extracting 
metabolites with cold 80% MeOH [183][184] and sonicating the mixture gently in ice to release 
as many metabolites from the cell debris as possible. Significant protein removal is achieved 
by the additional extraction step; 1H NMR signals in the spectral region between 6-10 ppm are 
markedly sharpened (Figure 9-5) compared with what was observed in Figure 9-4, indicating 
successful removal of cellular proteins.  
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Figure 9-5 1H NMR spectrum of liquid nitrogen-lysed and MeOH extracted VSM cell lysate 
(ns = 1024), showing a flat baseline and a number of sharp signals in this 6-10 ppm 
region. 
 
PLL incubation was repeated using cell lysate samples prepared by either FTL or LNL. Cell 
lysate samples discussed in this section and their sample codes are included in Table 9-3. 
Briefly, cells are cultured under either 1 g/L or 9 g/L glucose and lysed by FTL or LNL when 
they reach 90-95% confluency, roughly taking three days from seeding the cells. 
 
Table 9-3 A list of cell lysate samples described in this section, and their relevant details. All 
samples were obtained from VSMCs. FTL stands for freeze-thaw lysis; LNL stands 
for liquid nitrogen lysis. 1Day counting started from the day after cells are seeded. 
Sample Code Cell Culture Condition Cell Lysis MeOH Extraction Sonication 
CL5-9g-3d-L 
3-day exposure to 9 g/L Glc1 
LNL 
Yes Yes 
CL6-9g-3d-F FTL 
CL7-1g-L 
1 g/L Glc 
LNL 
CL8-1g-F FTL 
 
AGE fluorescence build-up curves for different cell lysate samples and PLL incubations are 
displayed in Figure 9-6, as well as a curve for 50 mM (9 g/L) Glc and PLL incubation as a 
positive control. After a 32-day incubation, the AGE florescence intensity in the different 
samples is in the order: 50 mM (9 g/L) Glc (blue curve in Figure 9-6) > CL6-9g-3d-F (grey 
curve in Figure 9-6) > CL8-1g-F (green curve in Figure 9-6) > CL5-9g-3d-L (orange curve in 
Figure 9-6) > CL7-1g-L (yellow curve in Figure 9-6). This difference in the amount of 
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fluorescent AGEs generated by different cell lysates samples suggests that in general, LNL 
samples contain fewer reactive metabolites and therefore produce less fluorescent AGEs than 
FTL samples. It is possible that LNL quenches cell metabolism faster and more effectively in 
the cell lysis process than FTL and FTL puts cells under stressed or non-physiological 
conditions causing cells to produce reactive metabolites during the lysis process. 
 
Figure 9-6 AGE fluorescence build up curves from incubating cell lysate from normally 
cultured VSMCs (1 g/L Glc) with Glc or PLL for 32 days. Blue: 50 mM (9 g/L) 
Glc+PLL. Grey: CL6-9g-3d-F+PLL. Green: CL8-1g-F+PLL. Orange: CL5-9g-3d-
L+PLL. Yellow: CL7-1g-L+PLL.  
  
-600.00
-100.00
400.00
900.00
1400.00
1900.00
2400.00
0 5 10 15 20 25 30A
G
E 
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Time points /days
Glc +PLL
CL 5 +PLL
CL 6 +PLL
CL 7 +PLL
CL 8 +PLL
 166 
9.2 Biogenic Glycating Metabolites – Identification and 
Quantification 
A HPLC-UV-MS based protocol was established to identify and quantify what metabolites 
provide glycation capability to the cell lysate. Briefly, cell lysate is first derivatised by 3-amino-
9-ethylcarbazole (AEC), a UV active molecule, via reductive amination (Figure 9-7) to allow 
the detection of reactive metabolites through UV absorption measurements. Then, metabolites 
with AEC adduct are separated by HPLC and verified by their retention times measured by UV 
absorption peaks (UV retention time) and their AEC-modified molecular weights by mass 
spectroscopy (MS). This method was adapted from reference [147] and optimised for the 
instrument used in this work. 
 
Figure 9-7 An example scheme of AEC derivatising reducing sugar or sugar phosphate. AEC 
can react with all carbonyl metabolites in the cell lysate, in theory, and this 
derivatisation scheme is similar to the initial steps of the glycation reaction. 
Method Testing 
Viability of this method to detect potential glycating agents was tested on a number of test 
glycating compounds, including glucose (Glc), fructose (Fru), ribose (Rib), glyceraldehyde 
(GA), fructose-6-phosphate (F6P), glucose-6-phosphate (G6P) and ribose-5-phosphate (R5P). 
Most of them are separated by HPLC-UV with at least 0.5 min difference in UV retention time 
(see Figure 9-8), and their AEC-modified molecular weights are confirmed by MS (Table 9-4) 
Some test compounds share the same MW, albeit with different structures such as Fru and Glc, 
are not distinguished by UV retention time. UV and MS peaks from excess AEC are observed 
in all samples.  
CH2O
(CHOH)n-2
CHO
Reducing 
Sugar 
or 
Sugar Phosphate
+
N
H2N
CH2CH3
AEC
H+ NaCNBH3
N
N
H
CH2CH3
H2C
(CHOH)n-2
CH2O
H or H2PO3
H or H2PO3
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Figure 9-8 A illustration of HPLC-UV-MS work flow, where t is UV retention time and t+Dt 
is MS retention time. The grey area underneath a peak is integrated and used as the 
peak area with units of mAU*min for UV or counts*min for MS. Due to the 
instrumental set up shown above, a time gap exists between UV retention time and 
MS retention time of the same species, in this case, Dt=0.14 min  
 
Table 9-4 UV retention times of test glycating compounds detected, including glucose (Glc), 
fructose (Fru), ribose (Rib), glyceraldehyde (GA), fructose-6-phosphate (F6P), 
glucose-6-phosphate (G6P) and ribose-5-phosphate (R5P). Fucose (Fuc) works as 
an internal standard for normalising UV retention time and UV absorption peak 
areas (integrated over time) between measurements. AEC (3-amino-9-
ethylcarbazole) is the derivatisation compound to achieve UV absorption of test 
glycating compounds.  
Compounds Fru/Glc Rib Fuc AEC GA F6P/G6P R5P 
Retention time /min 28.583 29. 287 29.783 30.383 31.933 33.443 34.830 
MW-AEC-H+ /m/z 375 345 359 211 285 455 425 
 
Then, a calibration curve between UV absorption peak areas detected at 254 nm (for the AEC 
moiety) and R5P concentrations was established using 2 mg/mL, 0.5 mg/mL, 0.1 mg/mL, 0.05 
mg/mL and 0.025 mg/mL R5P and derivatisation time, 2 hours: 
 𝑦 = 52.298𝑥, R; = 0.9999     (Equation 9-1) 
where 𝑥  is R5P concentration in mg/mL and 𝑦  is UV absorption peak area at 254 nm in 
mAU*min.  
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Results and Discussion  
Cell lysate samples were prepared by both FTL and LNL and derivatised by AEC (sample 
codes in the table below, Table 9-5) to compare the differences and similarities of cell lysate 
from these two different cell lysis protocols by HPLC.  
 
Table 9-5 Derivatised cell lysate samples and their details. All samples were obtained from 
VSMCs. FTL stands for freeze-thaw lysis; LNL stands for liquid nitrogen lysis.  
Sample 
Code 
Cell 
Lysis 
MeOH 
Extraction 
Sonication 
LNL-AEC LNL 
Yes No 
FTL-AEC FTL 
 
Many UV absorption peaks were observed in the HPLC-UV chromatographs. However, most 
UV absorption peaks are not intense enough to measure UV peak areas accurately nor exhibit 
intense enough MS peaks to assign to specific metabolites, except for AEC, Fuc-AEC and 
Glc/Fru-AEC peaks.  
 
MS peaks from some metabolites of interest can however be extracted from MS spectra using 
their MW-AEC-H (in Table 9-4). In this way, some metabolites are identified, such as G6P, 
Rib and R5P. Also, MS peaks can be used to trace back to UV retention time and then UV 
peaks, because MS is estimated to be recorded 0.14 min after UV absorption is recorded due 
to the equipment setup (see Figure 9-8). For example, R5P was identified in the FTL-AEC 
when its MS peak was extracted between 345-345.3 m/z, and its UV retention time was traced 
back from MS retention time. Then, its concentration was estimated based on its UV peak area, 
using the calibration curve (Equation 8-1), to be 14.1 µg/mL. This concentration is converted 
into that roughly 8 million VSMCs (a 90-95% confluent flask) produces 0.35 µg R5P (detailed 
calculation is explained in Table 9-6 caption). The same attempt to estimate R5P concentration 
was made on the LNL-AEC sample. However, its R5P UV peak was too weak to measure its 
peak area. Considering its MS peak area is about 5 times less than that in the FTL sample, it is 
estimated that its concentration is 5 times less than 14.1 µg/mL, to be around 3 µg/mL (Table 
9-6).  
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The HPLC-UV chromatographs in FTL-AEC samples showed more UV absorption peaks than 
LNL-AEC samples (sample codes are explained in Table 9-6), which indicates that FTL CL 
has more carbonyl metabolites than LNL CL - consistent with what was deduced in the 
previous section about FTL leading to cell stress and synthesis of reactive metabolites (Section 
9.1).  
 
Even though UV and MS peaks derived from other carbonyl metabolites are observed, such as 
Rib and G6P, it is not apparent that all reactive metabolites have the same reaction affinity 
towards AEC. So, for quantifying other reactive metabolites, corresponding calibration curves 
need to be established for each metabolite of interest.  
 
Table 9-6 R5P concentrations and masses of two VSMC cell lysate samples, calculated from 
HPLC-UV-MS results. 1This concentration is calculated from the calibration curve 
between the UV peak area and R5P concentration in Equation 8-1. 2Each sample 
has a total volume of 100 µL, made by extracting cellular metabolites from 4 flasks 
of 90-95% confluent VSMCs, giving around 8 million cells each flask. (0.014 
µg/µL * 100 µL / 4 flasks= 0.35 µg/flask = 0.35 µg/8M cells). 3These two numbers 
are estimated from the MS peak area of R5P of the LNL-AEC sample is about five 
times less than that of the FTL-AEC sample. 
Sample 
Code 
UV Peak 
Areas 
mAU*min 
MS Peak 
Areas 
counts*min 
R5P 
Concentration 
µg/mL 
R5P Mass 
µg/8 M cells 
LNL-AEC 
Too weak 
to measure 
4399.2608 2.983 0.073 
FTL-AEC 0.7373 20829.2433 14.101 0.352 
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9.2.1 Cancer Cell Model 
A highly metastatic mouse osteosarcoma cell line, K7M2, was studied to seek more 
pronounced effects of changing metabolism on the amount of carbonyl metabolites cells 
produce. Previously, DNA and RNA have been identified in lyophilised K7M2 FTL cell lysate 
[174], which was never seen in other cell types used in this project. The presence of DNA and 
RNA in K7M2 cell lysate indicates that K7M2 is under quick and continuous proliferation, 
involving fast replication of their DNA (for cell proliferation) and RNA (for protein synthesis 
for cell growth). This difference between K7M2 and non-cancerous cell lines suggests the 
production of pentose and pentose phosphate might be upregulated in K7M2 to support its fast 
proliferation.  
Method Optimisation 
In previous HPLC-UV-MS experiments, we found that UV absorption peaks from glycating 
metabolites are not intense enough to quantify their peak areas accurately while MS peaks are 
relatively simple to identify. So apart from the correlation between UV peak areas detected at 
254 nm and R5P concentrations (Equation 8-2 below), MS peak areas between 345-345.3 m/z 
and R5P concentrations are calibrated here as well (Equation 8-3 below). R5P concentrations 
used were 1 mg/mL, 0.5 mg/mL, 0. 25 mg/mL, 0.1 mg/mL and 0.05 mg/mL R5P, and 
derivatisation time was 1 hour. Also, the derivatisation reaction time was optimised on R5P to 
be 1 hour, rather than the previously used 2 hours. 
 𝑦 = 70.314𝑥, R; = 0.9948      (Equation 9-2) 
where 𝑥 is R5P concentration in mg/mL and 𝑦 is UV peak area at 254 nm in mAU*min.  
 𝑦 = 1081151.72𝑥, R; = 0.9599     (Equation 9-3) 
where 𝑥 is R5P concentration in mg/mL and 𝑦 is MS peak area between 345-345.3 m/z in 
counts*min.  
Results and Discussion  
K7M2 cell lysate was prepared by both FTL and LNL, modified by AEC and examined by 
HPLC-UV-MS (sample details are in Table 9-7 top). Similar to what was seen before, the peak 
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derived from Glc-AEC is much stronger than other metabolite-AEC peaks, except for Fuc-
AEC, the internal standard, and excess AEC. Most UV peaks are weak and can only be 
identified when traced back from MS peaks. Therefore, although the R5P concentration in 
derivatised cell lysate samples, LNL-AEC and FTL-AEC, is calculated from both UV peak 
areas and MS peak areas using Equation 8-2 and Equation 8-3 respectively, the results from 
MS peak areas may be more reliable, considering UV peaks are mostly around the noise level 
and heavily overlapped. The R5P concentration determined by both UV peak areas using 
Equation 8-2 and MS peak areas using Equation 8-3 is tabulated in Table 9-7 (bottom). The 
R5P concentration determined in LNL CL samples is averaged between two independent 
(biological) repeats to be 7.05 µg/mL; while in the FTL CL sample, it is 28.8 µg/mL. These 
concentrations are converted to 0.235 µg and 0.96 µg per eight million cells, respectively as 
above (Table 9-7).  
 
MS peak areas depend on not only the amount of metabolite-AEC present in the sample but 
also their responses to ionisation in the MS. So, the calibration curves between MS peak areas 
and R5P concentrations cannot be used for other metabolite-ACEs. Individual calibration curve 
needs to be established to quantify other carbonyl metabolites.  
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Table 9-7 Top: K7M2 CL sample code and sample details. Bottom: R5P concentrations and 
masses in K7M2 cell lysate were quantified using MS peak areas (in yellow shading) 
and UV peak areas (in blue shading) using separate calibration curves. 1This is 
calculated in the same way as explained in Table 9-6; except these samples are 
made from 3 flasks cells. 2This is the average between two repeats.  
Sample 
Code 
Cell 
Lysis 
MeOH 
Extraction 
Sonication 
LNL-AEC-1 
LNL 
Yes No LNL-AEC-2 
FTL-AEC FTL 
 
Sample 
Code 
MS Peak  
Areas 
counts*min 
R5P 
Concentration 
µg/mL 
R5P Mass 
µg/8 M cells 
UV Peak 
Areas 
mAU*min 
R5P 
Concentration 
µg/mL 
R5P Mass 
µg/8 M cells 
LNL-AEC-1 12171.76 11.26 
7.052 0.2351 
0.4811 6.84 
5.002 0.171 
LNL-AEC-2 3075.87 2.84 0.2214 3.15 
FTL-AEC 31132.52 28.80 0.961 1.1391 16.20 0.541 
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9.3 Summary 
Cell lysate was collected to study the glycating capacity of cellular metabolites in order to 
estimate the glycation damage under cell necrosis in diseases and establish the relevance of 
glycating agents used in previous in vitro studies and in this work.  
 
A healthy primary cell line, VSMC, and a cancer cell line, K7M2, were used to study the 
glycation potential of their metabolites, with focuses on establishing the relevance of R5P as 
glycating agents under cell necrosis conditions and estimating the R5P concentration in 
different cell lysates. Cell lysates from VSMC and K7M2 were collected by two different cell 
lysis methods and gave different results regarding their glycation capability and R5P quantities. 
Freeze-thaw lysis (FTL) is straightforward and sufficient for lysing cells and retrieving 
metabolites but insufficient in removing cellular proteins or effectively capturing snapshots 
truly representative of cell metabolism. However, the cell lysate collected by FTL might mimic 
stressed cell metabolism status because the results from this model suggested that FTL puts 
cells under stress during the slow freezing period and causes them to produce more glycating 
metabolites. The liquid-nitrogen lysis (LNL) protocol contains multiple steps but appears to be 
more suitable for this project. The LNL acts faster and more effectively than FTL in shutting 
down cell processes and thus better reflect cell metabolism status; the additional extraction step 
successfully eliminates cellular proteins and extracts cellular metabolites. 
 
Glycation potential of cell lysate is measured by incubating cell lysate with PLL and following 
the accumulation of AGE fluorescence over the incubation period. Our results conclude that 
cell lysate contains glycating agents, and their glycation capacities appear to be affected by the 
time length of exposure to high glucose concentration during cell culture and the speed of cell 
lysis. Extended exposure to high media glucose concentration and slow cell lysis appears to 
make cells produce more glycating agents and show strong glycating power in the cell lysate. 
However, PLL incubation experiments are rather qualitative because of the possible 
interference of fluorescence measurement from protein aggregation and possible colour 
changes. 
 
Glycating cell metabolites were further investigated by HPLC-UV-MS to identify and quantify 
specific carbonyl metabolites. R5P was quantified in both healthy and cancer cell models as a 
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powerful potential glycating agent. In addition, a general trend is observed that FTL cell lysate 
samples have more R5P than LNL cell lysate samples, and K7M2 cell lysate samples have 
more R5P than VSMC cell lysate samples. However, whether this trend is statistically relevant 
cannot be concluded from the data here. Many more independent and biological repeats of cell 
lysate samples are needed to work out averages and standard deviations of R5P concentrations 
in different cell models and cell lysis protocols before reaching a solid conclusion.  
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10 Conclusion and Future Work  
Glycation chemistry and glycation products have been studied extensively because of their 
implications in the development of diseases, such as diabetes and the development of diabetic 
complications, eventually affecting many tissues and organs. Nevertheless, the underlying 
chemistry is not yet fully understood due to the complex glycation reaction routes and 
numerous biogenic glycating agents. So, a better understanding of glycation chemistry and 
identifications of biogenic glycating agents and glycation products are important to study many 
pathologies and offer possibilities of early diagnoses and novel therapeutics.  
 
This project aims to study the glycation chemistry and identify glycation products, especially 
glycation intermediate products, in two in vitro collagenous ECM models, from vascular 
smooth muscle cells and osteoblasts, to mimic the effects of glycation in blood vessels and 
bone tissues using a combination of isotope labelling and solid-state nuclear magnetic 
resonance (SSNMR) spectroscopy. A combination of ribose and ribose-5-phosphate are used 
as glycating agents, which also models the effects of glycation by reducing sugars and reducing 
sugar phosphates. A number of glycation products has been identified, and structures of some 
glycation products have been suggested based on their NMR chemical shifts. The major 
glycation products identified in two types of collagenous ECM studied in this project appear 
to be very similar, which are lysine and arginine sidechain modification products, such as N-
carboxymethyl-, N-carboxyethyl- and N-acetyl- adducts, rather than the widely-studied 
intermolecular crosslinks. Therefore, it is possible that the observed changes of collagen 
accompanying the glycation reaction are caused by the copresence of amino acid sidechain 
modifications and intermolecular crosslinks rather than crosslinks alone, which are in relatively 
low quantities. Though some SSNMR glycation product signals are still unassigned, the work 
has demonstrated that a huge variety of glycation products, including glycation intermediates 
and advanced end products, are present in glycated collagenous ECM, giving yet further insight 
into the complexity of glycation chemistry. Clearly, there is further work to do to identify the 
unknown glycation products from the as-yet unassigned NMR signals and to investigate their 
roles in the consequences of glycation.  
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In contrast to previously used techniques, such as immunohistochemistry and LC-MS, we show 
here that SSNMR spectroscopy can capture the complex equilibria of the glycation reaction 
and has the potential to examine all the glycation products present in the collagenous ECM 
samples. This map of all glycation products with a focus on major glycation products so far 
has not been achieved by other techniques, because most techniques can only measure AGE 
concentrations of selective AGEs and lack of methods to identify or quantify glycation 
intermediates. This lack of glycation product profiles also means that the chemical species lead 
to the observed detrimental effects of glycation cannot be determined. Overall, SSNMR 
spectroscopy offers insights on the structures of glycation products, relative quantities of 
different glycation products generated in collagenous materials and might in the future 
contribute to the investigation of causes of glycation damages and the development of protocols 
to quantify the glycation intermediate products by more sensitive techniques, such as LC-MS. 
However, SSNMR spectroscopy has its intrinsic disadvantages regarding low sensitivity, long 
experiment time as well as high dependence on isotropic enrichment. This means SSNMR is 
not likely to detect glycation products present in minor quantities nor non-isotopically enriched 
fragments in glycation products. The ongoing development of DNP-SSNMR spectroscopy 
overcomes the disadvantages of conventional SSNMR spectroscopy to some extent and can 
offer new insights into the study of the glycation chemistry.  
 
With enhanced SSNMR sensitivity given by dynamic nuclear polarisation (DNP), DNP-
SSNMR spectroscopy contributes further to glycation products identification, especially by 
experiments observing 15N and 13C-15N correlations in the glycation model systems. Some 15N 
signals derived from U-13C6,15N2-lysine modifications in glycated collagenous ECM that have 
not been detected by conventional SSNMR spectroscopy are detected by DNP-SSNMR 
spectroscopy, such as carboxymethyl-lysine, an oxalamide-like fragment and a proline-like 
ring fragment. However, not all 15N signals observed in DNP-SSNMR spectra are assigned to 
specific glycation products because 15N chemical shifts are not as well studied as 13C chemical 
shifts in general and cannot be easily predicted, and thus assigned, by existing tools. Further 
15N signal assignments might be facilitated in the future by synthesising and studying 15N 
chemical shifts on model compounds structurally similar to predicted glycation products.  
 
In addition to identifying glycation products, the molecular conformation and integrity of 
collagen triple helix does not appear to be affected by the glycation reaction according to 
SSNMR data acquired in this project. The retention of an intact, largely undistorted collagen 
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triple helix after glycation suggests that consequences of collagen glycation are more likely to 
result from changes of K and R sidechain, including structural changes, charge alterations and 
conformational changes, and subsequent changes of collagen higher level structure, such as 
fibril alignments, rather than from significant disruption of collagen molecules themselves.  
 
In terms of the exploration of potential biogenic glycating agents, R5P is the focus in this work 
as it is an essential metabolite in nucleic acid metabolism and a vigorous glycating agent. A 
HPLC-UV-MS based protocol was established in this thesis to semi-quantify the R5P content 
circulating in cells to gain insight into the amount of R5P that could be released into the ECM. 
The results demonstrated that the R5P level is elevated under stress conditions and in cancer 
cells compared with healthy cells, potentially leading to increased R5P glycation of the ECM 
in diseased and cancerous tissues where there is cell necrosis. The HPLC-UV-MS protocol 
established in this work to quantify R5P in cell lysate can be easily applied to quantify other 
glycating metabolites, such as glucose-6-phosphate, and may also be applied to study the 
glycation supernatant in this model system to identify and quantify the soluble (di-)carbonyl 
glycation intermediates or sugar fragments to further study glycation mechanisms and advance 
glycation studies.  
 
The glycation reaction has been implicated in many diseases though its chemistry is not fully 
understood. Previous studies have attributed to the deleterious effects of glycation to the 
formation and accumulation of AGEs. However, without the investigation on the glycation 
intermediates, whether the glycation damages are purely caused by AGE accumulation cannot 
be determined. This thesis offers valuable insights on the presence of glycation intermediate 
products, which appears to be the major glycation products generated in the in vitro ECM and 
Rib/R5P glycation reaction. The employment of SSNMR spectroscopy allows revealing the 
structures of glycation intermediate products. The relative abundant presence of glycation 
intermediate products in the complex glycation equilibria suggests that the intermediate 
products are expected to contribute to glycation damages.  
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Appendix: Structures and 13C NMR Chemical 
Shifts of AGEs 
This appendix includes all the glycation products mentioned in Table 3-3 and Table 3-4, 
including their full names, abbreviations used in the main text, structures and their 13C chemical 
shifts extracted from solution-state NMR spectra, if known. 13C and 15N SSNMR chemical 
shifts identified in this project are in red, and literature values are in blue.  
 
1. N-carboxymethyl-lysine (CML) and 13C chemical shifts [185] 
 
2. N-carboxymethyl-hydroxylysine (CMhL) 
 
3. A: N-carboxyethyl-lysine (CEL)  
 
B: N-1-carboxyethyl-lysine (CEL) and 13C chemical shifts [186] 
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4. Pyrraline and 13C chemical shifts [187] 
 
5. GA-pyridine and 13C chemical shifts [100] 
 
6. Methylglyoxal-hydroimidazolone (MG-H1) and 13C chemical shifts [188] 
 
Methylglyoxal-hydroimidazolone (MG-H2) and 13C chemical shifts [188] 
 
Methylglyoxal-hydroimidazolone (MG-H3) and 13C chemical shifts [188] 
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7. Glyoxal-hydroimidazolone (G-H1) 
 
8. 3-Deoxyglucosone-hydroimidazolone (3DG-H) 
 
9. Argpyrimidine and 13C chemical shifts 
 
10. Tetrahydropyrimidine (THP) and 13C chemical shifts 
 
11. S-(carboxymethyl)cysteine (CMC) 
 
12. S-(carboxyethyl)cysteine (CEC) 
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13. Pentosidine  
 
14. Glucosepane 
 
15. Methylglyoxal-lysine dimer (MOLD) (or Imidazolysine) and 13C chemical shifts [189] 
 
16. Glyoxal-lysine dimer (GOLD) 
 
17. Lysine-dihydropyridinium (K2P) and 13C chemical shifts [107] 
 
18. Fructose-lysine 
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19. N-(carboxymethyl)arginine (CMA) 
 
20. Pentosinane and 13C chemical shifts [109] 
  
21. Glyoxal-derived-imidazoline-crosslink (GODIC) and 13C chemical shifts [110] 
 
22. Methylglyoxal-derived-imidazoline-crosslink (MODIC) and 13C chemical shifts [110] 
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23. DOGDIC and 13C chemical shifts [109] 
 
24. DOPDIC and 13C chemical shifts [109] 
 
25. Arg-hydroxy-triosidine and 13C chemical shifts [111] 
 
26. Vesperlysine A, B and C and 13C chemical shifts [112]  
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27. 3-Deoxyglucosone-lysine dimer (DOLD) 
 
28. GALA and 13C chemical shifts [114] 
 
29. GOLA and 13C chemical shifts [114] 
 
30. Glucose-lysine dimer (GLUCOLD) (above) and 13C chemical shifts from GLUCOLD 
analogue (below) [115] 
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31. Lys-hydroxy-triosidine and 13C chemical shifts [111] 
 
  
NH2
CH
C
H2
C
OH
O
H2
C
H2
C
H2
C N
H2C
H
N
H2
C
H2
C
H2
C
H2
C CH
NH2
C
OH
O
OH
62
65
45
150-160
~145
133
129
125-130
 186 
Bibliography 
[1] Cell Biology of Extracellular Matrix. Springer US: Boston, MA 1991. 
[2] Kini, U. and Nandeesh, B. N. Radionuclide and Hybrid Bone Imaging. 2012, 29–57.  
[3] Engel, J. and Bächinger, H. P. Collagen: Primer in Structure, Processing and Assembly. 
Springer Berlin Heidelberg: Berlin, Heidelberg 2005. 
[4] Collagen: Structure and Mechanics. Springer US: Boston, MA 2008. 
[5] Fibrous Proteins: Structures and Mechanisms. Springer International Publishing: Cham 
2017. 
[6] Canty, E. G. and Kadler, K. E. Collagen fibril biosynthesis in tendon: A review and recent 
insights. Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology 
2002, 133, 979–985.  
[7] Shoulders, M. D. and Raines, R. T. Collagen Structure and Stability. Annual Review of 
Biochemistry 2009, 78, 929–958.  
[8] Ricard, S. The Collagen Family. Cold Spring Harbor Perspectives in Biology 2011, 3, 1–
19.  
[9] Lodish, H.; Berk, A.; Zipursky, S. L.; Matsudaira, P.; Baltimore, D.; and Darnell, J. 
Molecular Cell Biology. 4th edition. W.H. Freeman and Co: New York 2000. 
[10] Mouw, J. K. , Ou, G. , and Weaver, V. M. Extracellular matrix assembly: a multiscale 
deconstruction. Nature Reviews Molecular Cell Biology 2014, 15, 771–785.  
[11] Bella, J. Collagen structure: new tricks from a very old dog. Biochemical Journal 2016, 
473, 1001–1025.  
[12] Ramshaw, J. A. . , Shah, N. K. , and Brodsky, B. Gly-X-Y Tripeptide Frequencies in 
Collagen: A Context for Host–Guest Triple-Helical Peptides. Journal of Structural Biology 
1998, 122, 86–91.  
[13] Brodsky, B. , Thiagarajan, G. , Madhan, B. , and Kar, K. Triple-helical peptides: An 
approach to collagen conformation, stability, and self-association. Biopolymers 2008, 89, 345–
353.  
[14] Fallas, J. A. , Dong, J. , Tao, Y. J. , and Hartgerink, J. D. Structural Insights into Charge 
Pair Interactions in Triple Helical Collagen-like Proteins. Journal of Biological Chemistry 
2012, 287, 8039–8047.  
[15] Ramachandran, G. X. and Chandrasekharan, R. Interchain hydrogen bonds via bound 
 187 
water molecules in the collagen triple helix. Biopolymers 1968, 6, 1649–1658.  
[16] Orgel, J. P. R. O. , Persikov, A. V. , and Antipova, O. Variation in the Helical Structure 
of Native Collagen. PLoS ONE 2014, 9, e89519.  
[17] Malhotra, V. and Erlmann, P. The Pathway of Collagen Secretion. Annual Review of Cell 
and Developmental Biology 2015, 31, 109–124.  
[18] Ferreira, A. M. , Gentile, P. , Chiono, V. , and Ciardelli, G. Collagen for bone tissue 
regeneration. Acta Biomaterialia 2012, 8, 3191–3200.  
[19] Orgel, J. P. , Wess, T. J. , and Miller, A. The in situ conformation and axial location of the 
intermolecular cross-linked non-helical telopeptides of type I collagen. Structure 2000, 8, 137–
142.  
[20] MILLER, A. and WRAY, J. S. Molecular Packing in Collagen. Nature 1971, 230, 437–
439.  
[21] Hulmes, D. J. S. , Miller, A. , Parry, D. A. D. , Piez, K. A. , and Woodhead-Galloway, J. 
Analysis of the primary structure of collagen for the origins of molecular packing. Journal of 
Molecular Biology 1973, 79, 137–148.  
[22] Bailey, A. J. , Paul, R. G. , and Knott, L. Mechanisms of maturation and ageing of collagen. 
Mechanisms of Ageing and Development 1998, 106, 1–56.  
[23] Fleischmajer, R. , Douglas MacDonald, E. , Perlish, J. S. , Burgeson, R. E. , and Fisher, 
L. W. Dermal collagen fibrils are hybrids of type I and type III collagen molecules. Journal of 
Structural Biology 1990, 105, 162–169.  
[24] Xu, J. and Shi, G.-P. Vascular wall extracellular matrix proteins and vascular diseases. 
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014, 1842, 2106–2119.  
[25] Wenstrup, R. J. , Smith, S. M. , Florer, J. B. , Zhang, G. , Beason, D. P. , Seegmiller, R. 
E. , Soslowsky, L. J. , and Birk, D. E. Regulation of collagen fibril nucleation and initial fibril 
assembly involves coordinate interactions with collagens V and XI in developing tendon. 
Journal of Biological Chemistry 2011, 286, 20455–20465.  
[26] Humphries, J. D. , Byron, A. , and Humphries, M. J. Integrin ligands at a glance. Journal 
of Cell Science 2006, 119, 3901–3903.  
[27] Bonnans, C. , Chou, J. , and Werb, Z. Remodelling the extracellular matrix in development 
and disease. Nature Reviews Molecular Cell Biology 2014, 15, 786–801.  
[28] Järveläinen, H. , Sainio, A. , Koulu, M. , Wight, T. N. , and Penttinen, R. Extracellular 
Matrix Molecules: Potential Targets in Pharmacotherapy. Pharmacological Reviews 2009, 61, 
198–223.  
[29] Bailey, A. Molecular mechanisms of ageing in connective tissues. Mechanisms of Ageing 
 188 
and Development 2001, 122, 735–755.  
[30] Law, B. , Fowlkes, V. , Goldsmith, J. G. , Carver, W. , and Goldsmith, E. C. Diabetes-
Induced Alterations in the Extracellular Matrix and Their Impact on Myocardial Function. 
Microscopy and Microanalysis 2012, 18, 22–34.  
[31] Butcher, D. T. , Alliston, T. , and Weaver, V. M. A tense situation: forcing tumour 
progression. Nature Reviews Cancer 2009, 9, 108–122.  
[32] Mouw, J. K. , Yui, Y. , Damiano, L. , Bainer, R. O. , Lakins, J. N. , Acerbi, I. , Ou, G. , 
Wijekoon, A. C. , Levental, K. R. , Gilbert, P. M. , Hwang, E. S. , Chen, Y.-Y. , and Weaver, 
V. M. Tissue mechanics modulate microRNA-dependent PTEN expression to regulate 
malignant progression. Nature Medicine 2014, 20, 360–367.  
[33] Levental, K. R. , Yu, H. , Kass, L. , Lakins, J. N. , Egeblad, M. , Erler, J. T. , Fong, S. F. 
T. , Csiszar, K. , Giaccia, A. , Weninger, W. , Yamauchi, M. , Gasser, D. L. , and Weaver, V. 
M. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell 2009, 
139, 891–906.  
[34] Frantz, C. , Stewart, K. M. , and Weaver, V. M. The extracellular matrix at a glance. 
Journal of Cell Science 2010, 123, 4195–4200.  
[35] Iozzo, R. V. and Schaefer, L. Proteoglycan form and function: A comprehensive 
nomenclature of proteoglycans. Matrix Biology 2015, 42, 11–55.  
[36] Schaefer, L. and Schaefer, R. M. Proteoglycans: from structural compounds to signaling 
molecules. Cell and Tissue Research 2010, 339, 237–246.  
[37] Couchman, J. R. and Pataki, C. A. An Introduction to Proteoglycans and Their 
Localization. Journal of Histochemistry & Cytochemistry 2012, 60, 885–897.  
[38] Pomin, V. and Mulloy, B. Glycosaminoglycans and Proteoglycans. Pharmaceuticals 2018, 
11, 27.  
[39] Häcker, U. , Nybakken, K. , and Perrimon, N. Heparan sulphate proteoglycans: The sweet 
side of development. Nature Reviews Molecular Cell Biology 2005, 6, 530–541.  
[40] FISCHER, G. M. and LLAURADO, J. G. Collagen and Elastin Content in Canine Arteries 
Selected from Functionally Different Vascular Beds. Circulation Research 1966, 19, 394–399.  
[41] Green, E. M. , Mansfield, J. C. , Bell, J. S. , and Winlove, C. P. The structure and 
micromechanics of elastic tissue. Interface Focus 2014, 4 
[42] Kielty, C. M. , Sherratt, M. J. , and Shuttleworth, C. A. Elastic fibres. Journal of Cell 
Science 2002, 115, 2817 LP – 2828.  
[43] Schwarzbauer, J. E. and DeSimone, D. W. Fibronectins, their fibrillogenesis, and in vivo 
functions. Cold Spring Harbor Perspectives in Biology 2011, 3, 1–19.  
 189 
[44] Hynes, R. O. and Naba, A. Overview of the Matrisome--An Inventory of Extracellular 
Matrix Constituents and Functions. Cold Spring Harbor Perspectives in Biology 2012, 4, 
a004903–a004903.  
[45] Monnier, V. and Cerami, A. Nonenzymatic browning in vivo: possible process for aging 
of long-lived proteins. Science 1981, 211, 491–493.  
[46] Cerami, A. Hypothesis: Glucose as a Mediator of Aging. Journal of the American 
Geriatrics Society 1985, 33, 626–634.  
[47] Kennedy, L. and Baynes, J. W. Non-enzymatic glycosylation and the chronic 
complications of diabetes: an overview. Diabetologia 1984, 26, 93–98.  
[48] Monnier, V. M. , Kohn, R. R. , and Cerami, A. Accelerated age-related browning of human 
collagen in diabetes mellitus. Proceedings of the National Academy of Sciences 1984, 81, 583–
587.  
[49] Sell, D. R. and Monnier, V. M. End-stage renal disease and diabetes catalyze the formation 
of a pentose-derived crosslink from aging human collagen. Journal of Clinical Investigation 
1990, 85, 380–384.  
[50] Singh, V. P. , Bali, A. , Singh, N. , and Jaggi, A. S. Advanced Glycation End Products and 
Diabetic Complications. The Korean Journal of Physiology & Pharmacology 2014, 18, 1.  
[51] Negre-Salvayre, A. , Salvayre, R. , Augé, N. , Pamplona, R. , and Portero-Otín, M. 
Hyperglycemia and Glycation in Diabetic Complications. Antioxidants & Redox Signaling 
2009, 11, 3071–3109.  
[52] Ahmed, N. Advanced glycation endproducts—role in pathology of diabetic complications. 
Diabetes Research and Clinical Practice 2005, 67, 3–21.  
[53] Smith, M. A. , Taneda, S. , Richey, P. L. , Miyata, S. , Yan, S. D. , Stern, D. , Sayre, L. 
M. , Monnier, V. M. , and Perry, G. Advanced Maillard reaction end products are associated 
with Alzheimer disease pathology. Proceedings of the National Academy of Sciences 1994, 91, 
5710–5714.  
[54] Sasaki, N. , Fukatsu, R. , Tsuzuki, K. , Hayashi, Y. , Yoshida, T. , Fujii, N. , Koike, T. , 
Wakayama, I. , Yanagihara, R. , Garruto, R. , Amano, N. , and Makita, Z. Advanced Glycation 
End Products in Alzheimer’s Disease and Other Neurodegenerative Diseases. The American 
Journal of Pathology 1998, 153, 1149–1155.  
[55] Yan, S. Du , Chen, X. , Fu, J. , Chen, M. , Zhu, H. , Roher, A. , Slattery, T. , Zhao, L. , 
Nagashima, M. , Morser, J. , Migheli, A. , Nawroth, P. , Stern, D. , and Schmidt, A. M. RAGE 
and amyloid-β peptide neurotoxicity in Alzheimer’s disease. Nature 1996, 382, 685–691.  
[56] Choi, B.-R. , Cho, W.-H. , Kim, J. , Lee, H. J. , Chung, C. , Jeon, W. K. , and Han, J.-S. 
 190 
Increased expression of the receptor for advanced glycation end products in neurons and 
astrocytes in a triple transgenic mouse model of Alzheimer’s disease. Experimental & 
Molecular Medicine 2014, 46, e75–e75.  
[57] Ansari, N. A. and Rasheed, Z. Non-enzymatic glycation of proteins: From diabetes to 
cancer. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry 2009, 3, 335–342.  
[58] Turner, D. P. Advanced Glycation End-Products: A Biological Consequence of Lifestyle 
Contributing to Cancer Disparity. Cancer Research 2015, 75, 1925–1929.  
[59] Foster, D. , Spruill, L. , Walter, K. R. , Nogueira, L. M. , Fedarovich, H. , Turner, R. Y. , 
Ahmed, M. , Salley, J. D. , Ford, M. E. , Findlay, V. J. , and Turner, D. P. AGE Metabolites: 
A Biomarker Linked to Cancer Disparity? Cancer Epidemiology Biomarkers & Prevention 
2014, 23, 2186–2191.  
[60] Maillard, L. C. Action of amino acids on sugars. Formation of melanoidins in a methodical 
way. Compte-Rendu de l’Academie des Science 1912, 154, 66–68.  
[61] Hodge, J. E. Dehydrated Foods, Chemistry of Browning Reactions in Model Systems. 
Journal of Agricultural and Food Chemistry 1953, 1, 928–943.  
[62] Mitsuda, H. , Yasumoto, K. , and Yokoyama, K. Studies on the Free Radical in Amino-
Carbonyl Reaction. Agricultural and Biological Chemistry 1965, 29, 751–756.  
[63] Namiki, M. , Hayashi, T. , and Kawakishi, S. Free Radicals Developed in the Amino-
Garbonyl Reaction of Sugars with Amino Acids. Agricultural and Biological Chemistry 1973, 
37, 2935–2936.  
[64] Namiki, M. and Hayashi, T. Formation of novel free radical products in an early stage of 
Maillard reaction. Progress in food and nutrition science 1981, 5, 81–91.  
[65] Slatter, D. A. , Avery, N. C. , and Bailey, A. J. Identification of a New Cross-link and 
Unique Histidine Adduct from Bovine Serum Albumin Incubated with Malondialdehyde. 
Journal of Biological Chemistry 2004, 279, 61–69.  
[66] Kita, K. , Kawashima, Y. , Makino, R. , Namauo, T. , Ogawa, S. , Muraoka, H. , and 
Fujimura, S. Detection of Two Types of Glycated Tryptophan Compounds in the Plasma of 
Chickens Fed Tryptophan Excess Diets. The Journal of Poultry Science 2013, 50, 138–142.  
[67] Thorpe, S. R. and Baynes, J. W. Maillard reaction products in tissue proteins: New 
products and new perspectives. Amino Acids 2003, 25, 275–281.  
[68] Mostafa, A. A. , Randell, E. W. , Vasdev, S. C. , Gill, V. D. , Han, Y. , Gadag, V. , Raouf, 
A. A. , and Said, H. El Plasma protein advanced glycation end products, carboxymethyl 
cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with 
diabetes. Molecular and Cellular Biochemistry 2007, 302, 35–42.  
 191 
[69] Nursten, H. E. The Maillard Reaction: Chemistry, Biochemistry and Implications. Royal 
Society of Chemistry: Cambridge 2005. 
[70] Odani, H. , Shinzato, T. , Matsumoto, Y. , Usami, J. , and Maeda, K. Increase in three 
alpha,beta-Dicarbonyl Compound Levels in Human Uremic Plasma: Specific in vivo 
determination of intermediates in advanced maillard reaction. Biochemical and Biophysical 
Research Communications 1999, 93, 89–93.  
[71] Paul, R. G. and Bailey, A. J. The effect of advanced glycation end-product formation upon 
cell-matrix interactions. International Journal of Biochemistry and Cell Biology 1999, 31, 
653–660.  
[72] Reigle, K. L. , Lullo, G. Di , Turner, K. R. , Last, J. A. , Chervoneva, I. , Birk, D. E. , 
Funderburgh, J. L. , Elrod, E. , Germann, M. W. , Surber, C. , Sanderson, R. D. , and San 
Antonio, J. D. Non-enzymatic glycation of type I collagen diminishes collagen-proteoglycan 
binding and weakens cell adhesion. Journal of Cellular Biochemistry 2008, 104, 1684–1698.  
[73] Hudson, D. M. , Archer, M. , King, K. B. , and Eyre, D. R. Glycation of type I collagen 
selectively targets the same helical domain lysine sites as lysyl oxidase–mediated cross-linking. 
Journal of Biological Chemistry 2018, 293, 15620–15627.  
[74] Avery, N. C. and Bailey, A. J. The effects of the Maillard reaction on the physical 
properties and cell interactions of collagen. Pathologie Biologie 2006, 54, 387–395.  
[75] Winlove, C. P. , Parker, K. H. , Avery, N. C. , and Bailey, A. J. Interactions of elastin and 
aorta with sugars in vitro and their effects on biochemical and physical properties. Diabetologia 
1996, 39, 1131–1139.  
[76] Li, Y. , Fessel, G. , Georgiadis, M. , and Snedeker, J. G. Advanced glycation end-products 
diminish tendon collagen fiber sliding. Matrix Biology 2013, 32, 169–177.  
[77] Dunn, J. A. , Patrick, J. S. , Thorpe, S. R. , and Baynes, J. W. Oxidation of glycated 
proteins: age-dependent accumulation of N.epsilon.-(carboxymethyl)lysine in lens proteins. 
Biochemistry 1989, 28, 9464–9468.  
[78] Dunn, J. A. , McCance, D. R. , Thorpe, S. R. , Lyons, T. J. , and Baynes, J. W. Age-
dependent accumulation of N.epsilon.-(carboxymethyl)lysine and N.epsilon.-
(carboxymethyl)hydroxylysine in human skin collagen. Biochemistry 1991, 30, 1205–1210.  
[79] Ahmedsq, M. U. , Thorpes, S. R. , and Baynesst, J. W. Identification of W-
Carboxymethyllysine as a Degradation Product of Fructoselysine in Glycated Protein. 1986, 
261, 4889–4894.  
[80] Sell, D. R. and Monnier, V. M. Structure elucidation of a senescence cross-link from 
human extracellular matrix. Implication of pentoses in the aging process. The Journal of 
 192 
biological chemistry 1989, 264, 21597–21602.  
[81] Sell, D. R. , Biemel, K. M. , Reihl, O. , Lederer, M. O. , Strauch, C. M. , and Monnier, V. 
M. Glucosepane Is a Major Protein Cross-link of the Senescent Human Extracellular Matrix. 
Journal of Biological Chemistry 2005, 280, 12310–12315.  
[82] Monnier, V. M. , Kohn, R. R. , and Cerami, A. Accelerated age-related browning of human 
collagen in diabetes mellitus. Proceedings of the National Academy of Sciences 1984, 81, 583–
587.  
[83] Hamlin, C. R. , Kohn, R. R. , and Luschin, J. H. Apparent Accelerated Aging of Human 
Collagen in Diabetes Mellitus. Diabetes 1975, 24, 902–904.  
[84] Fan, X. , Sell, D. R. , Zhang, J. , Nemet, I. , Theves, M. , Lu, J. , Strauch, C. , Halushka, 
M. K. , and Monnier, V. M. Anaerobic vs aerobic pathways of carbonyl and oxidant stress in 
human lens and skin during aging and in diabetes: A comparative analysis. Free Radical 
Biology and Medicine 2010, 49, 847–856.  
[85] Sugiyama, S. , Miyata, T. , Horie, K. , Iida, Y. , Tsuyuki, M. , Tanaka, H. , and Maeda, K. 
Advanced glycation end-products in diabetic nephropathy. Nephrology Dialysis 
Transplantation 1996, 11, 91–94.  
[86] Tanji, N. , Markowitz, G. S. , Fu, C. , Kislinger, T. , Taguchi, A. , Pischetsrieder, M. , 
Stern, D. , Schmidt, A. M. , and D’Agati, V. D. Expression of advanced glycation end products 
and their cellular receptor RAGE diabetic nephropathy and nondiabetic renal disease. Journal 
of the American Society of Nephrology 2000, 11, 1656–1666.  
[87] Zhu, Y. , Shu, T. , Lin, Y. , Wang, H. , Yang, J. , Shi, Y. , and Han, X. Inhibition of the 
receptor for advanced glycation endproducts (RAGE) protects pancreatic β-cells. Biochemical 
and Biophysical Research Communications 2011, 404, 159–165.  
[88] Schalkwijk, C. G. , Stehouwer, C. D. A. , and Hinsbergh, V. W. M. van Fructose-mediated 
non-enzymatic glycation: Sweet coupling or bad modification. Diabetes/Metabolism Research 
and Reviews 2004, 20, 369–382.  
[89] Hotta, N. , Kakuta, H. , Fukasawa, H. , Kimura, M. , Koh, N. , Iida, M. , Terashima, H. , 
Morimura, T. , and Sakamoto, N. Effects of a fructose-rich diet and the aldose reductase 
inhibitor, ONO-2235, on the development of diabetic neuropathy in streptozotocin-treated rats. 
Diabetologia 1985, 28, 176–180.  
[90] Schröter, D. and Höhn, A. Role of Advanced Glycation End Products in Carcinogenesis 
and their Therapeutic Implications. Current Pharmaceutical Design 2019, 24, 5245–5251.  
[91] Cairns, R. A. , Harris, I. S. , and Mak, T. W. Regulation of cancer cell metabolism. Nature 
Reviews Cancer 2011, 11, 85–95.  
 193 
[92] Riehl, A. , Németh, J. , Angel, P. , and Hess, J. The receptor RAGE: Bridging 
inflammation and cancer. Cell Communication and Signaling 2009, 7, 1–7.  
[93] Atsumi, T. Diabetes and risk of cancer. Diabetology International 2015, 6, 190–192.  
[94] Rojas, A. , Añazco, C. , González, I. , and Araya, P. Extracellular matrix glycation and 
receptor for advanced glycation end-products activation: a missing piece in the puzzle of the 
association between diabetes and cancer. Carcinogenesis 2018, 39, 515–521.  
[95] Shlomai, G. , Neel, B. , LeRoith, D. , and Gallagher, E. J. Type 2 Diabetes Mellitus and 
Cancer: The Role of Pharmacotherapy. Journal of Clinical Oncology 2016, 34, 4261–4269.  
[96] Rahbar, S. , Blumenfeld, O. , and Ranney, H. M. Studies of an unusual hemoglobin in 
patients with diabetes mellitus. Biochemical and Biophysical Research Communications 1969, 
36, 838–843.  
[97] Monnier, V. M. , Sun, W. , Sell, D. R. , Fan, X. , Nemet, I. , and Genuth, S. Glucosepane: 
a poorly understood advanced glycation end product of growing importance for diabetes and 
its complications. Clinical Chemistry and Laboratory Medicine 2014, 52 
[98] THORNALLEY, P. J. , BATTAH, S. , AHMED, N. , KARACHALIAS, N. , AGALOU, 
S. , BABAEI-JADIDI, R. , and DAWNAY, A. Quantitative screening of advanced glycation 
endproducts in cellular and extracellular proteins by tandem mass spectrometry. Biochemical 
Journal 2003, 375, 581–592.  
[99] Miyata, S. and Monnier, V. Immunohistochemical detection of advanced glycosylation 
end products in diabetic tissues using monoclonal antibody to pyrraline. Journal of Clinical 
Investigation 1992, 89, 1102–1112.  
[100] Nagai, R. , Hayashi, C. M. , Xia, L. , Takeya, M. , and Horiuchi, S. Identification in 
human atherosclerotic lesions of GA-pyridine, a novel structure derived from glycolaldehyde-
modified proteins. Journal of Biological Chemistry 2002, 277, 48905–48912.  
[101] Oya, T. , Hattori, N. , Mizuno, Y. , Miyata, S. , Maeda, S. , Osawa, T. , and Uchida, K. 
Methylglyoxal Modification of Protein. Journal of Biological Chemistry 1999, 274, 18492–
18502.  
[102] Eupen, M. G. A. van , Schram, M. T. , Colhoun, H. M. , Hanssen, N. M. J. , Niessen, H. 
W. M. , Tarnow, L. , Parving, H. H. , Rossing, P. , Stehouwer, C. D. A. , and Schalkwijk, C. 
G. The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals 
with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1. 
Diabetologia 2013, 56, 1845–1855.  
[103] Mostafa, A. A. , Randell, E. W. , Vasdev, S. C. , Gill, V. D. , Han, Y. , Gadag, V. , Raouf, 
A. A. , and Said, H. El Plasma protein advanced glycation end products, carboxymethyl 
 194 
cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with 
diabetes. Molecular and Cellular Biochemistry 2007, 302, 35–42.  
[104] Naudí, A. , Jové, M. , Cacabelos, D. , Ayala, V. , Cabre, R. , Caro, P. , Gomez, J. , 
Portero-Otín, M. , Barja, G. , and Pamplona, R. Formation of S-(carboxymethyl)-cysteine in 
rat liver mitochondrial proteins: effects of caloric and methionine restriction. Amino Acids 2013, 
44, 361–371.  
[105] D.R., S. , R.H., N. , S.K., G. , P., O. , A., L. , and J., F. Pentosidine: A molecular marker 
for cumulative damage to proteins in diabetes, aging, and uremia. Diabetes/Metabolism 
Reviews 1991, 7, 239–251.  
[106] Frye, E. B. , Degenhardt, T. P. , Thorpe, S. R. , and Baynes, J. W. Role of the Maillard 
Reaction in Aging of Tissue Proteins. Journal of Biological Chemistry 1998, 273, 18714–
18719.  
[107] Cheng, R. , Feng, Q. , Argirov, O. K. , and Ortwerth, B. J. Structure elucidation of a 
novel yellow chromophore from human lens protein. Journal of Biological Chemistry 2004, 
279, 45441–45449.  
[108] Iijima, K. , Murata, M. , Takahara, H. , Irie, S. , and Fujimoto, D. Identification of N-
carboxymethylarginine as a novel acid labile advanced glycation end product in collagen. 
Biochem. J. 2000, 347, 23–27.  
[109] Biemel, K. M. , Reihl, O. , Conrad, J. , and Lederer, M. O. Formation pathways for 
lysine-arginine cross-links derived from hexoses and pentoses by maillard processes: 
Unraveling the structure of a pentosidine precursor. Journal of Biological Chemistry 2001, 276, 
23405–23412.  
[110] Lederer, M. O. and Bühler, H. P. Cross-linking of proteins by maillard processes - 
Characterization and detection of a lysine-arginine cross-link derived from D-glucose. 
Bioorganic and Medicinal Chemistry 1999, 7, 1081–1088.  
[111] TESSIER, F. J. , MONNIER, V. M. , SAYRE, L. M. , and KORNFIELD, J. A. 
Triosidines: novel Maillard reaction products and cross-links from the reaction of triose sugars 
with lysine and arginine residues. Biochemical Journal 2003, 369, 705–719.  
[112] Nakamura, K. , Nakazawa, Y. , and Ienaga, K. Acid-stable fluorescent advanced 
glycation end products: Vesperlysines A, B, and C are formed as crosslinked products in the 
maillard reaction between lysine or proteins with glucose. Biochemical and Biophysical 
Research Communications 1997, 232, 227–230.  
[113] Skovsted, I. C.; Christensen, M.; and Mortensen, S. B. Characterisation of a Novel AGE-
Epitope Derived from Lysine and 3-Deoxyglucosone. In The Maillard Reaction in Foods and 
 195 
Medicine; Elsevier, 2005; p. 444. 
[114] Glomb, M. A. and Pfahler, C. Amides are novel protein modifications formed by 
physiological sugars. International Congress Series 2002, 1245, 501–502.  
[115] Nemet, I. , Strauch, C. M. , and Monnier, V. M. Favored and disfavored pathways of 
protein crosslinking by glucose: glucose lysine dimer (GLUCOLD) and crossline versus 
glucosepane. Amino Acids 2011, 40, 167–181.  
[116] Thornalley, P. J. Measurement of Protein Glycation, Glycated Peptides and Glycation 
Free Adducts. Peritoneal Dialysis International 2005, 25, 522–533.  
[117] Lapolla, A. , Traldi, P. , and Fedele, D. Importance of measuring products of non-
enzymatic glycation of proteins. Clinical Biochemistry 2005, 38, 103–115.  
[118] Thornalley, P. J. and Rabbani, N. Detection of oxidized and glycated proteins in clinical 
samples using mass spectrometry — A user’s perspective. Biochimica et Biophysica Acta (BBA) 
- General Subjects 2014, 1840, 818–829.  
[119] Ashraf, J. M. , Ahmad, S. , Choi, I. , Ahmad, N. , Farhan, M. , Tatyana, G. , and Shahab, 
U. Recent advances in detection of AGEs: Immunochemical, bioanalytical and biochemical 
approaches. IUBMB Life 2015, 67, 897–913.  
[120] Chow, W. Y. , Rajan, R. , Muller, K. H. , Reid, D. G. , Skepper, J. N. , Wong, W. C. , 
Brooks, R. A. , Green, M. , Bihan, D. , Farndale, R. W. , Slatter, D. A. , Shanahan, C. M. , and 
Duer, M. J. NMR Spectroscopy of Native and in Vitro Tissues Implicates PolyADP Ribose in 
Biomineralization. Science 2014, 344, 742–746.  
[121] Bunn, H. F. and Higgins, P. J. Reaction of monosaccharides with proteins: Possible 
evolutionary significance. Science 1981, 213, 222–224.  
[122] Keeler, J. H. Understanding NMR spectroscopy. John Wiley & Sons.: Chichester 2005. 
[123] Duer, M. J. Introduction to Solid-State NMR Spectroscopy. Wiley-Blackwell: Oxford 
2004. 
[124] Apperley, D. C.; Harris, R. K.; and Hodgkinson, P. Solid-State NMR : basic principles 
& practice. Momentum: New York 2012. 
[125] Bennett, A. E. , Rienstra, C. M. , Auger, M. , Lakshmi, K. V. , and Griffin, R. G. 
Heteronuclear decoupling in rotating solids. The Journal of Chemical Physics 1995, 103, 
6951–6958.  
[126] Fung, B. M. , Khitrin, A. K. , and Ermolaev, K. An Improved Broadband Decoupling 
Sequence for Liquid Crystals and Solids. Journal of Magnetic Resonance 2000, 142, 97–101.  
[127] Hartmann, S. R. and Hahn, E. L. Nuclear Double Resonance in the Rotating Frame. 
Physical Review 1962, 128, 2042–2053.  
 196 
[128] G, M., X, W., and O, S.S. Ramped-Amplitude Cross Polarization in Magic-Angle-
Spinning NMR. Journal of Magnetic Resonance Series A. , 110, 219–227. (1994).  
[129] Carver, T. R. and Slichter, C. P. Polarization of Nuclear Spins in Metals. Physical Review 
1953, 92, 212–213.  
[130] Overhauser, A. W. Polarization of Nuclei in Metals. Physical Review 1953, 92, 411–415.  
[131] Sauvée, C. , Rosay, M. , Casano, G. , Aussenac, F. , Weber, R. T. , Ouari, O. , and Tordo, 
P. Highly Efficient, Water-Soluble Polarizing Agents for Dynamic Nuclear Polarization at 
High Frequency. Angewandte Chemie International Edition 2013, 52, 10858–10861.  
[132] Szeverenyi, N. M. , Sullivan, M. J. , and Maciel, G. E. Observation of spin exchange by 
two-dimensional fourier transform 13C cross polarization-magic-angle spinning. Journal of 
Magnetic Resonance (1969) 1982, 47, 462–475.  
[133] Takegoshi, K. , Nakamura, S. , and Terao, T. 13C–1H dipolar-assisted rotational 
resonance in magic-angle spinning NMR. Chemical Physics Letters 2001, 344, 631–637.  
[134] Foerster, H., Struppe, J., Steuernagel, S., Aussenacc, F., Benevelli, F., Gierth, P., and 
Wegner, S. Solid State NMR AVANCE Solids User Manual. (2009).  
[135] Chow, W. Y. A Solid-State NMR Toolkit for Probing Collagen Atomic Structure in the 
Extracellular Matrix,  2013.  
[136] Wong, W. C. Elucidating Glycation-Induced Structural Changes in Collagen by Solid-
State NMR,  2016.  
[137] Lee, Y. . , Kurur, N. . , Helmle, M. , Johannessen, O. . , Nielsen, N. . , and Levitt, M. . 
Efficient dipolar recoupling in the NMR of rotating solids. A sevenfold symmetric 
radiofrequency pulse sequence. Chemical Physics Letters 1995, 242, 304–309.  
[138] Hohwy, M. , Jakobsen, H. J. , Edén, M. , Levitt, M. H. , and Nielsen, N. C. Broadband 
dipolar recoupling in the nuclear magnetic resonance of rotating solids: A compensated C7 
pulse sequence. Journal of Chemical Physics 1998, 108, 2686–2694.  
[139] Hohwy, M. , Rienstra, C. M. , Jaroniec, C. P. , and Griffin, R. G. Fivefold symmetric 
homonuclear dipolar recoupling in rotating solids: Application to double quantum 
spectroscopy. Journal of Chemical Physics 1999, 110, 7983–7992.  
[140] Hong, M. Solid-State Dipolar INADEQUATE NMR Spectroscopy with a Large Double-
Quantum Spectral Width. Journal of Magnetic Resonance 1999, 136, 86–91.  
[141] Rossum, B.-J. van , Förster, H. , and Groot, H. J. M. de High-Field and High-Speed CP-
MAS13C NMR Heteronuclear Dipolar-Correlation Spectroscopy of Solids with Frequency-
Switched Lee–Goldburg Homonuclear Decoupling. Journal of Magnetic Resonance 1997, 124, 
516–519.  
 197 
[142] Bielecki, A. , Kolbert, A. C. , and Levitt, M. H. Frequency-switched pulse sequences: 
Homonuclear decoupling and dilute spin NMR in solids. Chemical Physics Letters 1989, 155, 
341–346.  
[143] Schaefer, J. , McKay, R. A. , and Stejskal, E. O. Double-cross-polarization NMR of 
solids. Journal of Magnetic Resonance (1969) 1979, 34, 443–447.  
[144] Baldus, M. , Petkova, A. T. , Herzfeld, J. , and Griffin, R. G. Cross polarization in the 
tilted frame: Assignment and spectral simplification in heteronuclear spin systems. Molecular 
Physics 1998, 95, 1197–1207.  
[145] Knight, C. G. , Morton, L. F. , Onley, D. J. , Peachey, A. R. , Messent, A. J. , Smethurst, 
P. A. , Tuckwell, D. S. , Farndale, R. W. , and Barnes, M. J. Identification in Collagen Type I 
of an Integrin α 2 β 1 -binding Site Containing an Essential GER Sequence. Journal of 
Biological Chemistry 1998, 273, 33287–33294.  
[146] Lee, M. and Goldburg, W. I. Nuclear-magnetic-resonance line narrowing by a rotating 
rf field. Physical Review 1965, 140 
[147] Han, J. , Tschernutter, V. , Yang, J. , Eckle, T. , and Borchers, C. H. Analysis of Selected 
Sugars and Sugar Phosphates in Mouse Heart Tissue by Reductive Amination and Liquid 
Chromatography-Electrospray Ionization Mass Spectrometry. Analytical Chemistry 2013, 85, 
5965–5973.  
[148] Burrell, M. M. Enzymes of Molecular Biology. Humana Press: New Jersey 1993. 
[149] Mótyán, J. , Tóth, F. , and Tőzsér, J. Research Applications of Proteolytic Enzymes in 
Molecular Biology. Biomolecules 2013, 3, 923–942.  
[150] Hess, G. P. , McConn, J. , Ku, E. , and McConkey, G. Studies of the activity of 
chymotrypsin. Philosophical transactions of the Royal Society of London. Series B, Biological 
sciences 1970, 257, 89–104.  
[151] Appel, W. Chymotrypsin: Molecular and catalytic properties. Clinical Biochemistry 
1986, 19, 317–322.  
[152] Burrell, M. M. Enzymes of Molecular Biology. Humana Press: New Jersey 1993. 
[153] UniProt. https://www.uniprot.org  
[154] Gilbert, T. W. , Sellaro, T. L. , and Badylak, S. F. Decellularization of tissues and organs. 
Biomaterials 2006, 27, 3675–3683.  
[155] Crapo, P. M. , Gilbert, T. W. , and Badylak, S. F. An overview of tissue and whole organ 
decellularization processes. Biomaterials 2011, 32, 3233–3243.  
[156] Principles of Fluorescence Spectroscopy. Springer US: Boston, MA 2006. 
[157] Weert, M. van de and Stella, L. Fluorescence quenching and ligand binding: A critical 
 198 
discussion of a popular methodology. Journal of Molecular Structure 2011, 998, 144–150.  
[158] Royer, C. A. Probing Protein Folding and Conformational Transitions with Fluorescence. 
Chemical Reviews 2006, 106, 1769–1784.  
[159] Pundak, S. and Roche, R. S. Tyrosine and tyrosinate fluorescence of bovine testes 
calmodulin: calcium and pH dependence. Biochemistry 1984, 23, 1549–1555.  
[160] Vivian, J. T. and Callis, P. R. Mechanisms of Tryptophan Fluorescence Shifts in Proteins. 
Biophysical Journal 2001, 80, 2093–2109.  
[161] Johnson, M. Detergents: Triton X-100, Tween-20, and More. Materials and Methods 
2013, 3 
[162] Fritzsching, K. J. , Yang, Y. , Schmidt-Rohr, K. , and Hong, M. Practical use of chemical 
shift databases for protein solid-state NMR: 2D chemical shift maps and amino-acid 
assignment with secondary-structure information. Journal of Biomolecular NMR 2013, 56, 
155–167.  
[163] Bullock, P. T. B. , Reid, D. G. , Chow, W. Y. , Lau, W. P. W. , and Duer, M. J. A new 
glycation product “norpronyl-lysine” and direct characterization of cross linking and other 
glycation adducts: NMR of model compounds and collagen. Bioscience reports 2014 
[164] Management of Diabetes and Hyperglycemia in Hospitalized Patients. 
https://www.ncbi.nlm.nih.gov/books/NBK279093/  
[165] Swamy, M. S. , Tsai, C. , Abraham, A. , and Abraham, E. C. Glycation Mediated Lens 
Crystallin Aggregation and Cross-linking by Various Sugars and Sugar Phosphates In Vitro. 
Experimental Eye Research 1993, 56, 177–185.  
[166] Bubb, W. A. NMR spectroscopy in the study of carbohydrates: Characterizing the 
structural complexity. Concepts in Magnetic Resonance 2003, 19A, 1–19.  
[167] Bailey, A. J. , Sims, T. J. , Avery, N. C. , and Halligan, E. P. Non-enzymic glycation of 
fibrous collagen: reaction products of glucose and ribose. Biochemical Journal 1995, 305, 385–
390.  
[168] Clark, P. M. , Flores, G. , Evdokimov, N. M. , McCracken, M. N. , Chai, T. , Nair-Gill, 
E. , O’Mahony, F. , Beaven, S. W. , Faull, K. F. , Phelps, M. E. , Jung, M. E. , and Witte, O. 
N. Positron emission tomography probe demonstrates a striking concentration of ribose salvage 
in the liver. Proceedings of the National Academy of Sciences 2014, 111, E2866–E2874.  
[169] Munanairi, A. , O’Banion, S. K. , Gamble, R. , Breuer, E. , Harris, A. W. , and Sandwick, 
R. K. The multiple Maillard reactions of ribose and deoxyribose sugars and sugar phosphates. 
Carbohydrate Research 2007, 342, 2575–2592.  
[170] Drew, K. N. , Zajicek, J. , Bondo, G. , Bose, B. , and Serianni, A. S. 13C-labeled 
 199 
aldopentoses: detection and quantitation of cyclic and acyclic forms by heteronuclear 1D and 
2D NMR spectroscopy. Carbohydrate Research 1998, 307, 199–209.  
[171] Slatter, D. A. , Avery, N. C. , and Bailey, A. J. Collagen in its fibrillar state is protected 
from glycation. The International Journal of Biochemistry & Cell Biology 2008, 40, 2253–
2263.  
[172] Chow, W. Y. , Li, R. , Goldberga, I. , Reid, D. G. , Rajan, R. , Clark, J. , Oschkinat, H. , 
Duer, M. J. , Hayward, R. , and Shanahan, C. M. Essential but sparse collagen hydroxylysyl 
post-translational modifications detected by DNP NMR. Chemical Communications 2018, 54, 
12570–12573.  
[173] Delatour, T. , Fenaille, F. , Parisod, V. , Arce Vera, F. , and Buetler, T. Synthesis, tandem 
MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced 
glycation endproduct, 6-N-carboxymethyllysine. Amino Acids 2006, 30, 25–34.  
[174] Goldberga, I. , Li, R. , Chow, W. Y. , Reid, D. G. , Bashtanova, U. , Rajan, R. , Puszkarska, 
A. , Oschkinat, H. , and Duer, M. J. Detection of nucleic acids and other low abundance 
components in native bone and osteosarcoma extracellular matrix by isotope enrichment and 
DNP-enhanced NMR. RSC Advances 2019, 9, 26686–26690.  
[175] Chow, W. Y. , Bihan, D. , Forman, C. J. , Slatter, D. a. , Reid, D. G. , Wales, D. J. , 
Farndale, R. W. , and Duer, M. J. Hydroxyproline Ring Pucker Causes Frustration of Helix 
Parameters in the Collagen Triple Helix. Scientific Reports 2015, 5, 12556.  
[176] Chow, W. Y. , Forman, C. J. , Bihan, D. , Puszkarska, A. M. , Rajan, R. , Reid, D. G. , 
Slatter, D. A. , Colwell, L. J. , Wales, D. J. , Farndale, R. W. , and Duer, M. J. Proline provides 
site-specific flexibility for in vivo collagen. Scientific Reports 2018, 8, 1–13.  
[177] Chung, S. S. M. Contribution of Polyol Pathway to Diabetes-Induced Oxidative Stress. 
Journal of the American Society of Nephrology 2003, 14, 233S – 236.  
[178] Nagai, R. , Hayashi, C. M. , Xia, L. , Takeya, M. , and Horiuchi, S. Identification in 
Human Atherosclerotic Lesions of GA-pyridine, a Novel Structure Derived from 
Glycolaldehyde-modified Proteins. Journal of Biological Chemistry 2002, 277, 48905–48912.  
[179] Cheng, R. , Feng, Q. , Argirov, O. K. , and Ortwerth, B. J. Structure Elucidation of a 
Novel Yellow Chromophore from Human Lens Protein. Journal of Biological Chemistry 2004, 
279, 45441–45449.  
[180] Nakamura, K. , Nakazawa, Y. , and Ienaga, K. Acid-Stable Fluorescent Advanced 
Glycation End Products: Vesperlysines A, B, and C Are Formed as Crosslinked Products in 
the Maillard Reaction between Lysine or Proteins with Glucose. Biochemical and Biophysical 
Research Communications 1997, 232, 227–230.  
 200 
[181] Nakamura, K. , Hasegawa, T. , Fukunaga, Y. , and Ienaga, K. Crosslines A and B as 
candidates for the fluorophores in age- and diabetes-related cross-linked proteins, and their 
diacetates produced by Maillard reaction of α-N-acetyl- <scp>L</scp> -lysine with 
<scp>D</scp> -glucose. J. Chem. Soc., Chem. Commun. 1992, 992–994.  
[182] Shipanova, I. N. , Glomb, M. A. , and Nagaraj, R. H. Protein Modification by 
Methylglyoxal: Chemical Nature and Synthetic Mechanism of a Major Fluorescent Adduct. 
Archives of Biochemistry and Biophysics 1997, 344, 29–36.  
[183] Sapcariu, S. C. , Kanashova, T. , Weindl, D. , Ghelfi, J. , Dittmar, G. , and Hiller, K. 
Simultaneous extraction of proteins and metabolites from cells in culture. MethodsX 2014, 1, 
74–80.  
[184] McHugh, C. , Flott, T. , Schooff, C. , Smiley, Z. , Puskarich, M. , Myers, D. , Younger, 
J. , Jones, A. , and Stringer, K. Rapid, Reproducible, Quantifiable NMR Metabolomics: 
Methanol and Methanol: Chloroform Precipitation for Removal of Macromolecules in Serum 
and Whole Blood. Metabolites 2018, 8, 93.  
[185] Delatour, T. , Fenaille, F. , Parisod, V. , Arce Vera, F. , and Buetler, T. Synthesis, tandem 
MS- and NMR-based characterization, and quantification of the carbon 13-labeled advanced 
glycation endproduct, 6-N-carboxymethyllysine. Amino Acids 2006, 30, 25–34.  
[186] Thompson, J. and Miller, S. N6-(1-carboxyethyl)lysine formation by Streptococcus lactis. 
Purification, synthesis, and stereochemical structure. Journal of Biological Chemistry 1988, 
263, 2064–2069.  
[187] Bailey, R. G. , Ames, J. M. , and Mann, J. Identification of new heterocyclic nitrogen 
compounds from glucose-lysine and xylose-lysine Maillard model systems. Journal of 
Agricultural and Food Chemistry 2000, 48, 6240–6246.  
[188] Ahmed, N. , Argirov, O. K. , Minhas, H. S. , Cordeiro, C. A. A. , and Thornalley, P. J. 
Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay 
with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to 
Nε-carboxymethyl-lysine-and Nε-(1-carboxyethyl) lysine-modified albumin. Biochem. J. 
2002, 14, 1–14.  
[189] Nagaraj, R. H. , Shipanova, I. N. , and Faust, F. M. Protein Cross-linking by the Maillard 
Reaction. Journal of Biological Chemistry 1996, 271, 19338–19345.  
 
